var title_f16_7_16496="Larynx PI";
var content_f16_7_16496=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F83209&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F83209&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 505px\">",
"   <div class=\"ttl\">",
"    Larynx (voice box)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 485px; height: 613px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <p>",
"     The larynx (voice box) is the top part of the windpipe. The larynx has the vocal cords in it, which are small structures that let people speak. The muscles that control the vocal cords in the voice box are called the &ldquo;laryngeal muscles.&rdquo;",
"    </p>",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_7_16496=[""].join("\n");
var outline_f16_7_16496=null;
var title_f16_7_16497="Pulmonary hamartoma gross";
var content_f16_7_16497=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F61914&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F61914&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pulmonary hamartoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 340px; height: 266px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Photograph of a pulmonary hamartoma shows a well circumscribed mass with a variegated yellow and white appearance, which corresponds to fat and cartilage respectively.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     From Colby, TV, Koss, MN, Travis, WD. Tumors of the Lower Respiratory Tract. Armed Forces Institute of Pathology, Washington, DC.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_7_16497=[""].join("\n");
var outline_f16_7_16497=null;
var title_f16_7_16498="Surgical treatment of acute paronychia";
var content_f16_7_16498=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F57429&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F57429&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 580px\">",
"   <div class=\"ttl\">",
"    Surgical treatment of acute paronychia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 560px; height: 399px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Surgical drainage is indicated for patients with acute paronychia who present late and have an abscess cavity. The drawings illustrate the appropriate drainage procedure.",
"    <br>",
"     (Left) Pre-operative appearance.",
"     <br>",
"      (Center) Elevation and excision of lateral third of nail.",
"      <br>",
"       (Right) Incision of perionychial fold with the blade directed away from the nail bed and matrix.",
"       <div class=\"footnotes\">",
"       </div>",
"       <div class=\"reference\">",
"       </div>",
"      </br>",
"     </br>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_7_16498=[""].join("\n");
var outline_f16_7_16498=null;
var title_f16_7_16499="T1 oral tongue SCC";
var content_f16_7_16499=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F57360&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F57360&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Stage T1 oral tongue squamous cell carcinoma (SCC)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 319px; height: 396px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Neil D Gross, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_7_16499=[""].join("\n");
var outline_f16_7_16499=null;
var title_f16_7_16500="Assessment by lens vessels";
var content_f16_7_16500=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F79958&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F79958&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Anterior lens vessels",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 488px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Assessment of gestational age by examination of anterior vascular capsule of the lens.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Hittner, HM, Hirsch, NJ, Rudolph AJ. J Pediatr 1977; 91:455. Copyright &copy; 1977 Mosby, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_7_16500=[""].join("\n");
var outline_f16_7_16500=null;
var title_f16_7_16501="Quinapril and hydrochlorothiazide: Patient drug information";
var content_f16_7_16501=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Quinapril and hydrochlorothiazide: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?26/19/26935?source=see_link\">",
"     see \"Quinapril and hydrochlorothiazide: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F216431\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Accuretic&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F216432\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Accuretic&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10019902\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700281",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take if you are pregnant. Use during pregnancy may cause birth defects or loss of the unborn baby. If you get pregnant or plan on getting pregnant while taking this drug, call your doctor right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10019904\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691888",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat high blood pressure.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10019903\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702838",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to quinapril, hydrochlorothiazide, or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701385",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a sulfa (sulfonamide) allergy, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3915366",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes) and are taking aliskiren.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are not able to pass urine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10019908\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697780",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wear disease medical alert ID (identification).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696820",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not run out of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698421",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood pressure checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698463",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696833",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take antacids within 2 hours of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697207",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes), this drug may sometimes raise blood sugar. Talk with your doctor about how to fine tune this.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697111",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are taking this drug and have high blood pressure, talk with your doctor before using OTC products that may raise blood pressure. These include cough or cold drugs, diet pills, stimulants, ibuprofen or like products, and some natural products or aids.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696701",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Be careful in hot weather. Drink lots of fluids to stop fluid loss.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697794",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may get sunburned more easily. Avoid sun, sunlamps, bright indoor lights, and tanning beds. Wear clothing and eyewear that protects you from the sun. Sunscreens will not protect you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697740",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use birth control that you can trust to stop pregnancy while taking this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10019909\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697983",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Cough.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10019911\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699077",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of infection. These include a fever of 100.5&deg;F (38&deg;C) or higher, chills, very bad sore throat, ear or sinus pain, cough, more sputum or change in color of sputum, pain with passing urine, mouth sores, wound that will not heal, or anal itching or pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698650",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you have too much sweat, fluid loss, throwing up, or loose stools. This may lead to low blood pressure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Cough that does not go away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698634",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dark urine or yellow skin or eyes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699086",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sudden change in eyesight, eye pain, or irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10019906\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695786",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take as you have been told, even if you feel well.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695852",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take this drug at the same time of day.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695872",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may cause you to pass urine more often. To keep from having sleep problems, try to take before 6 pm.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694865",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Follow the diet and workout plan that your doctor told you about.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10019907\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10019912\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10019913\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11012 Version 36.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-203.80.222.8-5CA963D2D9-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_7_16501=[""].join("\n");
var outline_f16_7_16501=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F216431\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F216432\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019902\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019904\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019903\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019908\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019909\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019911\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019906\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019907\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019912\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019913\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?26/19/26935?source=related_link\">",
"      Quinapril and hydrochlorothiazide: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f16_7_16502="Instant glucose and intravenous dextrose: Pediatric drug information";
var content_f16_7_16502=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"0\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Instant glucose and intravenous dextrose: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"UTD.htm?13/40/13958?source=see_link\">",
"    see \"Instant glucose and intravenous dextrose: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?15/45/16084?source=see_link\">",
"    see \"Instant glucose and intravenous dextrose: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F158911\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      BD&trade; Glucose [OTC];",
"     </li>",
"     <li>",
"      Dex4&reg; [OTC];",
"     </li>",
"     <li>",
"      Enfamil&reg; Glucose [OTC];",
"     </li>",
"     <li>",
"      GlucoBurst&reg; [OTC];",
"     </li>",
"     <li>",
"      Glutol&trade; [OTC];",
"     </li>",
"     <li>",
"      Glutose 15&trade; [OTC];",
"     </li>",
"     <li>",
"      Glutose 45&trade; [OTC];",
"     </li>",
"     <li>",
"      Insta-Glucose&reg; [OTC];",
"     </li>",
"     <li>",
"      Similac&reg; Glucose [OTC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1058953\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antidote, Insulin",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antidote, Oral Hypoglycemic",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Fluid Replacement, Enteral",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Fluid Replacement, Parenteral",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Hyperglycemic Agent",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Hyperkalemia, Adjunctive Treatment Agent",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Intravenous Nutritional Therapy",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block don drugH1Div\" id=\"F11442285\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Neonatal",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Hypoglycemia: Note:",
"     </b>",
"     Doses may be repeated in severe cases:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Age-directed dosing:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     GA &lt;34 weeks: I.V.: 0.1-0.2 g/kg/dose (1-2 mL/kg/dose of D",
"     <sub>",
"      10",
"     </sub>",
"     W); followed by continuous I.V. infusion at a rate of 4-6",
"     <b>",
"      mg",
"     </b>",
"     /kg/minute",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     GA &ge;34 weeks: I.V.: 0.2 g/kg/dose (2 mL/kg/dose of D",
"     <sub>",
"      10",
"     </sub>",
"     W) and/or a continuous I.V. infusion at a rate of 5-8",
"     <b>",
"      mg&lt;",
"1ff8",
"/b&gt;/kg/minute to maintain serum glucose concentration to maintain plasma glucose &ge;40-50 mg/dL (Adamkin, 2011)",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     PALS Guidelines (PALS, 2010): I.V., I.O.: Newborns: 0.5-1 g/kg/dose (5-10 mL/kg/dose of D",
"     <sub>",
"      10",
"     </sub>",
"     W)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      Parenteral nutrition:",
"     </b>",
"     I.V.: Dextrose component (ASPEN Guidelines, 2002; ASPEN Pediatric Nutrition Support Core Curriculum, 2010):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Preterm neonates: Initial:5-7",
"     <b>",
"      mg",
"     </b>",
"     /kg/minute; daily increase: 1-2.5",
"     <b>",
"      mg",
"     </b>",
"     /kg/minute or 1% to 2.5% increments; maximum: 18",
"     <b>",
"      mg",
"     </b>",
"     /kg/minute",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Term neonates: Initial: 6-9",
"     <b>",
"      mg",
"     </b>",
"     /kg/minute; daily increase: 1-2",
"     <b>",
"      mg",
"     </b>",
"     /kg/minute or 2.5% to 5% increments; maximum: 18",
"     <b>",
"      mg",
"     </b>",
"     /kg/minute",
"    </p>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1058947\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"UTD.htm?13/40/13958?source=see_link\">",
"      see \"Instant glucose and intravenous dextrose: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Hypoglycemia: Note:",
"     </b>",
"     Doses may be repeated in severe cases:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Infants and Children:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     PALS Guidelines (PALS, 2010): I.V., I.O.: Infants and Children: 0.5-1 g/kg/dose (2&ndash;4 mL/kg/dose of 25% solution)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Infants 1-6 months: I.V.: 0.25-0.5 g/kg/dose (1-2 mL/kg/dose of 25% solution; 2.5-5 mL/kg of 10% solution; 0.5-1 mL/kg of 50% solution); maximum: 25 g/dose",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Infants &gt;6 months and Children: I.V.: 0.5-1 g/kg/dose (2-4 mL/kg/dose of 25% solution; 5-10 mL/kg of 10% solution; 1-2 mL/kg of 50% solution); maximum: 25 g/dose",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Children &gt;2 years: Oral: 10-20 g as single dose; repeat in 10 minutes if necessary",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Adolescents and Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     PALS Guidelines (PALS, 2010): I.V., I.O.: 0.5-1 g/kg/dose (1-2 mL/kg of 50% solution)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Alternate dosing: I.V.: 10-25 g (40-100 mL of 25% solution or 20-50 mL of 50% solution)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Oral: 10-20 g as single dose; repeat in 10 minutes if necessary",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      Hyperkalemia, treatment:",
"     </b>",
"     I.V. (in combination with insulin):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Infants and Children: 0.5-1 g/kg (using 25% or 50% solution) combined with regular insulin 1 unit for every 4-5 g dextrose given; infuse over 2 hours (infusions as short as 30 minutes have been recommended); repeat as needed",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Adolescents and Adults: 25-50 g dextrose (250-500 mL D",
"     <sub>",
"      10",
"     </sub>",
"     W) combined with 10 units regular insulin administered over 30-60 minutes; repeat as needed or as an alternative 25 g dextrose (50 mL D",
"     <sub>",
"      50",
"     </sub>",
"     W) combined with 5-10 units regular insulin infused over 5 minutes; repeat as needed",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     <b>",
"      Note:",
"     </b>",
"     More rapid infusions (&lt;30 minutes) may be associated with hyperglycemia and hyperosmolality and will exacerbate hyperkalemia; avoid use in patients who are already hyperglycemic",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      Parenteral nutrition:",
"     </b>",
"     I.V.: Dextrose component (ASPEN Guidelines, 2002; ASPEN Pediatric Nutrition Support Core Curriculum, 2010):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Infants &lt;1 year: Initial: 6-9",
"     <b>",
"      mg",
"     </b>",
"     /kg/minute; daily increase: 1-2.5",
"     <b>",
"      mg",
"     </b>",
"     /kg/minute or 1% to 2.5% increments; maximum: 18",
"     <b>",
"      mg",
"     </b>",
"     /kg/minute",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children 1-10 years: Initial: 10%; daily increase 1-2",
"     <b>",
"      mg",
"     </b>",
"     /kg/minute or 5% increments; maximum: 8-10",
"     <b>",
"      mg",
"     </b>",
"     /kg/minute",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children &gt;10 years and Adolescents: Initial: 3.5",
"     <b>",
"      mg",
"     </b>",
"     /kg/minute or 10%; daily increase: 1-2",
"     <b>",
"      mg",
"     </b>",
"     /kg/minute or 5% increments; maximum: 5-6",
"     <b>",
"      mg",
"     </b>",
"     /kg/minute",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F158895\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gel, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dex4&reg;: 40% (38 g) [tropical fruit flavor; provides dextrose 15 g/tube]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     GlucoBurst&reg;: 40% (37.5 g) [gluten free; contains potassium 10 mg/packet, sodium 30 mg/packet, sodium benzoate; arctic cherry flavor; provides dextrose 15 g/packet]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Glutose 15&trade;: 40% (37.5 g) [dye free; grape flavor; provides dextrose 15 g/tube]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Glutose 15&trade;: 40% (37.5 g) [dye free; lemon flavor; provides dextrose 15 g/tube]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Glutose 45&trade;: 40% (112.5 g) [dye free; lemon flavor; provides dextrose 45 g/tube]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Insta-Glucose&reg;: 40% (31 g) [contains sodium benzoate; cherry flavor; provides dextrose 12 g/tube and additional carbohydrates 12 g/tube]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Infusion: 5% (25 mL, 50 mL, 100 mL, 150 mL, 250 mL, 500 mL, 1000 mL); 10% (250 mL, 500 mL, 1000 mL); 20% (500 mL); 30% (500 mL); 40% (500 mL); 50% (500 mL, 1000 mL, 2000 mL [DSC]); 60% (500 mL [DSC], 1000 mL [DSC]); 70% (500 mL, 1000 mL, 2000 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution: 25% (10 mL); 50% (50 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Liquid, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dex4&reg;: 15 g/60 mL (60 mL) [gluten free; berry burst flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dex4&reg;: 15 g/60 mL (60 mL) [gluten free; lemon-lime flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Solution, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Enfamil&reg; Glucose: 5% (89 mL) [provides dextrose 4 g/bottle]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Enfamil&reg; Glucose: 10% (89 mL) [provides dextrose 9 g/bottle]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Glutol&trade;: 55% (180 mL) [lemon flavor; provides dextrose 100 g/180 mL]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Similac&reg; Glucose: 5% (59 mL) [provides dextrose 3 g/bottle]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Similac&reg; Gluc",
"1ff8",
"ose: 10% (59 mL) [provides dextrose 6 g/bottle]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, chewable, oral: 4 g",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     BD&trade; Glucose: 5 g [orange flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dex4&reg;: 4 g [assorted fruit flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dex4&reg;: 4 g [grape flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dex4&reg;: 4 g [grape, raspberry, tropical blast, watermelon flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dex4&reg;: 4 g [orange flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dex4&reg;: 4 g [raspberry flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dex4&reg;: 4 g [sour apple flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dex4&reg;: 4 g [watermelon flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     GlucoBurst&reg;: 5 g [gluten free; sour apple flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     GlucoBurst&reg;: 5 g [gluten free; sour cherry flavor]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F158884\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes: Infusion, injection, tablet",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1058958\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Oral: Must be swallowed to be absorbed",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Parenteral: For I.V. administration only, not SubQ or I.M. Further dilute concentrated dextrose solutions for peripheral venous administration to a maximum concentration of 12.5%; in emergency situations, 25% dextrose has been used peripherally; for direct I.V. infusion, administer over 1 minute at a  rate not to exceed 200 mg/kg; continuous infusion rates vary with tolerance and range from 4.5-15",
"     <b>",
"      mg",
"     </b>",
"     /kg/minute; hyperinsulinemic neonates may require up to 15-25",
"     <b>",
"      mg",
"     </b>",
"     /kg/minute infusion rates",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F1058950\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Stable at room temperature; protect from freezing and extreme heat; store oral dextrose in airtight containers",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1058957\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     I.V.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     5% and 10% solutions: Peripheral infusion to provide calories and fluid replacement",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     10% solution: Treatment of hypoglycemia in neonates",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     25% (hypertonic) solution: Treatment of acute symptomatic episodes of hypoglycemia to restore depressed blood glucose levels; adjunctive treatment of hyperkalemia when combined with insulin (FDA approved in neonates and older infants)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     50% (hypertonic) solution: Treatment of insulin-induced hypoglycemia (hyperinsulinemia or insulin shock) and adjunctive treatment of hyperkalemia in adolescents and adults",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &ge;10% solutions: Infusion after admixture with amino acids for nutritional support",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Oral: Treatment of hypoglycemia",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F158927\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Glutose&trade; may be confused with Glutofac&reg;",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      High alert medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       The Institute for Safe Medication Practices (ISMP) includes this medication (hypertonic solutions &ge;20%) among its list of drugs which have a heightened risk of causing significant patient harm when used in error.",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Other safety concerns:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Inappropriate use of low sodium or sodium-free intravenous fluids (eg D",
"       <sub>",
"        5",
"       </sub>",
"       W, hypotonic saline) in pediatric patients can lead to significant morbidity and mortality due to hyponatremia (ISMP, 2009).",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F158926\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     Most adverse effects are associated with excessive dosage or rate of infusion.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     Cardiovascular: Edema, dehydration, hyper-/hypovolemia, phlebitis, venous thrombosis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Fever, hyperosmolar syndrome, mental confusion, unconsciousness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Acidosis, hyperglycemia, hypokalemia, hypophosphatemia, hypomagnesemia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Genitourinary: Ketonuria, glycosuria, polyuria",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Diarrhea (oral), nausea, polydipsia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Local: Pain, tissue necrosis, vein irritation",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Pulmonary edema, tachypnea",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1058962\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to corn or corn products; diabetic coma with hyperglycemia; hypertonic solutions in patients with intracranial or intraspinal hemorrhage; patients with delirium tremens and dehydration; patients with anuria, hepatic coma, or glucose-galactose malabsorption syndrome",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F1058946\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution in premature infants, especially very low birth weight infants, as rapid changes is osmolality may produce profound effects on the brain, including intraventricular hemorrhage; small incremental changes in infusion rates are necessary in these patients; use with caution also in patients with diabetes mellitus.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1058945\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypertonic solutions (&gt;10%) may cause thrombosis if infused via peripheral veins; administer hypertonic solutions via a central venous catheter; rapid administration of hypertonic solutions may produce significant hyperglycemia, glycosuria, and shifts in electrolytes; this may result in dehydration, hyperosmolar syndrome, coma, and death especially in patients with chronic uremia or carbohy",
"1ff8",
"drate intolerance; excessive or rapid dextrose administration in very low birth weight infants has been associated with increased serum osmolality and possible intracerebral hemorrhage; hyperglycemia and glycosuria may be functions of the rate of administration of dextrose; to minimize these effects, reduce the rate of infusion; addition of insulin may be necessary; administration of potassium free I.V. dextrose solutions may result in significant hypokalemia, particularly if highly concentrated dextrose solutions are used; add potassium to dextrose solutions for patients with adequate renal function; administration of low sodium or sodium free I.V. dextrose solutions may result in significant hyponatremia or water intoxication in pediatric patients; monitor serum sodium concentration; abrupt withdrawal of dextrose solution may be associated with rebound hypoglycemia; an unexpected rise in blood glucose level in an otherwise stable patient may be an early symptom of infection; glucose is not absorbed from the buccal cavity; it must be swallowed to be effective; do not use oral forms in unconscious patients",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     Parenteral dextrose solutions contain aluminum which may accumulate to toxic levels with prolonged administration particularly in patients with impaired renal function. Patients with impaired renal function including premature neonates who receive aluminum at &gt;4-5 mcg/kg/day accumulate aluminum at levels associated with CNS and bone toxicity.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299170\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F158890\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no known significant interactions.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F158892\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (injection, infusion) (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F14207749\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     In patients who require parenteral nutrition for treatment of hyperemesis gravidarum, dextrose is part of the parenteral nutrition regimen (ASPEN, 2002).",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F1058952\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Serum and urine glucose concentrations; serum electrolytes, I &amp; O, caloric intake",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1058944\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Dextrose, a monosaccharide, is a source of calories and fluid for patients unable to obtain an adequate oral intake; may decrease body protein and nitrogen losses; promotes glycogen deposition in the liver; for the treatment of hyperkalemia, when combined with insulin, dextrose stimulates the uptake of potassium by cells, especially in muscle tissue",
"    </p>",
"   </div>",
"   <div class=\"block phd drugH1Div\" id=\"F1058960\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of action: Treatment of hypoglycemia: Oral: 10 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Maximum effect: Treatment of hyperkalemia: I.V.: 30 minutes",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1058961\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Rapidly from the small intestine by an active mechanism",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Metabolized to carbon dioxide and water",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak serum concentration: Oral: 40 minutes",
"    </p>",
"   </div>",
"   <div class=\"block adi drugH1Div\" id=\"F1058963\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Additional Information",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     1 g dextrose I.V. =  3.4 kcal",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     1 g glucose monohydrate = 1 g anhydrous dextrose",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Osmolarity:  Dextrose 10%:  505 mOsm/L; Dextrose 25%: 1330 mOsm/L; Normal body fluid: 310 mOsm/L",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Adamkin DH and Committee on Fetus and Newborn, \"Postnatal Glucose Homeostasis in Late-Preterm and Term Infants,\"",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 2011, 127(3):575-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?16/7/16502/abstract-text/21357346/pubmed\" id=\"21357346\" target=\"_blank\">",
"        21357346",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      ASPEN Board of Directors and the Clinical Guidelines Task Force, \"Guidelines for the Use of Parenteral and Enteral Nutrition in Adult and Pediatric Patients,\"",
"      <i>",
"       JPEN J Parenter Enteral Nutr",
"      </i>",
"      , 2002, 26(1 Suppl):1-138.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Carney LN, Nepa A, Cohen SS, et al, &ldquo;Parenteral and Enteral Nutrition Support: Determining the Best Way to Feed,&rdquo; In: Corkins MR, Balint J, Bobo E, et al, eds, The A.S.P.E.N Pediatric Nutrition Support Core Curriculum, Silver Spring: MD: American Society of Parenteral and Enteral Nutrition, 2010, 433-47.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Department Health and Human Services, Food Drug Administration, \"Aluminum in Large and Small Volume Parenterals Used in Total Parenteral Nutrition,\"",
"      <i>",
"       Federal Register",
"      </i>",
"      , 2000, 65(17):4103-11.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Institute for Safe Medication Practice, \"Plain D",
"      <sub>",
"       5",
"      </sub>",
"      W or Hypotonic Saline Solutions Post-Op Could Result in Acute Hyponatremia and Death in Healthy Chlidren,\" ISMP Medication Safety Alert, August 13, 2009. Available at file://www.ismp.org/Newsletters/acutecare/articles/20090813.asp",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kleinman ME, Chameides L, Schexnayder SM, et al, \"Part 14: Pediatric Advanced Life Support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care,\"",
"      <i>",
"       Circulation",
"      </i>",
"      , 2010, 122(18 Suppl 3):876-908.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?16/7/16502/abstract-text/20956230/pubmed\" id=\"20956230\" target=\"_blank\">",
"        20956230",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Mirtallo J, Canada T, Johnson D, et al, \"Safe Practices for Parenteral Nutrition,\"",
"      <i>",
"       JPEN J Parenter Enteral Nutr",
"      </i>",
"      , 2004, 28(6):S39-70.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"./instant-glucose-and-intravenous-dextrose-pediatric-drug-inf",
"1919",
"ormation/abstract-text/15568296/pubmed\" id=\"15568296\" target=\"_blank\">",
"        15568296",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 13222 Version 37.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-218.28.111.102-8C7B610DBC-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_7_16502=[""].join("\n");
var outline_f16_7_16502=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F158911\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1058953\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11442285\">",
"      Dosing: Neonatal",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1058947\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F158895\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F158884\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1058958\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1058950\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1058957\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F158927\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F158926\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1058962\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1058946\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1058945\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299170\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F158890\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F158892\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14207749\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1058952\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1058944\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1058960\">",
"      Pharmacodynamics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1058961\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1058963\">",
"      Additional Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13222\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13222|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?13/40/13958?source=related_link\">",
"      Instant glucose and intravenous dextrose: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?15/45/16084?source=related_link\">",
"      Instant glucose and intravenous dextrose: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f16_7_16503="Castrate resistant prostate cancer: Treatments targeting the androgen pathway";
var content_f16_7_16503=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Castrate resistant prostate cancer: Treatments targeting the androgen pathway",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/7/16503/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/7/16503/contributors\">",
"     Nancy A Dawson, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/7/16503/contributors\">",
"     Charles J Ryan, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/7/16503/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/7/16503/contributors\">",
"     Nicholas Vogelzang, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/7/16503/contributors\">",
"     Jerome P Richie, MD, FACS",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/7/16503/contributors\">",
"     W Robert Lee, MD, MS, MEd",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/7/16503/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/7/16503/contributors\">",
"     Michael E Ross, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?16/7/16503/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 21, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1409920\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Androgen deprivation therapy (ADT) is generally the initial treatment for men with metastatic prostate cancer. Standard approaches include bilateral orchiectomy or medical orchiectomy using a gonadotropin releasing hormone (GnRH) agonist either alone or in combination with an antiandrogen (complete androgen blockade). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/20/1353?source=see_link\">",
"     \"Initial hormone therapy for metastatic prostate cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Despite initial response rates of 80 to 90 percent, nearly all men eventually develop progressive disease following ADT; this is referred to as castrate-resistant prostate cancer. Contemporary research in men with castrate-resistant prostate cancer has led to the development of multiple agents that improved overall survival in phase III trials (",
"    <a class=\"graphic graphic_table graphicRef85716 \" href=\"UTD.htm?17/56/18317\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Insights into the mechanisms by which androgens stimulate growth of prostate cancer cells is leading to the development of new treatments with clinically significant activity in men with castrate resistant prostate cancer. These approaches are discussed here.",
"   </p>",
"   <p>",
"    An overview of the management of advanced prostate cancer is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/12/10442?source=see_link\">",
"     \"Overview of the treatment of disseminated prostate cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1409939\">",
"    <span class=\"h1\">",
"     RATIONALE AND MOLECULAR PATHWAYS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Contemporary research has demonstrated that androgen-based pathways continue to have a clinically significant role in the progression of castrate-resistant prostate cancer. In addition to androgen production by the adrenal gland and testis, several of the enzymes involved in the synthesis of testosterone and dihydrotestosterone, including cytochrome P450 17 alpha-hydroxysteroid dehydrogenase (CYP17), are highly expressed in tumor tissue [",
"    <a class=\"abstract\" href=\"UTD.htm?16/7/16503/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Collectively, these findings change the perspective on prostate cancer from what has long been considered an &ldquo;endocrine&rdquo; disease to one that is dependent on",
"    <span class=\"nowrap\">",
"     &ldquo;autocrine/paracrine&rdquo;",
"    </span>",
"    signaling for tumor progression and survival. This understanding has led to the development of drugs that act by inhibition of the enzymes responsible for androgen production, as well as agents that inhibit the androgen receptor.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1409964\">",
"    <span class=\"h2\">",
"     Androgen synthesis inhibitors",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?43/29/44503?source=see_link\">",
"     Abiraterone",
"    </a>",
"    was developed through screening chemical derivatives of a parent structure of pregnenolone. The structural changes in abiraterone account potent and irreversible inhibition of CYP17 [",
"    <a class=\"abstract\" href=\"UTD.htm?16/7/16503/abstract/2-4\">",
"     2-4",
"    </a>",
"    ]. In preclinical studies, abiraterone was ten times more potent than",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/34/33312?source=see_link\">",
"     ketoconazole",
"    </a>",
"    as an inhibitor of CYP17 [",
"    <a class=\"abstract\" href=\"UTD.htm?16/7/16503/abstract/4\">",
"     4",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H1409980\">",
"     'Abiraterone'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Although",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/34/33312?source=see_link\">",
"     ketoconazole",
"    </a>",
"    is a more potent inhibitor of the side chain cleavage enzyme, which plays a critical role in adrenal steroidogenesis, patients treated with either of these agents are at risk for adrenal insufficiency and require steroid replacement therapy. The use of ketoconazole is further limited by the potential for drug-drug interactions, particularly with statins and anti-depressants. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/39/38520?source=see_link&amp;anchor=H15#H15\">",
"     \"Secondary endocrine therapies for castration resistant prostate cancer\", section on 'Ketoconazole'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1385299623\">",
"    <span class=\"h2\">",
"     Androgen receptor antagonists",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some metastatic and primary prostate tumors retain activation of the androgen receptor in processes that are entirely independent of the androgen ligand. Several mechanisms, including up-regulation of androgen receptor expression through amplification of the androgen receptor gene [",
"    <a class=\"abstract\" href=\"UTD.htm?16/7/16503/abstract/5-7\">",
"     5-7",
"    </a>",
"    ], increased sensitivity of androgen receptor via overexpression of nuclear coactivators [",
"    <a class=\"abstract\" href=\"UTD.htm?16/7/16503/abstract/8\">",
"     8",
"    </a>",
"    ], and splice variant mutations of the receptor [",
"    <a class=\"abstract\" href=\"UTD.htm?16/7/16503/abstract/9,10\">",
"     9,10",
"    </a>",
"    ], have been proposed and may coexist. Importantly, these data suggest that progression of castrate-resistant prostate cancer in some patients may not be effectively treated by a focus solely on ligand-directed therapy.",
"   </p>",
"   <p>",
"    Small molecule antagonists of the androgen receptor, such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/46/16103?source=see_link\">",
"     enzalutamide",
"    </a>",
"    , are being developed and have important clinical activity. (See",
"    <a class=\"local\" href=\"#H1385299855\">",
"     'Enzalutamide'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1409980\">",
"    <span class=\"h1\">",
"     ABIRATERONE",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?43/29/44503?source=see_link\">",
"     Abiraterone",
"    </a>",
"    is an orally administered small molecule that irreversibly inhibits the products of the CYP17 gene (including both 17,20-lyase and 17-alpha-hydroxylase). In doing so, abiraterone blocks the synthesis of androgens in the tumor as well as in the testes and adrenal glands.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1385299281\">",
"    <span class=\"h2\">",
"     Efficacy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The activity of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?43/29/44503?source=see_link\">",
"     abiraterone",
"    </a>",
"    was established in two phase III trials in men with metastatic, castration resistant prostate cancer, the first in patients who had received prior",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/59/41913?source=see_link\">",
"     docetaxel",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?16/7/16503/abstract/11-13\">",
"     11-13",
"    </a>",
"    ], and the other in patients with chemotherapy-na&iuml;ve disease [",
"    <a class=\"abstract\" href=\"UTD.htm?16/7/16503/abstract/14,15\">",
"     14,15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1135663811\">",
"    <span class=\"h3\">",
"     Prior docetaxel chemotherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the first phase III trial, 1195 men who had previously been treated with a",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/59/41913?source=see_link\">",
"     docetaxel",
"    </a>",
"    -containing chemotherapy regimen were randomly assigned in a 2:1 ratio to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?43/29/44503?source=see_link\">",
"     abiraterone",
"    </a>",
"    (1000",
"    <span class=\"nowrap\">",
"     mg/day)",
"    </span>",
"    plus",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    (5 mg twice a day) or placebo plus prednisone [",
"    <a class=\"abstract\" href=\"UTD.htm?16/7/16503/abstract/11-13\">",
"     11-13",
"    </a>",
"    ]. Treatment was continued until disease progression. Disease progression was determined by a composite of worsening pain and decline in performance status, as well as objective progression on scans and by PSA rises. A rise in PSA on therapy (or a lack of decline) was not the sole criterion for discontinuation of therapy. The trial was terminated based upon an interim analysis when results exceeded prespecified criteria.",
"   </p>",
"   <p>",
"    The final analysis of overall survival was conducted at a median follow-up of 20 months. Overall survival, the primary endpoint of the trial, was significantly increased with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?43/29/44503?source=see_link\">",
"     abiraterone",
"    </a>",
"    compared with placebo (median 15.8 versus 11.2 months, hazard ratio [HR] 0.74, 95% CI 0.64-0.86). Benefits were similar in all subsets based upon preplanned analyses. Statistically significant improvements were also seen in time to PSA progression, radiologic progression-free survival, and PSA response rate (8.5 versus 6.6 months, 5.6 versus 3.6 months, and 29.5 versus 6.5 percent, respectively). Although patients with liver or lung metastases had a worse prognosis than those with disease limited to bone and lymph nodes, those receiving abiraterone did have similar improvement in overall survival compared with placebo (median 12.9 versus 8.3 months) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/7/16503/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Secondary analyses from the phase III trial focused on the impact of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?43/29/44503?source=see_link\">",
"     abiraterone",
"    </a>",
"    on symptoms due to bone metastases compared with placebo [",
"    <a class=\"abstract\" href=\"UTD.htm?16/7/16503/abstract/13\">",
"     13",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Overall approximately 90 percent of patients had bone metastases, and 41 percent of patients with bone metastases had clinically significant pain secondary to these metastases.",
"     </li>",
"     <li>",
"      There was a statistically significant improvement in the percentage of patients with palliation of pain intensity due to bone metastases with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?43/29/44503?source=see_link\">",
"       abiraterone",
"      </a>",
"      plus",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      compared with placebo plus prednisone (45 versus 29 percent), and palliation of pain intensity was achieved more rapidly (5.6 versus 13.7 months). Similar benefits for the combination of abiraterone plus prednisone were seen when the impact of pain on activities of daily living was assessed.",
"     </li>",
"     <li>",
"      Skeletal related events (pathologic fracture, spinal cord compression, or palliative radiation therapy",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      surgery to bone) were seen in 23 and 25 percent of all patients treated with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?43/29/44503?source=see_link\">",
"       abiraterone",
"      </a>",
"      plus",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      and placebo versus prednisone, respectively. However, there was a statistically significant increase in the time to first skeletal-related event (median 25 versus 20 months for the entire study population).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Increased isotope uptake on bone scan suggestive of progressive disease should be interpreted with caution when patients are started on therapy with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?43/29/44503?source=see_link\">",
"     abiraterone",
"    </a>",
"    . In a phase II study, follow-up bone scans obtained three months after treatment initiation were interpreted as worsening in 12 of 23 patients (52 percent) with a decrease in serum PSA of 50 percent or more [",
"    <a class=\"abstract\" href=\"UTD.htm?16/7/16503/abstract/17\">",
"     17",
"    </a>",
"    ]. In 11 of these 12, subsequent bone scans showed improvement or stabilization of bone disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1135663818\">",
"    <span class=\"h3\">",
"     Chemotherapy naive patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?43/29/44503?source=see_link\">",
"     Abiraterone",
"    </a>",
"    also delays disease progression and probably prolongs overall survival in men with castrate resistant prostate cancer who have not received chemotherapy.",
"   </p>",
"   <p>",
"    In a phase III trial, 1088 men with metastatic, asymptomatic or minimal symptomatic castration resistant prostate cancer were randomly assigned to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?43/29/44503?source=see_link\">",
"     abiraterone",
"    </a>",
"    plus",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    or placebo plus prednisone [",
"    <a class=\"abstract\" href=\"UTD.htm?16/7/16503/abstract/15,18,19\">",
"     15,18,19",
"    </a>",
"    ]. Patients could not have received prior chemotherapy. The co-primary endpoints of the trial were radiographic progression-free survival assessed by independent review and overall survival.",
"   </p>",
"   <p>",
"    Results from two planned interim analyses, which form the basis for the US Food and Drug Administration approval that includes all patients with metastatic castrate resistant prostate cancer, include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Radiographic progression-free survival was significantly increased with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?43/29/44503?source=see_link\">",
"       abiraterone",
"      </a>",
"      plus",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      compared with placebo plus prednisone (median 16.5 versus 8.3 months, HR 0.53, 95% CI 0.45-0.62) [",
"      <a class=\"abstract\" href=\"UTD.htm?16/7/16503/abstract/18\">",
"       18",
"      </a>",
"      ]. Secondary endpoints that also demonstrated a statistically significant superiority for abiraterone plus prednisone compared with placebo plus prednisone included time to initiation of cytotoxic chemotherapy, opiate use for cancer-related pain, PSA progression, and decline in performance status.",
"     </li>",
"     <li>",
"      Overall survival was increased with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?43/29/44503?source=see_link\">",
"       abiraterone",
"      </a>",
"      plus",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      (median 35.3 versus 30.1 months, HR 0.79, 95% CI 0.66-0.96). Analysis of overall survival is complicated by the used of additional active therapy following protocol participation [",
"      <a class=\"abstract\" href=\"UTD.htm?16/7/16503/abstract/15\">",
"       15",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1410012\">",
"    <span class=\"h2\">",
"     Toxicity",
"    </span>",
"    &nbsp;&mdash;&nbsp;The toxicity profile of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?43/29/44503?source=see_link\">",
"     abiraterone",
"    </a>",
"    is dependent upon its mechanism of action. CYP17, the target of abiraterone, regulates the conversion of pregnenolone and related steroids into androgens and is relatively specific for androgen production. However, there is inhibition of 17-alpha hydroxylase with decreased cortisol and a compensatory rise in ACTH, which is mediated by a hypothalamic response to partial adrenal inhibition.",
"   </p>",
"   <p>",
"    The increased ACTH release can cause increased adrenal mineralocorticoid production, which can lead to hypertension and hypokalemia. When",
"    <a class=\"drug drug_general\" href=\"UTD.htm?43/29/44503?source=see_link\">",
"     abiraterone",
"    </a>",
"    is given without concomitant glucocorticoids, patients typically do not experience clinical adrenal insufficiency since cortisol production is preserved. The effects of mineralocorticoid excess can be attenuated by coadministration with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    , which reduces ACTH mediated stimulation of the adrenal glands.",
"   </p>",
"   <p>",
"    In the phase III trial in men who had received prior",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/59/41913?source=see_link\">",
"     docetaxel",
"    </a>",
"    , the incidence of severe (grade 3 or 4) adverse events leading to discontinuation of treatment was similar in those treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?43/29/44503?source=see_link\">",
"     abiraterone",
"    </a>",
"    and placebo (10 and 13 percent, respectively) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/7/16503/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. Side effects that were more common with abiraterone included fluid retention and hypokalemia (33 versus 24 percent and 18 versus 9 percent, respectively). Non-specific cardiac abnormalities, abnormal liver function tests, and hypertension may also be more common in patients treated with abiraterone (16 versus 12 percent, 11 versus 9 percent, and 11 versus 8 percent, respectively).",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?43/29/44503?source=see_link\">",
"     Abiraterone",
"    </a>",
"    should be administered with 10 mg of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    daily, although the safety of lower doses of prednisone during long term therapy is under investigation. Monthly potassium and blood pressure monitoring are essential to the proper management of patients on abiraterone. Because the hypertension is mediated by an excess of mineralocorticoids, specific mineralocorticoid antagonists, such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/58/5031?source=see_link\">",
"     eplerenone",
"    </a>",
"    , may be useful; however, standard anti-hypertensive therapies are also of benefit.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1410046\">",
"    <span class=\"h2\">",
"     Clinical role",
"    </span>",
"    &nbsp;&mdash;&nbsp;Contemporary research in men with castrate-resistant prostate cancer has led to the development of multiple agents that have significantly improved overall survival in phase III trials (",
"    <a class=\"graphic graphic_table graphicRef85716 \" href=\"UTD.htm?17/56/18317\">",
"     table 1",
"    </a>",
"    ). These agents have not been compared with each other, and the appropriate sequencing of them in men with advanced disease is not established. The factors affecting the choice and proper sequence are discussed separately. &nbsp;(See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/12/10442?source=see_link&amp;anchor=H261299639#H261299639\">",
"     \"Overview of the treatment of disseminated prostate cancer\", section on 'Castrate resistant disease'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1385300125\">",
"    <span class=\"h2\">",
"     Other androgen synthesis inhibitors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other agents that inhibit CYP 17 are in clinical trials. The most advanced of these is orteronel (TAK-700), which is currently being compared with placebo in two multicenter, phase III trials. These trials are being conducted in chemotherapy-na&iuml;ve patients (",
"    <a class=\"external\" href=\"file://www.clinicaltrials.gov/ct2/show/NCT01193244?term=NCT01193244&amp;rank=1\">",
"     NCT01193244",
"    </a>",
"    ) and in those who have progressed on",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/59/41913?source=see_link\">",
"     docetaxel",
"    </a>",
"    (",
"    <a class=\"external\" href=\"file://www.clinicaltrials.gov/ct2/show/NCT01193257?term=NCT01193257&amp;rank=1\">",
"     NCT01193257",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1385299855\">",
"    <span class=\"h1\">",
"     ENZALUTAMIDE",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/46/16103?source=see_link\">",
"     Enzalutamide",
"    </a>",
"    binds to the androgen binding site in the androgen receptor, thereby leading to inhibition of nuclear translocation of the androgen receptor, and inhibition of the association of the androgen receptor with nuclear DNA. Phase",
"    <span class=\"nowrap\">",
"     I/II",
"    </span>",
"    studies showed that enzalutamide had significant activity in men with castration resistant prostate cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?16/7/16503/abstract/20,21\">",
"     20,21",
"    </a>",
"    ]. This has led to the assessment of enzalutamide in phase III trials.",
"   </p>",
"   <p>",
"    In the AFFIRM trial, 1199 men with castrate-resistant prostate cancer who had received prior",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/59/41913?source=see_link\">",
"     docetaxel",
"    </a>",
"    -based chemotherapy were randomly assigned to either",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/46/16103?source=see_link\">",
"     enzalutamide",
"    </a>",
"    (160 mg as a single dose once daily) or placebo in a two to one ratio (NCT00974311) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/7/16503/abstract/22,23\">",
"     22,23",
"    </a>",
"    ]. Concurrent therapy with steroids was permitted but not required on both treatment arms. The patient population in that trial was heavily pretreated, with approximately 50 percent of patients having received three or more prior endocrine therapies, and 25 percent had been treated with two or more chemotherapy regimens.",
"   </p>",
"   <p>",
"    Based upon the results of the planned interim analysis after 520 deaths, the blind was broken, and patients were allowed to cross over from placebo to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/46/16103?source=see_link\">",
"     enzalutamide",
"    </a>",
"    upon progression. Results of that interim analysis include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Overall survival was significantly increased with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/46/16103?source=see_link\">",
"       enzalutamide",
"      </a>",
"      compared with placebo (median 18.4 versus 13.6 months, HR 0.63, 95% CI 0.53-0.75). The survival benefit was consistent across all subgroups.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/46/16103?source=see_link\">",
"       Enzalutamide",
"      </a>",
"      was significantly better than placebo in all secondary efficacy endpoints, including PSA response (&gt;50 percent decrease, 54 versus 2 percent of patients, and &gt;90 percent decrease, 25 versus 1 percent), soft tissue response (29 versus 4 percent), quality of life response (43 versus 18 percent), time to PSA progression (8.3 versus 3.0 months), radiographic progression-free survival (8.3 versus 2.9 months), and time to first skeletal related event (16.7 versus 13.3 months).",
"     </li>",
"     <li>",
"      Treatment was well tolerated. For patients treated with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/46/16103?source=see_link\">",
"       enzalutamide",
"      </a>",
"      there was a higher incidence of fatigue (34 versus 29 percent), diarrhea (21 versus 18 percent), hot flashes (20 versus 10 percent), musculoskeletal pain (14 versus 10 percent) and headache (12 versus 6 percent). The one toxicity of potential concern was the development of seizures, which occurred in seven patients (0.9 percent) treated with enzalutamide and no patients assigned to placebo [",
"      <a class=\"abstract\" href=\"UTD.htm?16/7/16503/abstract/23\">",
"       23",
"      </a>",
"      ]. There was no statistically significant difference in the rate of treatment discontinuation due to adverse events (8 versus 10 percent with placebo).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Several secondary analyses of the AFFIRM trial were presented at the 2013 ASCO Genitourinary symposium.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Health related quality of life was significantly improved across all domains with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/46/16103?source=see_link\">",
"       enzalutamide",
"      </a>",
"      compared with placebo, based upon the Functional Assessment of Cancer Therapy-Prostate (FACT-P) scores [",
"      <a class=\"abstract\" href=\"UTD.htm?16/7/16503/abstract/24\">",
"       24",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In addition, the benefits in overall survival and delayed disease progression associated with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/46/16103?source=see_link\">",
"       enzalutamide",
"      </a>",
"      were similar in elderly men (&ge;75 years) compared with those seen in younger men [",
"      <a class=\"abstract\" href=\"UTD.htm?16/7/16503/abstract/25\">",
"       25",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A third analysis compared outcomes in patients who received corticosteroids along with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/46/16103?source=see_link\">",
"       enzalutamide",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?16/7/16503/abstract/26\">",
"       26",
"      </a>",
"      ]. Those given corticosteroids had a worse prognosis in terms of overall survival compared with those not receiving corticosteroids (median 11.5 months versus not reached, hazard ratio 0.40, 95% CI 0.33-0.48), but the benefits of enzalutamide were significant both in those receiving and not receiving corticosteroids.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A second phase III trial (PREVAIL) is comparing",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/46/16103?source=see_link\">",
"     enzalutamide",
"    </a>",
"    with placebo in asymptomatic or minimally symptomatic men with metastatic prostate cancer who are chemotherapy naive (",
"    <a class=\"external\" href=\"file://www.clinicaltrials.gov/ct2/show/NCT01212991?term=NCT01212991&amp;rank=1\">",
"     NCT01212991",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    There are no data on the efficacy of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/46/16103?source=see_link\">",
"     enzalutamide",
"    </a>",
"    in patients who have received",
"    <a class=\"drug drug_general\" href=\"UTD.htm?43/29/44503?source=see_link\">",
"     abiraterone",
"    </a>",
"    nor are there data for the use of abiraterone after enzalutamide.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4110730\">",
"    <span class=\"h1\">",
"     SURVEILLANCE DURING TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surveillance strategies during treatment for disseminated prostate cancer are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/52/10055?source=see_link&amp;anchor=H11088148#H11088148\">",
"     \"Follow-up surveillance during and after treatment for prostate cancer\", section on 'Metastatic prostate cancer'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1385299369\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Despite high response rates to ADT in men with advanced prostate cancer, nearly all eventually develop progressive, castrate-resistant disease. Contemporary research has led to the development of a number of therapies that have been demonstrated to significantly prolong overall survival (",
"      <a class=\"graphic graphic_table graphicRef85716 \" href=\"UTD.htm?17/56/18317\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/12/10442?source=see_link&amp;anchor=H261299899#H261299899\">",
"       \"Overview of the treatment of disseminated prostate cancer\", section on 'Castrate resistant disease'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Androgen-based pathways can continue to stimulate disease progression in men castrate-resistant prostate cancer. An understanding of this has led to the development of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?43/29/44503?source=see_link\">",
"       abiraterone",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/46/16103?source=see_link\">",
"       enzalutamide",
"      </a>",
"      , both of which may play a significant role in the management of men with advanced disease. Abiraterone and enzalutamide have not been compared with each other or with other agents that can prolong survival in the context of castrate-resistant disease (",
"      <a class=\"graphic graphic_table graphicRef85716 \" href=\"UTD.htm?17/56/18317\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H1409939\">",
"       'Rationale and molecular pathways'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/12/10442?source=see_link&amp;anchor=H261299183#H261299183\">",
"       \"Overview of the treatment of disseminated prostate cancer\", section on 'Sequence of systemic therapies'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?43/29/44503?source=see_link\">",
"       Abiraterone",
"      </a>",
"      plus",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      significantly improved overall survival, decreased pain due to bone metastases, and prolonged the time to skeletal related complications compared with placebo plus prednisone in a randomized phase III trial in men who had previously been treated with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?40/59/41913?source=see_link\">",
"       docetaxel",
"      </a>",
"      . In a second phase III trial in patients who were chemotherapy na&iuml;ve, abiraterone also significantly increased both overall and progression free survival in another phase III trial in patients who were chemotherapy na&iuml;ve, although additional follow-up data are required. (See",
"      <a class=\"local\" href=\"#H1385299281\">",
"       'Efficacy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/46/16103?source=see_link\">",
"       Enzalutamide",
"      </a>",
"      significantly improved overall survival compared with placebo in a phase III in men with castrate resistant metastatic prostate cancer who had previously been treated with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?40/59/41913?source=see_link\">",
"       docetaxel",
"      </a>",
"      . A phase III trial in men who are chemotherapy na&iuml;ve is in progress. (See",
"      <a class=\"local\" href=\"#H1385299855\">",
"       'Enzalutamide'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16503/abstract/1\">",
"      Montgomery RB, Mostaghel EA, Vessella R, et al. Maintenance of intratumoral androgens in metastatic prostate cancer: a mechanism for castration-resistant tumor growth. Cancer Res 2008; 68:4447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16503/abstract/2\">",
"      Barrie SE, Potter GA, Goddard PM, et al. Pharmacology of novel steroidal inhibitors of cytochrome P450(17) alpha (17 alpha-hydroxylase/C17-20 lyase). J Steroid Biochem Mol Biol 1994; 50:267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16503/abstract/3\">",
"      Attard G, Reid AH, A'Hern R, et al. Selective inhibition of CYP17 with abiraterone acetate is highly active in the treatment of castration-resistant prostate cancer. J Clin Oncol 2009; 27:3742.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16503/abstract/4\">",
"      Potter GA, Barrie SE, Jarman M, Rowlands MG. Novel steroidal inhibitors of human cytochrome P45017 alpha (17 alpha-hydroxylase-C17,20-lyase): potential agents for the treatment of prostatic cancer. J Med Chem 1995; 38:2463.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16503/abstract/5\">",
"      Visakorpi T, Hyytinen E, Koivisto P, et al. In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nat Genet 1995; 9:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16503/abstract/6\">",
"      Chen CD, Welsbie DS, Tran C, et al. Molecular determinants of resistance to antiandrogen therapy. Nat Med 2004; 10:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16503/abstract/7\">",
"      Edwards J, Krishna NS, Grigor KM, Bartlett JM. Androgen receptor gene amplification and protein expression in hormone refractory prostate cancer. Br J Cancer 2003; 89:552.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16503/abstract/8\">",
"      Gregory CW, Johnson RT Jr, Mohler JL, et al. Androgen receptor stabilization in recurrent prostate cancer is associated with hypersensitivity to low androgen. Cancer Res 2001; 61:2892.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16503/abstract/9\">",
"      Watson PA, Chen YF, Balbas MD, et al. Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor. Proc Natl Acad Sci U S A 2010; 107:16759.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16503/abstract/10\">",
"      Guo Z, Yang X, Sun F, et al. A novel androgen receptor splice variant is up-regulated during prostate cancer progression and promotes androgen depletion-resistant growth. Cancer Res 2009; 69:2305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16503/abstract/11\">",
"      de Bono JS, Logothetis CJ, Molina A, et al. Abiraterone and increased survival in metastatic prostate cancer. N Engl J Med 2011; 364:1995.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16503/abstract/12\">",
"      Fizazi K, Scher HI, Molina A, et al. Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study. Lancet Oncol 2012; 13:983.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16503/abstract/13\">",
"      Logothetis CJ, Basch E, Molina A, et al. Effect of abiraterone acetate and prednisone compared with placebo and prednisone on pain control and skeletal-related events in patients with metastatic castration-resistant prostate cancer: exploratory analysis of data from the COU-AA-301 randomised trial. Lancet Oncol 2012; 13:1210.",
"     </a>",
"    </li>",
"    <li>",
"     Ryan CJ, et al. Interim analysis (IA) results of COU-AA-302, a randomized, phase III study of abiraterone acetate (AA) in chemotherapy-naive patients (pts) with metastatic castration-resistant prostate cancer (mCRPC). J Clin Oncol 2012; 3): (suppl: abstract LBA 4518).",
"    </li>",
"    <li>",
"     file://www.accessdata.fda.gov/drugsatfda_docs/label/2012/202379s005lbl.pdf (Accessed on December 11, 2012).",
"    </li>",
"    <li>",
"     Goodman OB, et al. Exploratory analysis of the visceral disease (VD) patient subset in COU-AA-301, a phase III study of abiraterone acetate (AA) in metastatic castration-resistant prostate cancer (mCRPC). J Clin Oncol 2013; 31: (suppl 6; abstr 14).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16503/abstract/17\">",
"      Ryan CJ, Shah S, Efstathiou E, et al. Phase II study of abiraterone acetate in chemotherapy-naive metastatic castration-resistant prostate cancer displaying bone flare discordant with serologic response. Clin Cancer Res 2011; 17:4854.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16503/abstract/18\">",
"      Ryan CJ, Smith MR, de Bono JS, et al. Abiraterone in metastatic prostate cancer without previous chemotherapy. N Engl J Med 2013; 368:138.",
"     </a>",
"    </li>",
"    <li>",
"     Rathkopf D, et al. Updated interim analysis (IA) of COU-AA-302, a randomized phase III study of abiraterone acetate (AA) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) without prior chemotherapy. J Clin Oncol 2013; 31: (suppl 6: abstr 5).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16503/abstract/20\">",
"      Scher HI, Beer TM, Higano CS, et al. Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1-2 study. Lancet 2010; 375:1437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16503/abstract/21\">",
"      Rathkopf D, Liu G, Carducci MA, et al. Phase I dose-escalation study of the novel antiandrogen BMS-641988 in patients with castration-resistant prostate cancer. Clin Cancer Res 2011; 17:880.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16503/abstract/22\">",
"      Scher HI, Fizazi K, Saad F, et al. Increased survival with enzalutamide in prostate cancer after chemotherapy. N Engl J Med 2012; 367:1187.",
"     </a>",
"    </li>",
"    <li>",
"     file://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203415lbl.pdf?et_cid=29930410&amp;et_rid=463634184&amp;linkid=http%3a%2f%2fwww.accessdata.fda.gov%2fdrugsatfda_docs%2flabel%2f2012%2f203415lbl.pdf (Accessed on September 04, 2012).",
"    </li>",
"    <li>",
"     Miller K, et al. Effect of enzalutamide on health-related quality of life (HRQoL) in men with metastatic castration-resistant prostate cancer (mCRPC) following docetaxel-based therapy: Results from the AFFIRM study. J Clin Oncol 2013; 31: (suppl 6; abstr 17).",
"    </li>",
"    <li>",
"     Sternberg C, et al. Outcomes in elderly patients with metastatic castration-resistant prostate cancer (mCRPC) treated with the androgen receptor inhibitor enzalutamide: Results from the phase III AFFIRM trial. J Clin Oncol 2013; 31: (suppl 6; abstr 16).",
"    </li>",
"    <li>",
"     Scher H, et al. Impact of on-study corticosteroid use on efficacy and safety in the phase III AFFIRM study of enzalutamide (ENZA), an androgen receptor inhibitor. J Clin Oncol 2013; 31: (suppl 6; abstr 6).",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16351 Version 24.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-190.111.122.2-BE0BA8F269-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_7_16503=[""].join("\n");
var outline_f16_7_16503=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H1385299369\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1409920\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1409939\">",
"      RATIONALE AND MOLECULAR PATHWAYS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1409964\">",
"      Androgen synthesis inhibitors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1385299623\">",
"      Androgen receptor antagonists",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1409980\">",
"      ABIRATERONE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1385299281\">",
"      Efficacy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1135663811\">",
"      - Prior docetaxel chemotherapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1135663818\">",
"      - Chemotherapy naive patients",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1410012\">",
"      Toxicity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1410046\">",
"      Clinical role",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1385300125\">",
"      Other androgen synthesis inhibitors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1385299855\">",
"      ENZALUTAMIDE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4110730\">",
"      SURVEILLANCE DURING TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1385299369\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ONC/16351\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/16351|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?17/56/18317\" title=\"table 1\">",
"      Therapies for castrate resistant prostate cancer",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/52/10055?source=related_link\">",
"      Follow-up surveillance during and after treatment for prostate cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/20/1353?source=related_link\">",
"      Initial hormone therapy for metastatic prostate cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/12/10442?source=related_link\">",
"      Overview of the treatment of disseminated prostate cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/39/38520?source=related_link\">",
"      Secondary endocrine therapies for castration resistant prostate cancer",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f16_7_16504="Constrictive bronchiolitis Low";
var content_f16_7_16504=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F75444&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F75444&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Constrictive bronchiolitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 238px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Low power view of constrictive bronchiolitis in a patient with long standing rheumatoid arthritis and progressive airflow obstruction. There is luminal narrowing caused by peribronchiolar scarring and luminal mucus. Hematoxylin and eosin stain.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Talmadge E King Jr, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Section through a bronchiole",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 220px; height: 251px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Bronchioles are distinguished from bronchi by a lack of glands and cartilage. Hematoxylin and eosin stain.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     From: Corrin, B. Development and structure of the normal lung. In: Clinical Atlas Respiratory Diseases, Turner-Warwick, M, Hodson, ME, Corrin, B, Kerr, IH (Eds), JB Lippincott, London, 1989.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_7_16504=[""].join("\n");
var outline_f16_7_16504=null;
var title_f16_7_16505="Diagnostic evaluation of a pleural effusion in adults: Initial testing";
var content_f16_7_16505=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Diagnostic evaluation of a pleural effusion in adults: Initial testing",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/7/16505/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/7/16505/contributors\">",
"     John E Heffner, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/7/16505/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/7/16505/contributors\">",
"     Steven A Sahn, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?16/7/16505/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?16/7/16505/contributors\">",
"     Geraldine Finlay, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?16/7/16505/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 1, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Determining the cause of a pleural effusion is greatly facilitated by analysis of the pleural fluid. Thoracentesis is a simple bedside procedure that permits fluid to be rapidly sampled, visualized, examined microscopically, and quantified. A systematic approach to analysis of the fluid in conjunction with the clinical presentation should allow the clinician to diagnose the cause of an effusion in about 75 percent of patients at the first encounter [",
"    <a class=\"abstract\" href=\"UTD.htm?16/7/16505/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A definitive diagnosis, provided by the finding of malignant cells or specific organisms in the pleural fluid, can be established in approximately 25 percent of patients.",
"     </li>",
"     <li>",
"      A presumptive diagnosis, based on the pre-thoracentesis clinical impression, can be substantiated by pleural fluid analysis in an additional 50 percent of patients.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Even with a nondiagnostic thoracentesis, pleural fluid analysis can be useful in excluding other possible causes, such as infection, or guiding subsequent diagnostic studies. Thus, clinical decision-making information can be gained from pleural fluid analysis in over 90 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?16/7/16505/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An approach to pleural fluid analysis will be presented here. Pleural imaging, the technique of thoracentesis, and an approach to pleural effusions of uncertain etiology after the initial evaluation are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/56/21384?source=see_link\">",
"     \"Imaging of pleural effusions in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/23/12663?source=see_link\">",
"     \"Diagnostic thoracentesis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/36/2632?source=see_link\">",
"     \"Diagnostic evaluation of pleural effusion in adults: Additional tests for undetermined etiology\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     INDICATIONS FOR THORACENTESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The indication for diagnostic thoracentesis is the new finding of a pleural effusion. Observation, in lieu of diagnostic thoracentesis, may be warranted in uncomplicated heart failure and viral pleurisy. In the former setting, the clinical diagnosis is usually secure; in the latter, there is typically a small amount of fluid. However, if the clinical situation is atypical or does not progress as anticipated, thoracentesis should be performed [",
"    <a class=\"abstract\" href=\"UTD.htm?16/7/16505/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Only a select number of diagnoses can be established definitively by thoracentesis. These include malignancy, empyema, tuberculous pleurisy, fungal infection of the pleural space, lupus pleuritis, chylothorax, urinothorax, esophageal rupture, hemothorax, peritoneal dialysis, and extravascular migration of a central venous catheter (",
"    <a class=\"graphic graphic_table graphicRef50027 \" href=\"UTD.htm?42/19/43323\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?16/7/16505/abstract/3,4\">",
"     3,4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PLEURAL FLUID ANALYSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tests routinely performed on pleural fluid include cell count, pH, protein, lactate dehydrogenase (LDH), and glucose. Additional commonly performed tests in selected patients include amylase, cholesterol, triglycerides, gram and AFB stain, bacterial and AFB culture, and cytology.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Gross appearance",
"    </span>",
"    &nbsp;&mdash;&nbsp;Initial diagnostic clues can be obtained by gross inspection of pleural fluid as it is being aspirated from the patient's chest [",
"    <a class=\"abstract\" href=\"UTD.htm?16/7/16505/abstract/3\">",
"     3",
"    </a>",
"    ]. Observations that are helpful for diagnosis are listed in the table (",
"    <a class=\"graphic graphic_table graphicRef74757 \" href=\"UTD.htm?27/12/27852\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Characterization",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pleural fluid is next characterized as either a transudate or an exudate. (See",
"    <a class=\"local\" href=\"#H8\">",
"     'Diagnostic criteria'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Transudates",
"    </span>",
"    &nbsp;&mdash;&nbsp;Transudates are largely due to imbalances in hydrostatic and oncotic pressures in the chest. However, they can also result from movement of fluid from the peritoneal, cerebrospinal, or retroperitoneal spaces, or from iatrogenic causes, such as crystalloid infusion into a central venous catheter that has migrated [",
"    <a class=\"abstract\" href=\"UTD.htm?16/7/16505/abstract/2\">",
"     2",
"    </a>",
"    ]. Nevertheless, transudates have a limited number of diagnostic possibilities that can usually be discerned from the patient's clinical presentation (",
"    <a class=\"graphic graphic_table graphicRef73530 \" href=\"UTD.htm?38/49/39708\">",
"     table 3",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Exudates",
"    </span>",
"    &nbsp;&mdash;&nbsp;In contrast, exudative effusions present more of a diagnostic challenge. Disease in virtually any organ can cause exudative pleural effusions by a variety of mechanisms, including infection, malignancy, immunologic responses, lymphatic abnormalities, noninfectious inflammation, iatrogenic causes, and movement of fluid from below the diaphragm (",
"    <a class=\"graphic graphic_table graphicRef54055 \" href=\"UTD.htm?37/9/38045\">",
"     table 4",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?16/7/16505/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Exudates result primarily from pleural and lung inflammation (resulting in increased capillary and pleural membrane permeability) or from impaired lymphatic drainage of the pleural space (resulting in decreased removal of protein and other large molecular weight constituents from the pleural space) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/7/16505/abstract/2\">",
"     2",
"    </a>",
"    ]. Exudates can also result from movement of fluid from the peritoneal space, as seen with acute or chronic pancreatitis, chylous ascites, and peritoneal carcinomatosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/53/36695?source=see_link\">",
"     \"Mechanisms of pleural liquid accumulation in disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Diagnostic criteria",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Light's Criteria Rule is a traditional method of differentiating transudates and exudates that measures serum and pleural fluid protein and LDH [",
"    <a class=\"abstract\" href=\"UTD.htm?16/7/16505/abstract/5\">",
"     5",
"    </a>",
"    ]. Abbreviated versions of Light's criteria have similar diagnostic accuracy and have been recommended for clinical use [",
"    <a class=\"abstract\" href=\"UTD.htm?16/7/16505/abstract/6,7\">",
"     6,7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    According to Light's traditional criteria, if at least one of the following three criteria is present, the fluid is defined as an exudate [",
"    <a class=\"abstract\" href=\"UTD.htm?16/7/16505/abstract/5\">",
"     5",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Pleural fluid",
"      <span class=\"nowrap\">",
"       protein/serum",
"      </span>",
"      protein ratio greater than 0.5",
"     </li>",
"     <li>",
"      Pleural fluid",
"      <span class=\"nowrap\">",
"       LDH/serum",
"      </span>",
"      LDH ratio greater than 0.6",
"     </li>",
"     <li>",
"      Pleural fluid LDH greater than two-thirds the upper limits of the laboratory's normal serum LDH",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The combination of the three criteria has a higher sensitivity, but a lower specificity, than each individual criterion. This is an inherent consequence of combining two or more tests into a diagnostic rule when only one test must be fulfilled to define a positive result. The tradeoff is appropriate for screening pleural fluid because it is important that exudates not be missed, since they can have important prognostic implications.",
"   </p>",
"   <p>",
"    Light's criteria have been criticized for including both the pleural fluid",
"    <span class=\"nowrap\">",
"     LDH/serum",
"    </span>",
"    LDH ratio and the pleural fluid LDH because they are highly correlated [",
"    <a class=\"abstract\" href=\"UTD.htm?16/7/16505/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Alternative diagnostic criteria also exist. A meta-analysis of eight studies (1448 patients) examined pleural fluid tests and found that several tests identified exudates with accuracy similar to those used in Light's criteria, but did not require concurrent measurement of serum protein or LDH [",
"    <a class=\"abstract\" href=\"UTD.htm?16/7/16505/abstract/6\">",
"     6",
"    </a>",
"    ]. Proposed two-criteria and three-criteria diagnostic rules, which require one criterion to be met to define an exudate, include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Two-test rule",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Pleural fluid cholesterol greater than 45",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"     </li>",
"     <li>",
"      Pleural fluid LDH greater than 0.45 times the upper limit of the laboratory's normal serum LDH",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Three-test rule",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Pleural fluid protein greater than 2.9",
"      <span class=\"nowrap\">",
"       g/dL",
"      </span>",
"      (29",
"      <span class=\"nowrap\">",
"       g/L)",
"      </span>",
"     </li>",
"     <li>",
"      Pleural fluid cholesterol greater than cholesterol 45",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (1.165",
"      <span class=\"nowrap\">",
"       mmol/L)",
"      </span>",
"     </li>",
"     <li>",
"      Pleural fluid LDH greater than 0.45 times the upper limit of the laboratory's normal serum LDH",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The previous pleural fluid LDH cutoff point for differentiating between exudates and transudates in the traditional Light's criteria rule was 67 percent of (or 0.67 times) the upper limit of normal serum LDH. This has been changed to 45 percent, based on reanalysis of each criterion individually [",
"    <a class=\"abstract\" href=\"UTD.htm?16/7/16505/abstract/6,8\">",
"     6,8",
"    </a>",
"    ]. All available tests may misclassify pleural fluid as exudates or transudates when values are near the cutoff points [",
"    <a class=\"abstract\" href=\"UTD.htm?16/7/16505/abstract/5,6,8\">",
"     5,6,8",
"    </a>",
"    ]. Thus, clinical judgment is required when evaluating patients with borderline test results [",
"    <a class=\"abstract\" href=\"UTD.htm?16/7/16505/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Chemical analysis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The measurement of pleural fluid protein and LDH, glucose, pH, cholesterol, triglycerides, and amylase can provide useful information.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Protein",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most transudates have absolute total protein concentrations below 3.0",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    (30",
"    <span class=\"nowrap\">",
"     g/L),",
"    </span>",
"    although acute diuresis in heart failure can elevate protein levels into the exudative range [",
"    <a class=\"abstract\" href=\"UTD.htm?16/7/16505/abstract/10-12\">",
"     10-12",
"    </a>",
"    ]. However, such patients have a serum to pleural fluid albumin gradient (the difference between the serum and pleural values) greater than 1.2",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    (12",
"    <span class=\"nowrap\">",
"     g/L),",
"    </span>",
"    which correctly categorizes their effusions as transudates [",
"    <a class=\"abstract\" href=\"UTD.htm?16/7/16505/abstract/12,13\">",
"     12,13",
"    </a>",
"    ]. Elevated blood N-terminal pro-brain natriuretic peptide (NT-proBNP) also supports the diagnosis of heart failure when Light&rsquo;s criteria yield results in the exudative range [",
"    <a class=\"abstract\" href=\"UTD.htm?16/7/16505/abstract/14\">",
"     14",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H17\">",
"     'N-terminal pro-BNP'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Tuberculous pleural effusions virtually always have total protein concentrations above 4.0",
"      <span class=\"nowrap\">",
"       g/dL",
"      </span>",
"      (40",
"      <span class=\"nowrap\">",
"       g/L)",
"      </span>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?16/7/16505/abstract/5\">",
"       5",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      When pleural fluid protein concentrations are in the 7.0 to 8.0",
"      <span class=\"nowrap\">",
"       g/dL",
"      </span>",
"      (70 to 80",
"      <span class=\"nowrap\">",
"       g/L)",
"      </span>",
"      range, Waldenstr&ouml;m&rsquo;s macroglobulinemia and multiple myeloma should be considered [",
"      <a class=\"abstract\" href=\"UTD.htm?16/7/16505/abstract/15,16\">",
"       15,16",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     LDH",
"    </span>",
"    &nbsp;&mdash;&nbsp;The level of pleural fluid lactic dehydrogenase (LDH) is one of the key criteria for differentiating transudates and exudates. (See",
"    <a class=\"local\" href=\"#H8\">",
"     'Diagnostic criteria'",
"    </a>",
"    above.) Several specific disease associations have been noted with pleural fluid protein and LDH levels:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pleural fluid LDH levels above 1000",
"      <span class=\"nowrap\">",
"       IU/L",
"      </span>",
"      (with upper limit of normal for serum of 200",
"      <span class=\"nowrap\">",
"       IU/L)",
"      </span>",
"      are characteristically found in empyema [",
"      <a class=\"abstract\" href=\"UTD.htm?16/7/16505/abstract/17\">",
"       17",
"      </a>",
"      ], rheumatoid pleurisy [",
"      <a class=\"abstract\" href=\"UTD.htm?16/7/16505/abstract/18\">",
"       18",
"      </a>",
"      ], and pleural paragonimiasis [",
"      <a class=\"abstract\" href=\"UTD.htm?16/7/16505/abstract/19\">",
"       19",
"      </a>",
"      ], and are sometimes observed with malignancy.",
"     </li>",
"     <li>",
"      Pleural fluid secondary to Pneumocystis jirovecii pneumonia has the characteristic finding of a pleural",
"      <span class=\"nowrap\">",
"       fluid/serum",
"      </span>",
"      LDH ratio greater than 1.0 and a pleural",
"      <span class=\"nowrap\">",
"       fluid/serum",
"      </span>",
"      protein ratio of less than 0.5 [",
"      <a class=\"abstract\" href=\"UTD.htm?16/7/16505/abstract/20\">",
"       20",
"      </a>",
"      ]. Urinothorax is another cause of elevated pleural fluid LDH associated with low pleural fluid protein levels [",
"      <a class=\"abstract\" href=\"UTD.htm?16/7/16505/abstract/21\">",
"       21",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Cholesterol",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pleural cholesterol is thought to be derived from degenerating cells and vascular leakage from increased permeability. Measurement of pleural cholesterol has been used to improve the accuracy of differentiating transudative and exudative effusion. A pleural cholesterol level of greater than 45",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    is not by itself a definitive criterion for an exudate, but does figure in the two and three-test rules as noted above [",
"    <a class=\"abstract\" href=\"UTD.htm?16/7/16505/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An elevated cholesterol &gt;250",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    defines a cholesterol effusion (also known as pseudochylothorax or chyliform effusion), which occurs in patients with long-term effusions. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/45/31448?source=see_link&amp;anchor=H20969448#H20969448\">",
"     \"Clinical presentation, diagnosis and management of cholesterol effusions\", section on 'Diagnosis and differential diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25763845\">",
"    <span class=\"h3\">",
"     Triglycerides",
"    </span>",
"    &nbsp;&mdash;&nbsp;Elevated pleural fluid triglyceride concentrations greater than 110",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    supports the diagnosis of a chylothorax, a level less than 50",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    excludes a chylothorax with reasonable likelihood, and an intermediate level between 50 and 110",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    should be followed by lipoprotein analysis of the pleural fluid [",
"    <a class=\"abstract\" href=\"UTD.htm?16/7/16505/abstract/22\">",
"     22",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/20/37192?source=see_link&amp;anchor=H9#H9\">",
"     \"Etiology, clinical presentation, and diagnosis of chylothorax\", section on 'Pleural fluid analysis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Glucose",
"    </span>",
"    &nbsp;&mdash;&nbsp;A low pleural fluid glucose concentration (less than 60",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    [3.33",
"    <span class=\"nowrap\">",
"     mmol/liter],",
"    </span>",
"    or a pleural",
"    <span class=\"nowrap\">",
"     fluid/serum",
"    </span>",
"    glucose ratio less than 0.5) narrows the differential diagnosis of the exudate to the following possibilities [",
"    <a class=\"abstract\" href=\"UTD.htm?16/7/16505/abstract/23\">",
"     23",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Rheumatoid pleurisy",
"     </li>",
"     <li>",
"      Complicated parapneumonic effusion or empyema",
"     </li>",
"     <li>",
"      Malignant effusion",
"     </li>",
"     <li>",
"      Tuberculous pleurisy",
"     </li>",
"     <li>",
"      Lupus pleuritis",
"     </li>",
"     <li>",
"      Esophageal rupture",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    All transudates and all other exudates have pleural fluid glucose concentration similar to that of blood glucose.",
"   </p>",
"   <p>",
"    The mechanism responsible for a low pleural fluid glucose depends upon the underlying disease. Specific examples include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Decreased transport of glucose from blood to pleural fluid with rheumatoid pleurisy [",
"      <a class=\"abstract\" href=\"UTD.htm?16/7/16505/abstract/24,25\">",
"       24,25",
"      </a>",
"      ] or malignancy [",
"      <a class=\"abstract\" href=\"UTD.htm?16/7/16505/abstract/26\">",
"       26",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Increased utilization of glucose by constituents of pleural fluid, such as neutrophils, bacteria (empyema), and malignant cells [",
"      <a class=\"abstract\" href=\"UTD.htm?16/7/16505/abstract/27\">",
"       27",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The lowest glucose concentrations are found in rheumatoid pleurisy and empyema, with glucose being undetectable in some cases. In comparison, when the glucose concentration is low in tuberculous pleurisy, lupus pleuritis, and malignancy, it usually falls into the range of 30 to 50",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (1.66 to 2.78",
"    <span class=\"nowrap\">",
"     mmol/liter)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?16/7/16505/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     pH",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pleural fluid pH should always be measured in a blood gas machine rather than with a pH meter or pH indicator paper, as the latter will result in inaccurate measurements [",
"    <a class=\"abstract\" href=\"UTD.htm?16/7/16505/abstract/28,29\">",
"     28,29",
"    </a>",
"    ]. A pleural fluid pH below 7.30 with a normal arterial blood pH is found with the same diagnoses associated with low pleural fluid glucose concentrations [",
"    <a class=\"abstract\" href=\"UTD.htm?16/7/16505/abstract/30\">",
"     30",
"    </a>",
"    ]. The pH of normal pleural fluid is approximately 7.60, due to a bicarbonate gradient between pleural fluid and blood [",
"    <a class=\"abstract\" href=\"UTD.htm?16/7/16505/abstract/31\">",
"     31",
"    </a>",
"    ]. Thus, a pH below 7.30 represents a substantial accumulation of hydrogen ions. Transudates generally have a pleural fluid pH in the 7.40 to 7.55 range, while the majority of exudates range from 7.30 to 7.45 [",
"    <a class=\"abstract\" href=\"UTD.htm?16/7/16505/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The mechanisms responsible for pleural fluid acidosis (pH &lt;7.30) include;",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Increased acid production by pleural fluid cells and bacteria (empyema) [",
"      <a class=\"abstract\" href=\"UTD.htm?16/7/16505/abstract/27,32\">",
"       27,32",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Decreased hydrogen ion efflux from the pleural space, due to pleuritis, tumor, or pleural fibrosis. Specific examples include malignancy [",
"      <a class=\"abstract\" href=\"UTD.htm?16/7/16505/abstract/26\">",
"       26",
"      </a>",
"      ], rheumatoid pleurisy [",
"      <a class=\"abstract\" href=\"UTD.htm?16/7/16505/abstract/24,25\">",
"       24,25",
"      </a>",
"      ], and tuberculous pleurisy.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A low pleural fluid pH has diagnostic, prognostic, and therapeutic implications for patients with parapneumonic and malignant effusions [",
"    <a class=\"abstract\" href=\"UTD.htm?16/7/16505/abstract/33\">",
"     33",
"    </a>",
"    ]. Patients with a low pleural fluid pH malignant effusion have a high initial positive yield on pleural fluid cytology. They also tend to have a shorter survival and poorer response to chemical pleurodesis than those with a pH &gt;7.30, although the strength of these associations do not provide prognostic value for individual patients [",
"    <a class=\"abstract\" href=\"UTD.htm?16/7/16505/abstract/34-36\">",
"     34-36",
"    </a>",
"    ]. Clinicians should not use the pleural fluid pH as the sole criterion for the decision to recommend pleurodesis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/6/13416?source=see_link\">",
"     \"Management of malignant pleural effusions\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A parapneumonic effusion with a low pleural fluid pH (&le;7.15) indicates a high likelihood of necessity for pleural space drainage (",
"    <a class=\"graphic graphic_table graphicRef59099 \" href=\"UTD.htm?3/38/3693\">",
"     table 5",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?16/7/16505/abstract/37,38\">",
"     37,38",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/27/28089?source=see_link\">",
"     \"Parapneumonic effusion and empyema in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Amylase",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although not routinely tested in pleural fluid samples, amylase measurements can assist in settings wherein pancreatic or esophageal etiologies of an effusion appear possible. The finding of an amylase-rich pleural effusion, defined as either a pleural fluid amylase greater than the upper limits of normal for serum amylase or a pleural fluid to serum amylase ratio greater than 1.0, narrows the differential diagnosis of an exudative effusion to the following major possibilities [",
"    <a class=\"abstract\" href=\"UTD.htm?16/7/16505/abstract/2\">",
"     2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Acute pancreatitis",
"     </li>",
"     <li>",
"      Chronic pancreatic pleural effusion",
"     </li>",
"     <li>",
"      Esophageal rupture",
"     </li>",
"     <li>",
"      Malignancy",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Pleural fluid amylase, however, has low discriminative value for differentiating benign from malignant effusions so it is not routinely performed for this reason.",
"   </p>",
"   <p>",
"    Other rare causes of an amylase-rich pleural effusion include pneumonia, ruptured ectopic pregnancy, hydronephrosis, and cirrhosis [",
"    <a class=\"abstract\" href=\"UTD.htm?16/7/16505/abstract/39\">",
"     39",
"    </a>",
"    ]. Pancreatic disease is associated with pancreatic isoenzymes, while malignancy and esophageal rupture are characterized by a predominance of salivary isoenzymes [",
"    <a class=\"abstract\" href=\"UTD.htm?16/7/16505/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Adenosine deaminase",
"    </span>",
"    &nbsp;&mdash;&nbsp;Measurement of adenosine deaminase (ADA) may be helpful with a differential diagnosis of malignant versus tuberculous pleurisy when an exudative effusion is lymphocytic, but initial cytology and smear and culture for tuberculosis are negative [",
"    <a class=\"abstract\" href=\"UTD.htm?16/7/16505/abstract/40-42\">",
"     40-42",
"    </a>",
"    ]. The level of ADA is typically greater than 35 to50",
"    <span class=\"nowrap\">",
"     U/L",
"    </span>",
"    in tuberculous pleural effusions [",
"    <a class=\"abstract\" href=\"UTD.htm?16/7/16505/abstract/41,43\">",
"     41,43",
"    </a>",
"    ]. Specificity is increased when the lymphocyte to neutrophil ratio is greater than 0.75 and the ADA is greater than 50",
"    <span class=\"nowrap\">",
"     U/L",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?16/7/16505/abstract/44\">",
"     44",
"    </a>",
"    ]. False negatives and positive ADA results do occur, so ADA results need to be considered in the context of other features of the patient&rsquo;s clinical presentation [",
"    <a class=\"abstract\" href=\"UTD.htm?16/7/16505/abstract/43\">",
"     43",
"    </a>",
"    ]. ADA testing may be more valuable for ruling in the diagnosis of tuberculous pleurisy in geographic locations with high prevalence of tuberculosis, although the negative predictive value of ADA testing remains high in lower tuberculosis prevalence regions [",
"    <a class=\"abstract\" href=\"UTD.htm?16/7/16505/abstract/45\">",
"     45",
"    </a>",
"    ]. Some studies suggest greater diagnostic value of pleural fluid interferon gamma in differentiating malignant from tuberculous lymphocytic exudates, but the lower cost and ready availability has promoted the use of ADA testing in this setting [",
"    <a class=\"abstract\" href=\"UTD.htm?16/7/16505/abstract/46,47\">",
"     46,47",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/35/12856?source=see_link\">",
"     \"Tuberculous pleural effusions in HIV-negative patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     N-terminal pro-BNP",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several studies have demonstrated that N-terminal pro-brain natriuretic peptide (NT-proBNP) is elevated in the pleural fluid of patients who have heart failure and a pleural effusion [",
"    <a class=\"abstract\" href=\"UTD.htm?16/7/16505/abstract/48-55\">",
"     48-55",
"    </a>",
"    ]. Measuring pleural fluid NT-proBNP, however, has no added value as compared with blood NT-proBNP levels, which are elevated in heart failure and have a high degree of correlation with pleural NT-proBNP results [",
"    <a class=\"abstract\" href=\"UTD.htm?16/7/16505/abstract/14\">",
"     14",
"    </a>",
"    ]. Blood NT-proBNP testing is useful for diagnosing a cardiogenic pleural effusion in patients whose pleural fluid appears exudative (eg, due to diuresis). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/22/19818?source=see_link\">",
"     \"Natriuretic peptide measurement in heart failure\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Tumor markers",
"    </span>",
"    &nbsp;&mdash;&nbsp;No single pleural fluid tumor marker is accurate enough for routine use in the diagnostic evaluation of pleural effusion [",
"    <a class=\"abstract\" href=\"UTD.htm?16/7/16505/abstract/56\">",
"     56",
"    </a>",
"    ]. Measuring a panel of tumor markers (eg, carcinoembryonic antigen (CEA), carbohydrate antigen (CA) 125, CA 15-3, CA 19-9, cytokeratin fragment CYFRA 21-1) in pleural fluid has also been examined [",
"    <a class=\"abstract\" href=\"UTD.htm?16/7/16505/abstract/57,58\">",
"     57,58",
"    </a>",
"    ]. At levels that provide 100 percent specificity, individual sensitivities are less than 30 percent and a combination of four markers (CEA, CA 125, CA 15-3, and CYFRA 21) only reached 54 percent sensitivity in one study [",
"    <a class=\"abstract\" href=\"UTD.htm?16/7/16505/abstract/58\">",
"     58",
"    </a>",
"    ]. Similar results were reported in a meta-analysis that looked at various combinations [",
"    <a class=\"abstract\" href=\"UTD.htm?16/7/16505/abstract/57\">",
"     57",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Mesothelin is a glycoprotein that is highly over expressed in malignant mesothelioma cells [",
"    <a class=\"abstract\" href=\"UTD.htm?16/7/16505/abstract/59\">",
"     59",
"    </a>",
"    ]. Elevated levels of soluble mesothelin-related peptides (SMRPs), cleaved or unbound peptide fragments of mesothelin, have been found in pleural fluid",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    serum of patients with mesothelioma, ovarian, and pancreatic cancer. The role of SMRPs in the diagnosis of pleural mesothelioma is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/50/32552?source=see_link&amp;anchor=H1568139496#H1568139496\">",
"     \"Clinical presentation, diagnosis, and staging of malignant pleural mesothelioma\", section on 'Tumor markers'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Nucleated cells",
"    </span>",
"    &nbsp;&mdash;&nbsp;The total pleural fluid nucleated cell count is virtually never diagnostic. There are, however, some settings in which the count may be helpful:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Counts above",
"      <span class=\"nowrap\">",
"       50,000/microL",
"      </span>",
"      are usually found only in complicated parapneumonic effusions, including empyema",
"     </li>",
"     <li>",
"      Exudative effusions from bacterial pneumonia, acute pancreatitis, and lupus pleuritis usually have total nucleated cell counts above",
"      <span class=\"nowrap\">",
"       10,000/microL",
"      </span>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?16/7/16505/abstract/2,60\">",
"       2,60",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Chronic exudates, typified by tuberculous pleurisy and malignancy, typically have nucleated cell counts below",
"      <span class=\"nowrap\">",
"       5000/microL",
"      </span>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?16/7/16505/abstract/2,60\">",
"       2,60",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The timing of thoracentesis in relation to the acute pleural injury determines the predominant cell type. The early cellular response to pleural injury is neutrophilic. As the time from the acute insult lengthens, the effusion develops a mononuclear predominance if the pleural injury is not ongoing [",
"    <a class=\"abstract\" href=\"UTD.htm?16/7/16505/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Lymphocytosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pleural fluid lymphocytosis, particularly with lymphocyte counts representing 85 to 95 percent of the total nucleated cells, suggests tuberculous pleurisy, lymphoma, sarcoidosis, chronic rheumatoid pleurisy, yellow nail syndrome, or chylothorax [",
"    <a class=\"abstract\" href=\"UTD.htm?16/7/16505/abstract/2,3,61\">",
"     2,3,61",
"    </a>",
"    ]. Carcinomatous pleural effusions will be lymphocyte-predominant in over one-half of cases; however, the percentage of lymphocytes is usually between 50 and 70 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?16/7/16505/abstract/61\">",
"     61",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/35/12856?source=see_link\">",
"     \"Tuberculous pleural effusions in HIV-negative patients\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/15/30969?source=see_link\">",
"     \"AIDS-related lymphomas: Primary effusion lymphoma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/20/37192?source=see_link\">",
"     \"Etiology, clinical presentation, and diagnosis of chylothorax\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Eosinophilia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pleural fluid eosinophilia (defined by pleural fluid eosinophils representing more than 10 percent of the total nucleated cells) usually suggests a benign, self-limited disease, and is commonly associated with air or blood in the pleural space [",
"    <a class=\"abstract\" href=\"UTD.htm?16/7/16505/abstract/62,63\">",
"     62,63",
"    </a>",
"    ]. However, two studies have noted that malignancy is as prevalent in eosinophilic as noneosinophilic pleural effusions [",
"    <a class=\"abstract\" href=\"UTD.htm?16/7/16505/abstract/64,65\">",
"     64,65",
"    </a>",
"    ]. The differential diagnosis of pleural fluid eosinophilia includes [",
"    <a class=\"abstract\" href=\"UTD.htm?16/7/16505/abstract/62,63,66\">",
"     62,63,66",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Pneumothorax",
"     </li>",
"     <li>",
"      Hemothorax",
"     </li>",
"     <li>",
"      Pulmonary infarction",
"     </li>",
"     <li>",
"      Benign asbestos pleural effusion",
"     </li>",
"     <li>",
"      Parasitic disease",
"     </li>",
"     <li>",
"      Fungal infection (coccidioidomycosis, cryptococcosis, histoplasmosis)",
"     </li>",
"     <li>",
"      Drugs",
"     </li>",
"     <li>",
"      Malignancy (carcinoma, lymphoma)",
"     </li>",
"     <li>",
"      Catamenial pneumothorax with pleural effusion",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Pleural fluid eosinophilia appears to be rare with tuberculous pleurisy on the initial thoracentesis [",
"    <a class=\"abstract\" href=\"UTD.htm?16/7/16505/abstract/62,63\">",
"     62,63",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/53/29527?source=see_link\">",
"     \"Pleural fluid eosinophilia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Mesothelial cells",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mesothelial cells are found in small numbers in normal pleural fluid, are prominent in transudative pleural effusions, and are variable in exudative effusions. The major clinical significance of mesothelial cells in exudates is that tuberculosis is unlikely if there are more than 5 percent mesothelial cells [",
"    <a class=\"abstract\" href=\"UTD.htm?16/7/16505/abstract/61,63,67,68\">",
"     61,63,67,68",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A listing of most of the causes of pleural effusion, differentiated by whether the fluid is transudative or exudative, is given in the tables (",
"    <a class=\"graphic graphic_table graphicRef50027 \" href=\"UTD.htm?42/19/43323\">",
"     table 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef74757 \" href=\"UTD.htm?27/12/27852\">",
"     table 2",
"    </a>",
"    ). The evaluation of pleural effusions of undetermined etiology after the above evaluation is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/36/2632?source=see_link\">",
"     \"Diagnostic evaluation of pleural effusion in adults: Additional tests for undetermined etiology\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?9/50/10018?source=see_link\">",
"       \"Patient information: Pleural effusion (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?24/3/24624?source=see_link\">",
"       \"Patient information: Thoracentesis (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H365048\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Analysis of pleural fluid can help to establish a diagnosis in approximately 75 percent (",
"      <a class=\"graphic graphic_table graphicRef50027 \" href=\"UTD.htm?42/19/43323\">",
"       table 1",
"      </a>",
"      ). Even when pleural fluid analysis does not identify the exact cause of a pleural effusion, characterizing the features of the pleural fluid can help narrow the differential diagnosis. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Characteristics of the gross appearance of pleural fluid that are helpful in identifying the cause of the effusion are listed in the table (",
"      <a class=\"graphic graphic_table graphicRef74757 \" href=\"UTD.htm?27/12/27852\">",
"       table 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Gross appearance'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      An important initial step in the analysis of pleural fluid is to ascertain whether the fluid is a transudate or an exudate. Transudates are largely due to imbalances in hydrostatic and oncotic pressures in the chest (",
"      <a class=\"graphic graphic_table graphicRef73530 \" href=\"UTD.htm?38/49/39708\">",
"       table 3",
"      </a>",
"      ). Exudates are caused by a variety of mechanisms, including infection, malignancy, immunologic responses, lymphatic abnormalities, noninfectious inflammation, and trauma (",
"      <a class=\"graphic graphic_table graphicRef54055 \" href=\"UTD.htm?37/9/38045\">",
"       table 4",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Characterization'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      According to Light's traditional criteria, if at least one of the following three criteria is present, the fluid is defined as an exudate (see",
"      <a class=\"local\" href=\"#H8\">",
"       'Diagnostic criteria'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Pleural fluid",
"      <span class=\"nowrap\">",
"       protein/serum",
"      </span>",
"      protein ratio greater than 0.5",
"     </li>",
"     <li>",
"      Pleural fluid lactate dehydrogenase",
"      <span class=\"nowrap\">",
"       (LDH)/serum",
"      </span>",
"      LDH ratio greater than 0.6",
"     </li>",
"     <li>",
"      Pleural fluid LDH greater than two-thirds the upper limits of the laboratory's normal serum LDH",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Other sets of criteria, called the two and three test rules have been developed to avoid needing simultaneous measurement of LDH or protein. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Diagnostic criteria'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A low pleural fluid glucose concentration (less than 60",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      [3.33",
"      <span class=\"nowrap\">",
"       mmol/liter])",
"      </span>",
"      or a pleural",
"      <span class=\"nowrap\">",
"       fluid/serum",
"      </span>",
"      glucose ratio less than 0.5 narrows the major differential diagnoses to rheumatoid pleurisy, tuberculous pleurisy or other infection, lupus pleuritis, malignant effusion, and esophageal rupture. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Glucose'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The measurement of cholesterol, triglycerides, amylase, and pH can provide useful additional information in selected patients. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Cholesterol'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H25763845\">",
"       'Triglycerides'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H14\">",
"       'pH'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H15\">",
"       'Amylase'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Measurement of adenosine deaminase may be helpful when an effusion is lymphocytic, but initial smear and culture for tuberculosis are negative. The level of adenosine deaminase (ADA) is typically greater than 50",
"      <span class=\"nowrap\">",
"       U/L",
"      </span>",
"      in tuberculous pleural effusions. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Adenosine deaminase'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Predominant populations of neutrophils, lymphocytes, or eosinophils in the pleural fluid can help narrow the diagnostic possibilities. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Nucleated cells'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The evaluation of pleural effusions of undetermined etiology after the above evaluation is discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?2/36/2632?source=see_link\">",
"       \"Diagnostic evaluation of pleural effusion in adults: Additional tests for undetermined etiology\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16505/abstract/1\">",
"      Collins TR, Sahn SA. Thoracocentesis. Clinical value, complications, technical problems, and patient experience. Chest 1987; 91:817.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16505/abstract/2\">",
"      Sahn SA. State of the art. The pleura. Am Rev Respir Dis 1988; 138:184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16505/abstract/3\">",
"      Sahn, SA. The diagnostic value of pleural fluid analysis. Semin Respir Crit Care Med 1995; 16:269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16505/abstract/4\">",
"      Ali HA, Lippmann M, Mundathaje U, Khaleeq G. Spontaneous hemothorax: a comprehensive review. Chest 2008; 134:1056.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16505/abstract/5\">",
"      Light RW, Macgregor MI, Luchsinger PC, Ball WC Jr. Pleural effusions: the diagnostic separation of transudates and exudates. Ann Intern Med 1972; 77:507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16505/abstract/6\">",
"      Heffner JE, Brown LK, Barbieri CA. Diagnostic value of tests that discriminate between exudative and transudative pleural effusions. Primary Study Investigators. Chest 1997; 111:970.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16505/abstract/7\">",
"      Gonlugur U, Gonlugur TE. The distinction between transudates and exudates. J Biomed Sci 2005; 12:985.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16505/abstract/8\">",
"      Porcel JM, Pe&ntilde;a JM, Vicente de Vera C, et al. Bayesian analysis using continuous likelihood ratios for identifying pleural exudates. Respir Med 2006; 100:1960.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16505/abstract/9\">",
"      Heffner JE, Highland K, Brown LK. A meta-analysis derivation of continuous likelihood ratios for diagnosing pleural fluid exudates. Am J Respir Crit Care Med 2003; 167:1591.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16505/abstract/10\">",
"      Chakko SC, Caldwell SH, Sforza PP. Treatment of congestive heart failure. Its effect on pleural fluid chemistry. Chest 1989; 95:798.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16505/abstract/11\">",
"      Shinto RA, Light RW. Effects of diuresis on the characteristics of pleural fluid in patients with congestive heart failure. Am J Med 1990; 88:230.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16505/abstract/12\">",
"      Romero-Candeira S, Fern&aacute;ndez C, Mart&iacute;n C, et al. Influence of diuretics on the concentration of proteins and other components of pleural transudates in patients with heart failure. Am J Med 2001; 110:681.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16505/abstract/13\">",
"      Roth BJ, O'Meara TF, Cragun WH. The serum-effusion albumin gradient in the evaluation of pleural effusions. Chest 1990; 98:546.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16505/abstract/14\">",
"      Porcel JM. Utilization of B-type natriuretic peptide and NT-proBNP in the diagnosis of pleural effusions due to heart failure. Curr Opin Pulm Med 2011; 17:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16505/abstract/15\">",
"      Winterbauer RH, Riggins RC, Griesman FA, Bauermeister DE. Pleuropulmonary manifestations of Waldenstrom's macroglobulinemia. Chest 1974; 66:368.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16505/abstract/16\">",
"      Rodr&iacute;guez JN, Pereira A, Mart&iacute;nez JC, et al. Pleural effusion in multiple myeloma. Chest 1994; 105:622.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16505/abstract/17\">",
"      Light RW, Girard WM, Jenkinson SG, George RB. Parapneumonic effusions. Am J Med 1980; 69:507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16505/abstract/18\">",
"      Pettersson T, Klockars M, Hellstr&ouml;m PE. Chemical and immunological features of pleural effusions: comparison between rheumatoid arthritis and other diseases. Thorax 1982; 37:354.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16505/abstract/19\">",
"      Johnson JR, Falk A, Iber C, Davies S. Paragonimiasis in the United States. A report of nine cases in Hmong immigrants. Chest 1982; 82:168.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16505/abstract/20\">",
"      Horowitz ML, Schiff M, Samuels J, et al. Pneumocystis carinii pleural effusion. Pathogenesis and pleural fluid analysis. Am Rev Respir Dis 1993; 148:232.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16505/abstract/21\">",
"      Garcia-Pachon E, Padilla-Navas I. Urinothorax: case report and review of the literature with emphasis on biochemical diagnosis. Respiration 2004; 71:533.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16505/abstract/22\">",
"      Staats BA, Ellefson RD, Budahn LL, et al. The lipoprotein profile of chylous and nonchylous pleural effusions. Mayo Clin Proc 1980; 55:700.",
"     </a>",
"    </li>",
"    <li>",
"     Sahn SA. Pathogenesis and clinical features of diseases associated with a low pleural fluid glucose. In: The Pleura in Health and Disease, Chretien J, Bignon J, Hirsch A (Eds), Marcel Dekker, New York 1985. p.267-285.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16505/abstract/24\">",
"      Carr DT, McGuckin WF. Pleural fluid glucose. Serial observation of its concentration following oral administration of glucose to patients with rheumatoid pleural effusions and malignant effusions. Am Rev Respir Dis 1968; 97:302.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16505/abstract/25\">",
"      Taryle DA, Good JT Jr, Sahn SA. Acid generation by pleural fluid: possible role in the determination of pleural fluid pH. J Lab Clin Med 1979; 93:1041.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16505/abstract/26\">",
"      Good JT Jr, Taryle DA, Sahn SA. The pathogenesis of low glucose, low pH malignant effusions. Am Rev Respir Dis 1985; 131:737.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16505/abstract/27\">",
"      Sahn SA, Reller LB, Taryle DA, et al. The contribution of leukocytes and bacteria to the low pH of empyema fluid. Am Rev Respir Dis 1983; 128:811.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16505/abstract/28\">",
"      Cheng DS, Rodriguez RM, Rogers J, et al. Comparison of pleural fluid pH values obtained using blood gas machine, pH meter, and pH indicator strip. Chest 1998; 114:1368.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16505/abstract/29\">",
"      Bowling M, Lenz P, Chatterjee A, et al. Perception versus reality: the measuring of pleural fluid pH in the United States. Respiration 2012; 83:316.",
"     </a>",
"    </li>",
"    <li>",
"     Sahn SA. Pleural fluid pH in the normal state and in diseases affecting the pleural space. In: The Pleura in Health and Disease, Chretien J, Bignon J, Hirsch A (Eds), Marcel Dekker, New York 1985. p.253.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16505/abstract/31\">",
"      Sahn SA, Willcox ML, Good JT Jr, et al. Characteristics of normal rabbit pleural fluid: physiologic and biochemical implications. Lung 1979; 156:63.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16505/abstract/32\">",
"      Good JT Jr, Antony VB, Reller LB, et al. The pathogenesis of the low pleural fluid pH in esophageal rupture. Am Rev Respir Dis 1983; 127:702.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16505/abstract/33\">",
"      Sahn SA, Good JT Jr. Pleural fluid pH in malignant effusions. Diagnostic, prognostic, and therapeutic implications. Ann Intern Med 1988; 108:345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16505/abstract/34\">",
"      Burrows CM, Mathews WC, Colt HG. Predicting survival in patients with recurrent symptomatic malignant pleural effusions: an assessment of the prognostic values of physiologic, morphologic, and quality of life measures of extent of disease. Chest 2000; 117:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16505/abstract/35\">",
"      Heffner JE, Nietert PJ, Barbieri C. Pleural fluid pH as a predictor of survival for patients with malignant pleural effusions. Chest 2000; 117:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16505/abstract/36\">",
"      Heffner JE, Nietert PJ, Barbieri C. Pleural fluid pH as a predictor of pleurodesis failure: analysis of primary data. Chest 2000; 117:87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16505/abstract/37\">",
"      Heffner JE, Heffner JN, Brown LK. Multilevel and continuous pleural fluid pH likelihood ratios for draining parapneumonic effusions. Respiration 2005; 72:351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16505/abstract/38\">",
"      Jim&eacute;nez Castro D, D&iacute;az Nuevo G, Sueiro A, et al. Pleural fluid parameters identifying complicated parapneumonic effusions. Respiration 2005; 72:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16505/abstract/39\">",
"      Joseph J, Viney S, Beck P, et al. A prospective study of amylase-rich pleural effusions with special reference to amylase isoenzyme analysis. Chest 1992; 102:1455.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16505/abstract/40\">",
"      Piras MA, Gakis C, Budroni M, Andreoni G. Adenosine deaminase activity in pleural effusions: an aid to differential diagnosis. Br Med J 1978; 2:1751.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16505/abstract/41\">",
"      Riantawan P, Chaowalit P, Wongsangiem M, Rojanaraweewong P. Diagnostic value of pleural fluid adenosine deaminase in tuberculous pleuritis with reference to HIV coinfection and a Bayesian analysis. Chest 1999; 116:97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16505/abstract/42\">",
"      Liang QL, Shi HZ, Wang K, et al. Diagnostic accuracy of adenosine deaminase in tuberculous pleurisy: a meta-analysis. Respir Med 2008; 102:744.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16505/abstract/43\">",
"      Ogata Y, Aoe K, Hiraki A, et al. Is adenosine deaminase in pleural fluid a useful marker for differentiating tuberculosis from lung cancer or mesothelioma in Japan, a country with intermediate incidence of tuberculosis? Acta Med Okayama 2011; 65:259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16505/abstract/44\">",
"      Burgess LJ, Maritz FJ, Le Roux I, Taljaard JJ. Combined use of pleural adenosine deaminase with lymphocyte/neutrophil ratio. Increased specificity for the diagnosis of tuberculous pleuritis. Chest 1996; 109:414.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16505/abstract/45\">",
"      Porcel JM, Esquerda A, Bielsa S. Diagnostic performance of adenosine deaminase activity in pleural fluid: a single-center experience with over 2100 consecutive patients. Eur J Intern Med 2010; 21:419.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16505/abstract/46\">",
"      Liu YC, Shin-Jung Lee S, Chen YS, et al. Differential diagnosis of tuberculous and malignant pleurisy using pleural fluid adenosine deaminase and interferon gamma in Taiwan. J Microbiol Immunol Infect 2011; 44:88.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16505/abstract/47\">",
"      Kalantri Y, Hemvani N, Chitnis DS. Evaluation of real-time polymerase chain reaction, interferon-gamma, adenosine deaminase, and immunoglobulin A for the efficient diagnosis of pleural tuberculosis. Int J Infect Dis 2011; 15:e226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16505/abstract/48\">",
"      Kolditz M, Halank M, Schiemanck CS, et al. High diagnostic accuracy of NT-proBNP for cardiac origin of pleural effusions. Eur Respir J 2006; 28:144.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16505/abstract/49\">",
"      Tomcs&aacute;nyi J, Nagy E, Soml&oacute;i M, et al. NT-brain natriuretic peptide levels in pleural fluid distinguish between pleural transudates and exudates. Eur J Heart Fail 2004; 6:753.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16505/abstract/50\">",
"      Porcel JM, Vives M, Cao G, et al. Measurement of pro-brain natriuretic peptide in pleural fluid for the diagnosis of pleural effusions due to heart failure. Am J Med 2004; 116:417.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16505/abstract/51\">",
"      Porcel JM, Mart&iacute;nez-Alonso M, Cao G, et al. Biomarkers of heart failure in pleural fluid. Chest 2009; 136:671.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16505/abstract/52\">",
"      Zhou Q, Ye ZJ, Su Y, et al. Diagnostic value of N-terminal pro-brain natriuretic peptide for pleural effusion due to heart failure: a meta-analysis. Heart 2010; 96:1207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16505/abstract/53\">",
"      Porcel JM, Chorda J, Cao G, et al. Comparing serum and pleural fluid pro-brain natriuretic peptide (NT-proBNP) levels with pleural-to-serum albumin gradient for the identification of cardiac effusions misclassified by Light's criteria. Respirology 2007; 12:654.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16505/abstract/54\">",
"      Long AC, O'Neal HR Jr, Peng S, et al. Comparison of pleural fluid N-terminal pro-brain natriuretic peptide and brain natriuretic-32 peptide levels. Chest 2010; 137:1369.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16505/abstract/55\">",
"      Janda S, Swiston J. Diagnostic accuracy of pleural fluid NT-pro-BNP for pleural effusions of cardiac origin: a systematic review and meta-analysis. BMC Pulm Med 2010; 10:58.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16505/abstract/56\">",
"      Light RW. Tumor markers in undiagnosed pleural effusions. Chest 2004; 126:1721.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16505/abstract/57\">",
"      Liang QL, Shi HZ, Qin XJ, et al. Diagnostic accuracy of tumour markers for malignant pleural effusion: a meta-analysis. Thorax 2008; 63:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16505/abstract/58\">",
"      Porcel JM, Vives M, Esquerda A, et al. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions. Chest 2004; 126:1757.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16505/abstract/59\">",
"      Hassan R, Remaley AT, Sampson ML, et al. Detection and quantitation of serum mesothelin, a tumor marker for patients with mesothelioma and ovarian cancer. Clin Cancer Res 2006; 12:447.",
"     </a>",
"    </li>",
"    <li>",
"     Light RW. Pleural diseases, 3rd ed, Williams &amp; Wilkins, Baltimore 1995.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16505/abstract/61\">",
"      Yam LT. Diagnostic significance of lymphocytes in pleural effusions. Ann Intern Med 1967; 66:972.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16505/abstract/62\">",
"      Adelman M, Albelda SM, Gottlieb J, Haponik EF. Diagnostic utility of pleural fluid eosinophilia. Am J Med 1984; 77:915.",
"     </a>",
"    </li>",
"    <li>",
"     Spriggs AI, Boddington NM. The Cytology of Effusions, 2nd ed, Grune and Stratton, New York 1968.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16505/abstract/64\">",
"      Rubins JB, Rubins HB. Etiology and prognostic significance of eosinophilic pleural effusions. A prospective study. Chest 1996; 110:1271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16505/abstract/65\">",
"      Mart&iacute;nez-Garc&iacute;a MA, Cases-Viedma E, Cordero-Rodr&iacute;guez PJ, et al. Diagnostic utility of eosinophils in the pleural fluid. Eur Respir J 2000; 15:166.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16505/abstract/66\">",
"      Fatimi SH, Deedar-Ali-Khawaja R. Catamenial pneumothorax associated with ascites, eosinophilic pleural effusion, and relatively low glucose content. Am Surg 2010; 76:E212.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16505/abstract/67\">",
"      Light RW, Erozan YS, Ball WC Jr. Cells in pleural fluid. Their value in differential diagnosis. Arch Intern Med 1973; 132:854.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?16/7/16505/abstract/68\">",
"      Hurwitz S, Leiman G, Shapiro C. Mesothelial cells in pleural fluid: TB or not TB? S Afr Med J 1980; 57:937.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6698 Version 12.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-115.66.252.144-6ED53622C5-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_7_16505=[""].join("\n");
var outline_f16_7_16505=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H365048\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      INDICATIONS FOR THORACENTESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PLEURAL FLUID ANALYSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Gross appearance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Characterization",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Transudates",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Exudates",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Diagnostic criteria",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Chemical analysis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Protein",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - LDH",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Cholesterol",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H25763845\">",
"      - Triglycerides",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Glucose",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - pH",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Amylase",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Adenosine deaminase",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - N-terminal pro-BNP",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Tumor markers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Nucleated cells",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Lymphocytosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Eosinophilia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Mesothelial cells",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H365048\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PULM/6698\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/6698|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?42/19/43323\" title=\"table 1\">",
"      Dx by pleural fluid analysis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?27/12/27852\" title=\"table 2\">",
"      Pleural fluid characteristics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?38/49/39708\" title=\"table 3\">",
"      Transudative pleural effusions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?37/9/38045\" title=\"table 4\">",
"      Exudative pleural effusions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?3/38/3693\" title=\"table 5\">",
"      Parapneumonic effusion drainage",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/15/30969?source=related_link\">",
"      AIDS-related lymphomas: Primary effusion lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/45/31448?source=related_link\">",
"      Clinical presentation, diagnosis and management of cholesterol effusions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/50/32552?source=related_link\">",
"      Clinical presentation, diagnosis, and staging of malignant pleural mesothelioma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/36/2632?source=related_link\">",
"      Diagnostic evaluation of pleural effusion in adults: Additional tests for undetermined etiology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/23/12663?source=related_link\">",
"      Diagnostic thoracentesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/20/37192?source=related_link\">",
"      Etiology, clinical presentation, and diagnosis of chylothorax",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/56/21384?source=related_link\">",
"      Imaging of pleural effusions in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/6/13416?source=related_link\">",
"      Management of malignant pleural effusions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/53/36695?source=related_link\">",
"      Mechanisms of pleural liquid accumulation in disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/22/19818?source=related_link\">",
"      Natriuretic peptide measurement in heart failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/27/28089?source=related_link\">",
"      Parapneumonic effusion and empyema in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?9/50/10018?source=related_link\">",
"      Patient information: Pleural effusion (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?24/3/24624?source=related_link\">",
"      Patient information: Thoracentesis (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/53/29527?source=related_link\">",
"      Pleural fluid eosinophilia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/35/12856?source=related_link\">",
"      Tuberculous pleural effusions in HIV-negative patients",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f16_7_16506="Dissecting cellulitis of the scalp";
var content_f16_7_16506=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F75929%7EDERM%2F81039&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F75929%7EDERM%2F81039&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Dissecting cellulitis of the scalp",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 379px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAF7AfgDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5tNJQTRmrOcTvSNkUtJ3z3oAPrSHpQTg+1GaChv40h6DFGOKKAEJwM+lRKcvlvWpcgcdQetTNDEF3ZwMdMVS0Gis6jHDZA7VZheOOA70OSMCo44kbLpyPSpJFYgOy49jVDLFsACgHzFv0ragxFF8wXPcnsKwos7gIwQO5qSSV2RiznHQDNZTjzM1py5didSs0rbnZFz971q8MrEAmBGvHzHmsy1YrH+9Usx/h9a0Zmkig825WMcYWM/e+tFrKwk9bsoqMSBVAMshwO5/CrE9rLI8IlCoemBxj61UjcAxzMNzDnGcGry3ck67ztSOPnI602kgTb0IriB96RhtxA6joK1tNthahJZAJS3B3HmqtjAzyeYwJX07j6itaAvdOqRbUUDOS3T8KxqSb2RtSiluyrI8cjPujZv7g7A+tTwwOAxlxhSAEYYzXQWFlbZQQgs6fNluCKytRVGu/LifzQnJ3Ngk1KknoXKLWpmyWc927SgKpJx5fYD61fnZY4kKwmGVVAwB8v15qBpJfNW1slEaMwO0vu2n1zUlxD5chkaWGVI8B1c5yfYetOxN7DJ5HdI8/M5OAh7H1qSx8+CWf7RCs5aM4x0FWopFctIbRW8sYG4j8AK0VklCKY5goePhAMyH29ql2Q1d7sydLtZIrIsiqMcLIxPH0Fa7+UlmyzjfPD94wrnP4VXs7ZFtyY2byt26Rs5KH0x3qxdLdb1hgdvKYhpJJCFP4Cp3L2Me8mS2Jg2eT5hDbgvb1zT9RjW8MbkhbSGPcMnG8+vvW29lZyEQ3DRSzqN7hyWwMVjSzW842xRbLdDtyAflOexq9Ohnd9SqiCecGzhwygM+eMe9Fi8lxcyeYxEMZP3WAxitfSbKOXUXk3T3bjCbfujHvVCe0C6hcM5jyZeFB4KjsPSi/QaC0uFkkuZo1d4o0yAejN9avW9kWQXN9LKZOFXaflTPQVUe0a5vpEt87cBgFOAQOcYqy0RtJWN6HWzkw/lrkbX7ZqZIpa7inT3juBFc5UbsLhtzH3qgiyfapSSJEJIjVjhuP0rSkjYbh5Q+1eYrwLJkBjjpmoLBA967zwsyhz5mBuGfTHYA0ktLg9GZ051K2JiErIzfNuxny17YNOsIwIW8qPeSNzTSnOc+1bBQC9lVzusZG2BQO+M/WoLp42tSlrCbby5AfUuPb2ob0BIimhhVyBC4VlVi5bK/nWcts5lmQZZM87WwMV0scsV/ZjzBGi42tG3BPuDWOLS5E6JG4aJdykN2A7Uk9NRtFae0WKIF1DNwsa9R9TWXeXiwJM8tqvm7+H9fwrZDrFdHyCrkcnJ4A9KxdR33Dz/KgxJtAHOR7Va7mckUJJWvI9iJvnc5I2421p6a0qBYxGCAdpHTBqFSrSCOFDG0iYLk5IpLWSfcBCcxR8SSj/Cq32Jvbcj1uMxzdGjTvnqTVKPyWEbSEA9CR3rWFzJcjzwA6xL8+8cAVSDx3cgWNF8tehHFNCe+hNaTKyyQh0AYcO3asTU4SrbUG4dNw6GrojZZZF2hRHyQe9MQ+cWIJyOQB0FWtCN9jGA8okN1olhKoH42n0q/IiyyGSVNq96qXS7SAh+XsKskgzg8U6mjG33pVOaZLHA4NSA5FRgZpwOOnIqxD80opgI3e9OFK4h4pc88U0UoNMQ/OaXNMU806pSsA+jNNB6U6qAKKCcUUANNJRig9MVmSIx7UhNLTW9aAE60UdsDrRQUBpjNjjvTicVEQXfimMltYzJIOQOav3CxwvtzuPpSad5SQvK+OPu5qt5iz3ADNx60PUpaE8OVWRYYyWPfsKijOUwWb5eoPerkdw8cD28BARjy2OailtjGUDYVuuAev1qr62BIcQg2g5BI6Ci3giRgZXVlJ4AOTmokdGuguSCepq1ZzRw6qjyRJMinlSOtDGh1xKv2lDuDgDBAGKZJJJNKvm5CJwQOSBV26AmjN0YVVmOCijgCqNw4iiYW67SThieajfUb03LU0VhHIXtXmm5IGegHrmremWdrPbv5sjpKV3ZOAKx7ZpCiBlfZ0bYP51pafFi4jYqWDfcwelNuyFGN2aNnZ20UOZLpojnJbpn2rUtbWwVJLiEs3ZWZsYPYgd6yb1ITdRIWkkDNnYDgD61pTs5khgkWMAjZkKML+H0rn5mdXKRpLfwvIIv8AWSEDceQR70LJJbGeG5WLz2OXAGSf/rUs0yQXBSIGOAqF4OWIz1/Gql3vku44Y94aXIBDZI+tJKzBu5XujulDSMfNcYjQcHH+0B0qRdPbcWktX2u3yhjtGB/SrUQi0i8Uyb5JDgZY8n6+1XLgG+dJp5xOr4AiVsKi+hNVewrDLLTZriM+SDKYx8h6RnnoD3NXrGyuHld4bWZZy+GldwAOOQB7U6XUwzR2sIjmhhHysSVVpD0VR7Yq9CzeU5u5tk8zDKl+EHt70pNjSIYDaWsj+UNqLkKpyc9i2fWjyn/s0zkl7gKzHnogPX61bvrX7LpsMHLbTgbjyq/xMfrVQaZLLYSuJmWOE7g+eCp9RUPQvcz/ACGudkjSYyS5QHlxngE1oQxNqMkcCoALdNrRjC7OfvZ71ab7ELYI8oZgPldTtH5Gsyxtpg+21kkjZ8726hqFKwOnoMlkm0+6ktbZ9xkmDiYHOD3yfSrBtWXVZ45HhMDAFpAAQSeeMVcTTDJaeTIk0QZ/3rRDnPtUJ0qa4EYhFqkEe4HcxDMAerD1o5kxcrW42+hha6WWOV5ESNgWjwMkVdtb6zfTFi1CP5pwdgdSzkdAahNzFNaLFabFkilEe5k4b8PeqUs8KXU8sTu0pkVQqjJTHUj2qbsq1i5rDQrZWGnRMvnykbRv3SIB0PseKrLElpeutt5jPG/73ceAMc/Ws3U9lxqrXFuqq+7cFxyCBzT47y5hhBhd3LSb5GYZUZqtloJK+5PMkf20QxuGDf6sg4LBu+avapEIF3gA+Qg3KGzu9AKzorG2lC7pFM45U5KgEnp/+qpNN+0Lq88My+ZFCu0Sg/ebsPwotcm9mWZI4jp8BuGMTyM0jIeMY7CqdgvnMJpJHZFQuMDBb15q7cW/nTG6vgHWVTGqRn7p9SOxqis9raXcW6VniERCLggg+hpFoyykkk8qxAgk7ogy/Mw6nNblnp0UtokriMyH5hgYbJPNWlsDHPbAlVlERd+cmr9hbRgiUHOV+6o6H1qKktNC6cNdTJvbGCL95GFDAfMmK5GC2DXdwGLLGecKeCfSvQ7q1jnLL5YyAfmHWuV1DSDljE7L3I96inVLqUtDBnt2hs5ijBozyydx7VNZfZbe0Roojtbq7joa043toY5EmG126AjIIHes+NsiWO7k4blAOBiuhSucsoWehSnlW5uhudS33QVHBqrdsIyRCVDdGUCmcwzMQqMFyEJ/nUi4kSIsNs+dxOeorSxjcpTIyqqvjDdKo3AZArdc8Vq3qCW7UFT5WecHkVQvLaeBzHIvyfeUn0rVWIbKI5pwUZ64zTV69akaNiu7t60xMUcH60q9KYoI609e1NEsUDFOU4NJminYQvOeOlOBpopwpiDJ4xUnOB0qOnA0APFLTe3HWlFS3qA6ikAJoqgG5pG4GaWkrMkTtQ1HPrSn3oKsMoNBNITgUwGSn5cUsCHaTUDtvYjtUsc2wMMdRiq0sWkLuxDk881LbRgfM/LY4A7VAAvlfN69Kt2ZHGBnOfwoEXNNnjVpDIu444PpTZnEu/zB1HBqs7PE2EAKnrTyokxglfaku5V+hNaWuD5km0KB+JqxbPFFLJMvzDgADuahZilsWUfOwwoNFmzWsXIV95+6eSPeoeu5cfd2LZhd0w8m1s59sUhh+2O0IDM2eAOMY7n2qM3MtxJIc+WAcID3qxZqrRyHLISeefvA+9Pm5VcbjzSsKli0MG8/Kjk7cHrjvUtjmIxeUEUZxuPb3NWJyWYQbmdVTCbePwNaMNlvMSSghGxkDgVg6nc3jS7FCOxuLyY37zQiNmKbUb5sAdh6VJbWkoZNitiXIzK3b1qzI/2S6MC8xIcMAOT+PtVaVo1mLzRz+XjGQeWY9var3Rns7FyKGKzMtvIPMgmKnzueTjoT2FXoZoBIrRhMshQKwPK+xqtCkctxGmStghEnlM+4lscCtI3FpcSOkEBEyjHlKmcY759Kzm7GtJXILS1t7oyCaKT7PjIGOnvzWglnZ2aSJaQlyeMMOvuMUaYhmaTa6mT7u0HI/wDr1twwpA8Rud0spO5VjXCg+9ZKbeh0Omk+YwfKECwtcwyRWr9E8vJDepPXmq0+orO0ktvaEykBGtpV+7tP3s1uajcG81OJyYlYcpAVPy+oAqIhTOLyGJpZznHmNt5B5BHpWnmc7TKt01ubKMb1Amf5Qhyw9Q2e1PghcRofNfd9yTdwCO31pZraHgs6MzsWdtu0ZJ5/AUR4EYFpu2jjluG56is6jsjanEybsO87bo1nfGFbtWhpEJE0AupJEVeSUXLfSnPE0hbykAHUZ7+4q/bxEgFxuJHXJH0rCU3udKgh6ZVmxdPES/AAOfY0yYGffG6icg7iZG+Zh3q23mrKGPBI27QBwfXNVWiYXDliHfaTlevPvS5rkuCRUlAWYTeUreYMB2zhB0wAO/vUtzo8b2hlNwilBtZU4ZgOnSn6pcNGkERSORGG1VHU/Wq8TbrFpc/OHxu2459D9K2U7GHKrmJIpjvreWzVzdpGFWELndzyWNa1r8ziK7YRMHIZ4VyMnt/TNUNXMcd0kloGMp5Lx5A6jP4VXtxJeTvLG4jbJ8xGbbz61oveRk/dehotiyn2XMamWWTKRh8lT/ePpVezF7da1CbppB8x3CH5QCP73rStHDC/79hJHIwL4OTwMj5quQwyrcLPGoleYGTaCf3J7ZB70xLuXm81GupfL2BpVVUdchj/AHifpWTqMJhuo5JFDOTmN15H19KswyBtSCL5jxMMyheMv2UfjV1og0RjVZFi37kDEA8fw1FrFp66jgkstv5siqWQAAkdPrVd72NBLFE371GDsGbAIPofSpRcW5jk3naEHzu2cYJ7VjSxk27DdI4DgAbeJE9d1NR5kVzcrOjhvI3DhiigHIKnO5fWoLiyP2vzl+aFl+XNYvleXLEGwuF8shuOvbNXbPWI0uPs8hYGPoi9Co6isZU7M1jVujN1G1S4ZgkQXGQc9M1zjW0sw85VOFO0j0x6V3l7eQXDLGRsy6qDkDOah1C1EYMcUSo+fvev4U03EUoqR5hPCftkgwEBJIVjUssRjtVmcou/op6itjVbWKe6lVlwQeWxWBPG6xyK8jbYm+6TjI9RXZTmpaM4alOzuiYALIrJ8yYztHJrQvo7Wax3FsuR8pbqPasi1mVbpGYsgPCtUsytMoOc9Rkd6eq1JVmjHuIBbzjB3RnvUsew7gGB9BV64gWdMAbAnXNZbp5bhQfmHeqTuQ1YZOpVyDilHG2mysX5xjFKjEj3rRMljqWg9KZzRcgfTgaaORSiqAeOlC00dacDg0C2HUopvWnCoe4DgfSikop8wCUh4GKWipYkNHSjHvTugpM0DGniop26Doe9TEc81TlO6Q+1NDS1HEc4A4NBAR+e1AY8c0qZySR+dVYokLbo0BAx14q1aoTCwTtzUcaqUyRjParEbiONiMdMUXQEk8VuIY2tnbeVzIGHGabawtIFLBgW6nFM/dzQrH8oKeg5NaNmrQ2ckrcllwi9cVM2klcqELsgufLJSNCMp1Oev0q3aWjtucoCiDLN/hUU0CTyR+RHswvOTyx9a1baJmkCA7SwG76VEpJGkKbZjOPNjULG55wB3zVxAEaOCJd0hYEqeceua0Ly3EQhEIZlJOQOv1pLWeNZ4Yo7dUuUBV+OahyTiaxhaRf0mzFuGST5yTuyOgPpW3ahJ3aJuqHrnAzWbCjqWByE2liD1q3Y20m0yyArxwM9a4m76ndZbIeLKM+cII3llDYxt5/A+lQaxbWtrKZrn5cthI0BLdOARWxNdRafbeYd880ibsehrl7ia5nYyjcsshO9SpOF/p+FdEG3ozlnFR1RVuFlure1S3hjikgQ7pUypkyf1xV7TIrqe9+WRwZRsKg4LDFNMq2MUiSbHnKfLKG2hU9APWuh8Ly28ElsUjDu6sS8i5K/LgCqctbdB0qfuubG6dDBZQxywSqsgDCQOPu8/wA62ZNRtkLGzlSeMptfcCCzY5C+n1rAuWY5jhQLFBI0pLYAII+6Aev1pNQmke7hktYYUinQBsEHkds/1qbaFt62EuJntbdELSxag5+RFIYqvbLHpWmhW20+NZpoZ5ScsgBPmE9ST61iWZEeoMkpdpAdzbVyq+gzWwIbmS3Fz5QECtt3N3PYYqHLoVGnzashIsTDI0ayK+Mosn3QT1H0qA27NPHsBLquRk4ANW1topGlaZ0RY0EmG4H0pdL3XERmCb1ByiMOoHvWUpOSLilFl+xhYltziVwAGGeFHYA1pWdsCSCysQeQRyPYVJpbtKqLMCHGCVAAQk+9TTNFPdmPyj83DsnT6e1RZPc25ilOYxMDMrNKDwo9D7VXnMY+cfJjnbjmrV1GLW437iSBtIdMbR6571mX86TyQK0LReccZBzkZ4x/Ola+iJb7kN7HDcnyYGiXecSSZ5FYzXiWV3JFeNMUBJMmOc9Bj61d1SD7EJAi+ZFvCJuXGT3aqNxp5ntwZo1WFgDvDHcvP3SPeuiENDlnJJ3Q1L6ONwkW/fMC75bIQD+9/hUS3JmuFe3jVWk/eBCm0Mo+8vPXjpVJ7W5WDZZuksKTBmiX5WA5x9frTjGl3aRzX08i3i5WJwo4RT7fxVolYyk2zRWQXNrCqkmO4Yx+WpxtZTkEjsavx3KT72kO+4LiGIAnLdvmx06Vzk8TNJCsMrTRtIcuny/Un1q3FEHtpVmleAb9pVVwxPbB70MFc2JJY21SUlo0Zf8AVrn5dw4OfeluIvP3TyyD7ICHEjZB3Z/lTbTSVEQbyPMk25+Y4B9eK0GQWkKRGSVkQF+DuU+xqW9bItLS5WMCTEBMz4G4qrY+ToR9KjkuIksH8tEUQg5hkJAKDt9ajgnkJL7zAu7eCjAn/dq3Iy3sEqxQlUfhmlX5ST71N2i+W5mWIhmupHspCttKgk2k5KyelZd4sH2xbli5kIIKEbQTnGR71u2ttJbQ3D20KqifuiI+SG/vc1BdxyyRTT+WzqUO4MuMkf1q7mbVhL+SB9OhnjiDNGf3gPXIrorIJeWzyyqokI3IGPQY6VyWkiGW7l/ebPMGxWc9cjPStHT797axjtrgs0gO0SA9cng1MotFwlfQz9VXbIjCLcq5GcZrnNVs2kAcxjzG+8G44rrLueGSGEtOQEzyOOvrVPUfs8tpGI2V2A49W560JNWYVGtjgrnyxhd7ZX2yAKZDIqRlUZiCcqc8VbvYVt7iWNFZhyTxmsy2VpldVH3TnHeuuOqOGWj0NK5l8yIKMKx6+9ZEpIU5PzqevtW0kMsj5jj8zCjLDsKqatp7QASqjeW4zn0PpSirOw2+ZXM52V49zcMO1QxnnmrKRpIu3BDBctVTo/FavXYzZNSHkUZpe5pIgAetOpvagdKoB45NLx60yl70XBkinIpaagxml7Gk0IdRRRUgBpKWk6UMSCk59KUc5o/nQMY5IU+1VAck1NdtgbR1qFQRzTTsXFaDgcN70/Hycn5j2qHJLdKljBJJIOKpO4NFqOQ7MkAHoAadbkbWMgzz6023QyyMz8BRxUsoVURogWJPJqSkQ7TNdmOM7R0zWzZW1xIm1typtO0+uKzbZAXabox6D0rWt5yrlJG27Bgc9KiorK5dN6liwLTGQvtUqOWA5xVq3QwwiWTazHIXZ1rIimZJGC5Ut1PrV6z2NKzFiSABjOAKycOhvCWiaOh0yeS33psVZJEwWYZwM5496y2DXGryXZA3bsMw4FXNWu4obKKNZFSbG3J681laHFI026Xdt3Atk9azSdtTZ2bsjoYZGYqVIy2c55z7V0drEJYlyuD7+vr9KwXhQxSmDAYdK0NNvRMRb7yUQAZP8R7israaHQ3Y0oYoWnm8w5ZYvkA45+vpXPanbXlvqEaZSRpTuwj4AH9361q6tdwWbIssiyluCq/8sx6k/wBKgthHPE99I8WBJsTPA/8A11rHRXMJWbOY1CL7PLvkK3GH2h89CT0xW9o0VzHOJZZYUlkIEZzkgDrwOlZfiOWMXcUcGxyz72DLhc4qxoMQMF7cSeUGiG52c/N7baltvUuGmhqyojTy3N0shQHDkAYkPse30rCuvs7Xak2/l2uMhwc5HqTSXUV4bZhA2+Nn/eK4O0nsfr7CqmpTT4dhBEojCxvEg+Q+59+OlVHUxnpqbllPDAihzKuG/wBXjJPoTXQWttcJvZYfNnCFo1LfKvrx7VzWhzOJHkkDK8gBeMpgjn5Rn0rWv9USK+eaO2LFEKM8mVRfXB70nAtVNCSWRXjYzQgRzLhe65H9M1HY2011FH5U5hcAtIUXag7Y/Os+91Aahf2Vr58bnYyyFRgNjoBiryTz2qX0YWWZ/KWNIRkhM85z61PLpYSnc2IlMV0sZcvFEv8Aq+o3etWbUywx3M0jNggl9rDr6GsKO/hN0xuVUMxEewMcplR8x+lQvqU1rBdW5dfIUksVPLFiOnfgelT7Nl+0L322OZDIWbDAFNwJYZ4PHpU93bTWtkmJN04G0Rq3JX1qlpU8V3KguCxMEmfljxkbflGOpJPrW7Gs8zLPfCO0CYZt2XKJ33fWly2Y1K6Ma6WOezMbQhbaHhWf73m+lQ2enwNbRM7pHMH2XCTcM4Hfjp/Kuis7AXU2y08uNEDPmRSd7EZ3AdSTXOXmnajFrcs0c+YCFQykZwOpA9K2hoZS8iW/tWFo1zCrlA4RAi43L/hVCSwFpHLLDM9xCy7Y1K42Me358V1SoIojbXEZeIpvEwPGM1zviEXOoaOQsTwyxsSdhIztI7d8ii4NaXMvSjcI0PythoSmxlwFOTvB/wAaq3EUkMkDb3GG3xhPrjBrYtJJbbVIZ0ZpbOaEEq3VD6+nXtU0GwG8kupPMZJFB8xsbfTHoOabdiVqPt7QSMplSYQMxc/N8wPsfrUjzST3BSSCQSx9MDbtz6f3qWW7eIxo0KFUGJGU52qT19xUkcZvbB4IvMeWMH7PMXwHFZt21L0ZWjuIGu3ube3dJQ3lyJjgAfxe1aSrDqLCFX2OcEAsQGNZ5jNlIXu5JJJyoDeQuNoPHzetQK8tukoUMJYFJjHRmXPvUy1ehrCSs0y7c/6Gww7sI8klTkOR2IrOuZp3QLIy4fc/yqSU9j9apXPiK0nuFkg+0nBKHIwo46Z+tXQzx26yTPFDcMu0Zxz9a0XumMveKMdtCzWzRurRjDxBkwVJ/hJ/rTjxdRpdqY3jP7jb0cdcVXhuDBLG0nlu5ZVMatlST6ntjrUGuyXLvvbzZoo5FJb+6PQVpuYrQo61IkVsFQs779wAHPP8wDUVtKbqQKsRWXBbHQE45xVqWOO6eKWFyMMVjz1T2qO+aQOguMo3mbW28bafSwn3Od2vK7q27evOAevsagigEqyGLMcqjBIPU1u6hbGGRJELRllB2DqwH8VZtsF86Vip8snt/OrT0uZuNmVYLie0doZZGWNj8zDrWpI4n0ryEcs33lz3FR3NgDCp2FnYg8ntTn2K4CDDAcrU8yepootKxgwRlZGySCcgioZUVWwueKvXWwSK6jbjqDVGZ3aXjOO1bRlc52rCAFTgjFA4zT5Sdq7hzTeop7kMKO9FLihOwgpwptOFUlYBe/TNPHSmc5FL3xSbAcKKUDHSipEFIfelpCM0kDYnelFGKTrQSVrg5fNRjpTpMGTn6UrkA8AirSNQRcnHSrCYU/PkKewqGNGZwFH41ZZN6kD7wpjRNANykRA471KSI4ZISPnfAB9KXTiolKykKAKZeSoXYgHDHgdzWfUrpcggkP2lVjwFHBzV2GMtdkeds4Jy3TpVOzH+kghVyuTVnrbS7gGZjx/smmwSH+axQegGOKu2jKqhNoBZNwYnOT6VStUQwqHYrkHHrmpI4ylpFIAchsHjgY70m11KjduxoRMbi/kecMHCDAI+761sq6WkUW+McNgNnmqGmg3MwluFVXlI2AHqM96uXt7uuGt4IlwzbAzD5QP61jUWtkdFOVlcnkvII0RI5FLvkgnikjm81t6O6bATnOMn1+lYd+rDUxG0Sh1YLnuQP6VqamYzaKFfEe4A44x9B7mlypIftJSZqiXyba1m8obHcK+88OT3NTXUaSSqqQNFBDkqc4DZ56d8etZ1rH59wttFGkohjyFdj8rEdT9KszzyWsTR3EckkkYyEfOBnuD3FTJW2Ki1fUp3GPPjfbzAwLMV5bPcetWY1VrS8WIg+aGdhjn25p0qST2QnaRtykOVReSvTA9qkt5Zg0yo0QQRkICoJz2B9Khq5rzLqIdRc6eItzEtiQrjHzjgYqhfxz3jvNOyLsIxER/F/ePqKtTGFJZjNGsgliUH+I54ztI/Osu4vDCPmCzSIxWNsE7hjGTWlNa3MajurM1ZZFe73A+YyFQVdsA/LyDj9K1biOXUYzJJ5ghG3EDcLJj0H0rF0i1dZlluVeRSVxtXd82MYNdG0lunW+kk8yH5lkHMODgAdutKd1sOKXKZVnFaWF814h3NGDIrtyqAnkY9vWtkyR77S9j8z99cvIWAyyYB2jHcYrB0lmuUW3kl2mUbGXALSqDgbT2xXR3UL2mswQxW8kkMEG1QEzknqc+tN+YkuxgahBGG1GUl5ZpII7jeqdMn5iB7AVYsbZbjSJ9Ru0dU80NDM3O/B6ZxxUkNkks3mmZpGmQtsaTYVj6Y+ntVrTrt9JxZXCs9jKCUizkxEDuPQ5oeuguVrUdo9s82qy3gHk+YvJEmNj4BA/Cu0e7Qlri7jii/ciAqDkkgcH3JrzbVrq7t4hBZkvbvIoEijBBzzn2JH1rpfDgnutTUandfKm2REzgSrnqT14PWplF3LjJLQ2LWfydRmubmaS2htI1dniGdr4Hf8hiqGpX1zCmoR5j3SndGJOBJnv7HuRWhcCMrNNM5+wufMjhRN25j90ufY5rB1a9uptQt1toIYg9yQm7HIAwfzquWyuLmuV7i5MMSS29xPEs6iJmOGjD4xx7fzqtZrPJcMSjwM0DLtd+RMBnIHZSBjmq+nwt9qubK6Y29tIjvsPKhg33uehrWnkg+3z+bICdgIDLkgY6+4NSwSuYcNw8enXFxFhbd8xujfwuRxj2zV6wtVuBKLy4ilmMStkKNrMRx16YrHtgircWUl0I7O6lyNw5U56j07da2IfMtY2VY0uLNP3Zcp2Pf6D1ptCQXViVhtUiH+kk7JUZuUAOc8dc1NdNPFZRyxMFEK7H2sNrEc49V4qtaxR75rf7SArhp7W56theMEelIsU96AC6ws7JHMrjasqnocfXvQ0K5PbX32qCJJVnfT7kbBJtwyvnOMn0qK8juftLQTym6ijJKyRAbkz2NR2NkVe+jukuo5Y2326BvkHGDj60+3BEjXEatbrKAxXPOcYz75pPR6FLVamba6fBbXyfafL8gqXDMu0qT0Bz6+tLc2zQrKZLeIqoIOHJwetaWrRteaZKiusl0gRPYjuD7iqWoR3MlpA8n+jgDAULjJ9aE77j5ewy406GS3S8ldFWSNdvknbhvWqSzt9mWLcxmVtzb1PzAfzrNtpg94I4Gke05CIT91v6V0GoPHcNG6uTPDlNyjk/44702Zx1ZGlrbTW8LoUBU7twB5I7GqWohb+V3UNuJyccAH1q+W3EQrhCoGSCOT60lwEtIIHiV2n+bzMDoM9xQr7mkkmjnbyebzFClWKwlckZ/I1Vl8oxL5Eb5KDDrzlu9bxntY4LmBbAss4zG6Nkqf8Kx4rT7NKrXDhSi4Vc4AJrRbHPIn06zklgWVmzGo4+vpiqV0hhv08xR975sd1q/orlWmtZJMAksvPWk1G189WBIV1PBJ7Vk9J6m8feiYniCK2ivGNoxkt2A7cg1jpy4wu5Qa1LljDujwGQnPPaicWqkeTuw6/MSOhrphI45xKMoUKRjPNVug5q7cII4shieKpZ3KKpKxnJ31GsOeKX/AAooFBItKOtJR34q2A+nAjIpi0o/Sp3AfmiiincQtHeiisyQpGOBmlpkv3DTQ0imMmTOO9SQr50wRiRzUSfep6kpJkVVtDUuyhICVBJOcYFSBdgyozuqlCwLM7gnvV6EnaSO/rTbsNoaEKyHAPzdKtLEHjBCkyKKdC8Zt5JJWCyDACmrUPlwt98FSM1nN6XNKSu7MqC3MNv54XnPPrTraOR2UMCqk5JbpV5JVkhnj8sln+ZSe1K8OyBZJnT5gDgHpUc90aqnZ2M4PEJCNpdgMH2PrVuLdNA0e1htBPHeoNKVZ7xlULuJ71q6riCMRBSq9WYdSPSp5rysEY2jcraO5OU3DIxhSeRg81YEivei5jPyIMhAcfNnHWs23MiRyeVzkYYN2H1q9Hbq9qryriNRkqnQ+mauaaJi7kEl68t9HIIwsgwGPXdzzWhr11M16sQjSFdgUMORu/xrHupWhVVRSI2Ay2MGrT3bTJgwiRVO0zfUe/emvedxXtdF7StRu1uGnhQ+a687hgEDgtWvrF6buZIZC0TAKNpGN59R60aJBFKrXEiSfZlQpGB0Dfj2qlqNlLd6hHPO2AcLG/JAY/dz6VEkm7I0jeMVJmzbSoLdwhxsU/uz1Zvb1FZluGfVC9uzeSV+cDIz/ex61baGSCVraYKXKDdIeBx1wfSn6ZaIfss6SHfzFGpPDe9QluXKV7DZrYNeSx26GbI3pLnB4xxjscUyOxSSV/NSR41YRqQoByRwCO1djJo7W1nZPO48tmEnycE8E4z6eopmtxC3dp7QbYWizceWv3jnKsB39KE+Vg4qWpiWDPbWO6QCEu37sMpG0fxcD3/lTpba3ktbi6IC2m0KGQ4G8dWIx+tTxRzalbAKx2iTzmHYAZJwT/nmtNGnmujNp1pHOu3EaSf6sZHUjoaH3C9zn/D6y/a/ta2yGBYhGRkEKBySc+vWuoNvM2nzSXD3EpiVpoXQZDr1XcO3H8q53TvtcExWZFmWGUfuEwEYgZ2nnnPrXXDVC+mXV9ay27R3Hyy28SECM/3TnpgZFNoUWYkDWqw6b5QDea4Zg2PlLZ3dO3erGo2jWDQXkNu01krFpWhw7YPQjvxUL2FyYdHYyWyWpkB27MjZnOTjkjHUeta0ZtbVLdUFzLY6lE8RdBtRDkjIH8NNx5QUkznbaylvb8C4kjeW6G9DgqkWOQzY74wKv3VhFcTWTwTmMvGVYRjkMODjPJBqxo0DWOlXCQIztHMALkDeSoxkhTzgLmqXii8Sa6E0Q/crKLqGRYyQ6ZwflHTnGaBbGTYpeWWsTad5gSBpMOhcueFOCueoOfwrTtdNh1i4hFvJLHbwFXKxHLRMCRuz3GRzWXdvJca5bS6lH9nljJmyCGVlOentWjHdT6ZbQXlo0k0EUuAF4UxvyQ3p9DVPRkxLY0gWtwqM/wDaU6iRpFjbcefr79qy9Nlg0/VG+3JMuVOzdyGToU+orootQs7WS7utJkFxDcsskh3fvY+xz6iqfiGBLhESC6iEf3yF5IVu2fU89KmWptG1iO/hs9SnEMSxi1ZN9wWQgoVHGPeriW4m08W1spS3aHdBKrDaWx90+op+gI0IvkidbeB28xFi+bYAOx7Z9DVG98rzdsk6m1eXajw9mZQRx2z/ADqL30E0c7HZStc+UA6w28OCcgMobqPcZ7VvfYheW/mooAMYiywyGQcgj0p15KkGl6fFNauksjKFvFH+rYN/EDzg0lpdbiEvUIkjlMZCcoB1XPoaG2TG17Eyx3kU6rM4gnhkUhsFgFHQc+oqtcN9qv1SSBAkx3CGL+HvuPoa03lJbE8oY4/1vUewb1qo1pF5ySfamec8BFTG31B9e3NS5N6M25LalX+zp7m2aRWWKSA7XKNksPemRtFPpwhnkYqGI+UZBX19jV5by3s5opLiLzGz5MjdCBnqR7etSRGKeeWSAoYBkcchsc1HNYfKcTrOkrb2bXFpIsbEYKMfvZPYVfs7gwadFC6IYwoJYcHnrtq1eW8M+ovIFYoRuTHbHsapRxw/vJJyTIvyrCTwVx19qvmT3J5ddiC4uPs8AbZGN7bhlOSprQSeT7GLmEqN64wTnI9qqiNTYiI7WZRvjbnkf3TVLS/Nt7NxKzIckqpGV2k9vSm12Fqr3IYZJkLvs+Rt20gcgHt9M1W1G1ElitxcyjyyCFDeo/rXTqLX+zWjKiFjlWJ5yOoINYJRLjSZ4XUmHzPlY/wnrVMxs2ncyI4VEkRHAkGVI7cVqWgWS0bey7h8p3fzrKtZPLQGVXwX3J7duKYZCl2qxn9yTkqeo9qqceZChLkYt7aqw6ADtispVBYxscHoK6S6YPF8g4Y9R2rAljMV9ggZBpU9rBWXUilSRoTEAHA5z3FUHTYcV0N04MO9VG4jG5e9Ydxnvnd71utNDmkiDFHekGTRkUyBaBxR6UVS1ELilBANIKXvTYDwaKaOaKgRJRS4pKVyQpsuPLPrTqbJ900h2KS8cinMQ3GKb/F7VIq+Y+F6CtTW5bhiRIi27j3pbbYwOecnioWlVYtjD5vTtVi0KF1ZuQPSpGIkW9yu87/bpW1Z27MR5wAwM89az4hJDKZYgM565q210u91kI8wnl/WonqjWnoywJArjaBxnIFVbu5jkB/dnCDpTtyxwuwGWBwDVeSTdDtODjlscVnFGkp6D9BmAuDIFCkciuwudPiubDzbtwzYyMVyOlYMokwqrnGPWusWZZIti4Kx/eJrOrdS0NKDTjqc7d2hFu0qoxfORuIwabG9zGQlxv8AIIwwU5z6dKvXs/mxyogHl7du8ntVNpZbeRAW2qoG1hz+GK2i3JamMoqMtDcsra1YxOEWRYuCpPUe9Ub6ziF00rRiFHk3+WhOQK0dHaKGEGQmNCcnIyd3Ye9U7q5a4v7gSL85cKwBxk9iD+lS+ZOxonFq7Oz0g2ssKxgEjkqjdQOBWfqKC0W4RJF2uwUx8cemKx7e6u7TzHt7feVGN0bZ2g9jVi4urucq9zDGIwcgo2ST24NZcri7mqkpKxrW8AMp8yMEKNitIchiehz2xUU5itdUhgnMj2UW4oytgLIe+fTNWAi3lgUBET4D7SOd1W/EKWsdu1pbSrcHytuU55POD6VomRKHVEVs19c2c1pbyu/kAOi/eWQnq3PbipppbrUYFijLQyh9rFscJj5j6ViwXs8DxCSYbDEyF1yQv+z9c1swXjxQW9paRxXDXCMuGyzIAcZPrnrQ1Z6Ep+7YraZcqtv9htZJGhKnaHHLE8ZHrk54q1pUwtY7iyiiaOHyyQynA3g+p4GOabd+TpemW8zKyScRlk+8rKeVP16inahHG1pFNDkRyIsUiDBCNkkk+pNLRjRWurZrwsiOiW80imOTHzMBjOCO1WZJ7uSybUDZ27SzTtI6hSIw0Yx0+gzz3qfVHubu20VVCxQliiRxDbs4wct67R0oviF021s4p1W5d3e3Qr93jkk+vXg1SZLVtSfSo74W8JuR5qyslxEkK7ioHVM+tXNTvRFp4SOVXilRxGImAx1JDj+EjHXvVZLu9tNOilsbzyJZpD5rSDcxycfLj29Kzn0YTaZdQ3UogaIGVdylgd3RQRzn/GlZtjVrGjpWo3dzcQJcxtDbmHzY3jxlkA+YfXGTWbq0NwL+2WFSo2tLG5bEc8PqD+YIpIJW0m9s7mW4kS1fPmIkRfY4HG32PoajtpcwwXs9wksUMphW3lJ+RGJJPtyRTS7ibvsZV9aXUd/sFmXtk+aEb+fJBztjHcAn9KVNWNhbzvBE8kF0AVDS/ccHGWH0z1rS07VZLHxMsksHmfZoZIGiKFlROwHp2q3YaHY3Xhy7Nysb6g05lhlR8JknlGHbAwacpBCJlaBdqxu1mjiTYhmDqMAAHJX6H2rctDCtqHuJUhmuT50RlJZYRngAj2qt5/8AZNtPEkEDEhYzKCGIU88DHr60+CO4lgdLdvIRSG5IIlHpyOMDtWMpdTWMehdEsmmWskGnIJoZG8+e6iO5dpbkf/W96ji0+zNkEleGQzt5sceDmKUDI5Hc9u1IA1nZGO1WWNnOzaQMKWHUiotVhke1ijtWH2iJP3bggHcPbqQalTVy3EtvGIvIhkgcRRw4lUsJPmJBG7vkHqaiZDeXYtrf953c+VjzDjnPtms68u7i1nihuZIrS68pi12OAT1IP+FXtLka4svtZZ/tcRQmTODIMdBj3pyemooqz0Jb2wuYMh1dV4BUr8pB7iqV01xAo+wkRufl2novriujj1S31CBkupcSHjuTn1PpVG6hWGWIRvHIZlKqqno2OcZ71i/i93Y6Gvdu0Yeqx/2naJcR7oruM7XRm4Y5+7+ta2isnmPFLHGpjUYx8vT+tYLCRdWi+zIJtp3yj07Zrbt5DHLJJtZnaUMAB97jt3qmnYhNXM/xBbNZ3JnR82smNz5+aPPb6GpZLK3uY43LhiFyp43Y9PcVup5UvnQzbMkEsJD27LXOahALafMAChW+8OjoR3HYihL3RtambqRZVbylfocAcc1kWk73NtIA5KqOY34x6itiZ82kpV1EiD7p5qncBGnhnt1RWC/vP7rf/Xoi7LVkTV2UCweIfMyxkYUM2SB3FNZFjSSzDOB/rIpV6kYzS3ccVxKxlRo4up3HHPsRTkZoXUA+bAw4kxgjjv8A41vzK2hzcrvqVEs1FyJI5iQEzs781myWkoMxmBZ9+GJ7Cuxs4beSyk80jzuilTnIrltSUGNmyWY8KQehz0pwnryiqRVrk1lOZbVVZlwP4fpWffIyurLjB4Ge9Swr5cQEZ3sQcKexppkV7ZTcHO3O0AfzoUUndCcrxswgVWtGQj94D+FUby0Z8ksAFGTmtawCYUyKCHGRg9KpavGTGcevFPmaZLScbGAzAnAqP+KlKEMQetB610HKLiikpasQopaQUtJoByjmikGaKYEuaQ9KKU1iQIetNf7tOpG5HFNDRRPB/GpU3RjK1G3B/GrOnKz3KgjK+laPQ0RDOrO4yMGrdigHGct6Uy8bN03GB3p9sFRw6MTUPa5aVnqTB/lJYkANyKe8kSyFogPxPWq8ybSzsSynkim2yxJIrTAso5wDSTuNqxrGSP7Em37zHknvVCYH5lZCQRgEVatLUzzOWBVOwbjFacunx24HIkxjBB4NQ2ovU0jBzWhi2JW3VHkkD/MQUB5Ax1rprC8iYhtobf8ALz/D71h6tYxQFJELHecc9RUumTeVMXUnI5Uf1olaS5gheL5TV1hHS0EZQbi4AAHLEelVZAWtI38xBCRhw55Pv7Gte+eO6htIk3MI1Mk0q8/Of8KwLSASXK+Y5MYb5o34Ljtiqg0iaiZtw2qNp2TcMYAN8Yxg7yOPwqtcWCwhLgJceY0edwbgt61LpNsLiMpISduflz90Z4wKuQXA/s6eM4kuIW4RhwAeMConJ30RpGNlqzMtbu7itolUxqm5VJIwCM8sT3NdTawRNcLIyvIrHduY5U49KwrNpY7trcWxnbyj5UbDoT1z711PhS2imihtZ5D9nSQkuw+VOMlQf0qJ6bGtOz3IIW26hLIBiIS7R6e/4VbaGG8R5IzsjTIEjKMMe3Heq818lmknkxtvUsANuQvPHHuKsaVe29u8b3gMeVyqHGASPQd81H95GrVtGVb6wjMKwbXiRVLS9izew9KqaC09iWvfLx5TmJXkX5mbHy8evPSpr2/updRmSNVCRrsYSkqzDqSfTHpVIsttApnl23EcoCQGToc5DAd8Z6+9arazMGrvQ2zqG83VkRHP50gkbcMnlcEf7PNVLRIbC5tUuVIhSZnMm/O49FUjtioZTetMZDEkIbILgllU4OCeOT9KtwpFHBM+pBmujCAqFSQ24/eH86VktUO5cvfJmvLbCyREyBTvmG0Ag5IHQmlhIW48xQDdwzqBtQhWU8c/zNZ+m2d7cR/YleOOCFjMhlwoG3o2e59q2NZtS6qi3Rkn2hpto2kkjBIPbJ4pLTYNzQtz5Wl3OnXENnDcs+6HB5WQEH5G7A/p0q8lxGuoCG6ia0uIGjZoJR80u75c57DNc7BDa22oiaNlmRI/LmZjhVJXIC56t2z681emvLW2ltImDTT3LK0t27BiY05KN3BHAzSem5S9DY1S1RtGXfbPEZnLXEq4PlsGOMDPzk4FcbeyIrEWsE0ImVobrcgZHI/iwe5z+HFbur6mBqU9zZ4MMDrMmVLMpHVQO46GuP1vW3vb4tC6rZSSqXRAXXd3PTqT1pqWhM4ojtTdSrPN5ziaKRYgy5bZjnLeowMVvz7obv7RfXXmeaqi1VUASQnqSB2HvVGJLg3895aedAXXYu7AH5f54qER308LxXUQVm+be3PGeMf/AFqh1NTSNPQWW9F9NGY0gidJxujz/rCvRselLpYvJtRMMDxrhtsyg4AbOQR6+tU9H0poLi4BufK2KWOUySvXAPrXW6Jo87rFcSnahUZCEB2HOM0+aLWgKEr6klzLJH5O/YZWcoXQ8jjnI6VDdwW9ztLQhyq5LqRkL6j/AArbvNGa4gWOyk8uRHyol+b/AD3rKitFd42ChZP+WgA4GP7o9659mdKV7mFKl9NK8Eyi+tohvCyJ8wj7nPXcPSpPDl9bLq15ZyMsUUqBrUM/y7fT2Na2oC6S+ga3Y7olx5ZPUHufwrKe3jOo+e8CEKowyLgnnrWqmmYuLTuaut36pF5dzZw+U2AjKOv1I5xVBrASBCjvnBcfPkZJ7CpLieaVpheI8ifL5bO338DGR6fSrtm9qPLtibpd2AZgudhHIJ9u1O3M9S732ORuU1NNX+zuGjhXlrllIz7Z9DXS6VHLeO0hYLLEvCn+92ra1kwsFiQedIDgsT8pI5xz2puiWca2byQvF94jAbBGaid0tAglcy7mG9tZPPkUsHXawX5ipHQn0zRJBHcIrTO+7GDj19x6YrcTygryhizY2lc9fY1mRwT3CMIAS+cEbeKiL1900m7I5nUYBbqSAPLHysdpHHvWLb3QaeWBmZVwVbb/AHfSuuu9Aa6mlt7iYoVXcSX+UkdutcRf6YLeeYK8iiM53hSCo/8Aic961SuczuiaaJyJ4HcSqwEkQTnPqKknzBEzRuNmABkZwPes9vtFskUtrIxAPzKedpxnj61o6TqMNzBKjRgs4wwYUpJocWnoNuJF+wozDFwnOU4ytZU6pcLtjXBGG9M1o6jbefLiM4TZwBxg1z7s8cgjBJcJjB7HOa0h3MqitoatrCvzohUTHkeYcYI7Vaj09Lyz5QRyoOQPusfWqdq0N1CHnkCSMcYbsa6XT9iWoLOGbbg/T2q5S6oinG71OOW0W2lxK7B1fp2xS6oGwMj5ParmuhWLbGzg5BqBg4iz8rh1yDUp82o5R5XY5m9wXBAxVWrl+oWUIxHHXFVGwDhTkV0R2OOe4lFAoFWmQKBmlFIM5GASTwAO9bd9oB07WbPTdS1C0t5JlU3Dgl1tN3aTHcDBOPWndDMZSG6UVreLItRh12aHWZI5LuNI1EkWNjxhRsZcdQVxzRTEZtFFGaxJsFIaM8+1L3zTGilJwxpYXKuCDS3I+cYpVjITzBjbmr3LTsWpgJCpHNJIBGowSGpyqpt9yn94egzUYSN1OWPmD3qfIrdXLcEbGFxIuSRkH0p/kQ7UBzvHenWsjKCHG0belJI4Eyh0IVjkepqOps9ULZsRcKHLbj0+tdBvWaVU2iMRryB3PrWNZxB7lpYwT5fPPQVatrgteuQd24ZLelZ1Fd6F0Wo7li8QXED26qQwO4MxxmsrTMr98/KpwR/eOelX9R1JZseWDkDCt7+1UrW4jll+ZNzA5wOADTgmo6iqOPNodXa+Wqwo2EGeQv8AHVYxx/2qZBsVYkyWPY4PWooTmcjIOPu55xn0qK7lljacqvmbiSWdcE8URdm7lSjdK3Qktr0WQlniUZnONp4PvUFpdNC000EasoYsEb5mCmqlo8stxBCvzO7qxJ5J9gKvyO9tdSBYXaKR1VndMZcHoBV6LYzV2acM8Zt5LhcpMGwd5xlsdPoelbWlXbyxs7wmJXOWRR93A5/CuX2wNfguNyxv8x5659O+K7VSPs2IItsed5kcckYx/wDXrGpKyszpoxu7kN7C15E8sJbzFwwwMBe2Ce9U71BJZQPArJtlU+Z/dx3/ADrRt991brmRktgd21ePl9Wqpqs81pYotrEjRXIAQZ3FWzkfnWUWzWe5m6bMdTa8lkdVZSDJKOMg8dPrTrXT5n1BpZlhJXKLvGSoBxuPrmqej+TBPqAllX7I0sZZ+5b+5j69q32C3cFzHeSPDKu4b242Kfu59Olat2ZhDYvXFy8FvcRXHzqsWUWMjBZuAMnnjrxWRaXgRoreadCGxEWLFiWAxuHc8VLFqUt1Zqr7XRXBGY/lcKMcHsf8Kk0Gxhv7ZLy4zuRtmdmdrHoTTT0uHXQivpolu3mstpMUgco7Md4PIQj8MntVybV45bCZY4Q00x3ST+YcsB/CM9Bmqmn3oi1C6muLB08kiJpVTceM5I9etN0rTboXEs7hZIOAsZ4PXgine+4le+h0NpZOik6gweLd50qKoKxkg7Rnr+Jqlp0o07Vru6u7VGtwMIZ2BVV6HgdTWilrNEsgae4Ekq4m245XGAMf1qBbVLa58hIXZUjHkwHG0sfvE569qxc1c35GkUNQxag3EFvG8bjzfMyVCL02kH60unaU/wBoikjijWJiXCbcbzj9K3zb3kkheSOGSOQEyKFwAMcKO3FXNPZLOJLflGfEaEj5Y8nkknrSU+5caZBHaxSErsSCVcDC+vvmrKWi20jPHF5p2kEY3EDvV1reQyKsJNyFO0MPuj/GnkywjzGjI2/KVIrCV73OhRVjCEKq+VXaTlQTg4OOAc1Xn1iCzt3Fv/x9g7ZA4x5o5OR9OlWtTiUPLNCpJcLnnkZ6cd68/vnuJbzdPFKsir5aqx44/wA/hWlNXbOepo7s6pNbeb7PdAuY2jIkQdUYdCa0IrxdspjYCTAYBhj5TXE2FwtvKYwWVnUBy6nAI4x6E+9dDBNPLFJDGCLcKNrOAG6YHP8ASnUg0OFVPRsffyPLIyRsfOYAkjkBR6/nVWYvbQ7o3MikYcJ91R1yCferem20ixSSZcSN8rMwxU9xCDbRqFPT5sHgn6fSslNLRluDeqM4yTKxMEbTRBQGZ1wcHt/9etPSpwVcztCpiO7DNtIPTj/CqKXkVtcrFdOIUVCAAmfNHoTnqKzbsosLy2dwomJ3IjDO4dcHv2rpUbnNKTjudE09ul2nmvE4O51BBDE49+9MWIuzXcaRRy5GYVHyyjOD/wACrknuby6jjNzIo/erlehJPUKe3XrW5qFysFrD5KsgClhls7X75+vShp7MlO+qOsureOO1aWGM5TDYHUH0xVOO6+027wS28ds4A2mN+DTLe9hlghQTKs8wJ8iUkDB44I71bibTSVSdspGQflYgk455PYVnyO+jOuDXLqZ01l9pCozjABJJ57etUp7SIaeRbq3nbtpLc8enuDW61tMI4ruPy5LdznJOfl6DNPtIIw33VCk/ezUylKL5RyhGSuee3lgyRmG4jX/ZYLgj3965bUUKXTva74nQABF5zjv+NekeJI5IrgzZVuQBnqR6VzepRxGUu6FCcbivBx6Y9aunPozCpC2qMyS/AXLjD43MCOtZ2sECQyqm0Oo5PGT61LfKZYJHiPmMMyFiOiD29at35V9LgIfe7gEdDgelaqKjqc8puSsUYLOCZPNuRhfvuyngD/ZrQtEJjzFN52DgjviotGjjKzW875X17fSrEgSwuBHwucbSvenJ3LhFJDtS04ojfaPkDIGHHrXNI7RwsrE7VODjsK6vV2a4sUZ5gwA2/SuWFzHbTsJl3QyAgilTb+0TWtujJnjEkgAPrye9U3GGKjtVqXmYlCSp5HsKrzDqw+ldKVkcEnqR0uab94elFUnYkerFGDKcMpyD6EV31xBpfiSX+177RvEsVzOA0yWVv5kMzYwWVjyoOPeuAjIDoSobDD5T0PPQ16r4psvE19rMtzpevW8VlIqmKBNUSMQjaPkwGxx7UPUpHCeLrye+12WW4spLALHHFFayAhoolUBAc+wzmioPEMN/b6tLFqtyt1eBVLSicTZGOBvBOePyoq0JlOkNGKKzsRcTv7UtGeKTNIZHOMrmoNzFdnbvVmQ/Kc9KqjrWiGtiygxAykke4pI22soPAzzSwsSTxkAdqYCXkY4z39qVi0y08heYOzfKOABVq4kDPEyDJXoKy0k5XAzz3q3JNh1eNdrE4P0pNalJmlZOZYJ0UMBnJx61RaUxSNtyAy4OacLo26jC477veq085OCyHaxyMjrWaTuU2uUYWnfaFzxyorZshDaxKDh5JhhuPu1mW8kjT44GF/Kr9m4j/fycux2J7VUuwQNDw/P/AKXKWYyOwxzwAOlbV7fn7Iyxwb5f+WhUdu351y7ym3ud+cNkZPX8q2ftqeVPHEXGMEs5ySawcftHRGWnKZltcC1uFaYPA6tnf/EfQY7Ve+1+dAlwyqWTLbXbPfjA9T61VvCl0yuUxlCfkB3Z+tVJLJo7i2DtlZ3AADdB2ye1aR20Mp6M6zSQFEk0PLSfMpdeSepIz6Vq3Fy7W08YuAyLHy+MBsjkCqVhcW/mj7iCFGUqW5XsAPXvUWq3FtFYlThw2PlY/eHoPxrnkrs64NKJuWl+lzp0lxCGSxiAhMQGC2PWsizvFLEbnRNxZHCcKvYj6HmmaOpGhajLcS+QLcbssM/MTxj3qhb3E97JaL5EjlW2pIvRu5G2mly6sTd9Bbk26aPPcCWWedpiyhIzsLZ5Yn3q5aWsWqQo/wBqlh3kfaAz7U6gBSe9bujaZH5ckc0WzzBvCDhBk4PFMntbLTprtHiaSHZHIgQYJOccfQ0e0u7MpUko3Rj39xPbWkGnwTPDY5YPKASASentx3q1baxcS38kVtcNHb/6priMfL93gkd+nWrur2rWV7FPdRO8M67MDgsSO46YxWH4YFvFr0kgjke2jkJijkGFJA6exFXDVGMvdehPc6i5Bjn3wQgloyCcsx4B9SMZ5Peul0iWdbyQMzNCIfKEznG1B2GK5Z9MMuqTS3CKrZLogkyMdlB7Guv0vw9czX8dpacwpG086BwBtUEkE+2OamorrQ2ow11Nm2mMKnjO7ABYAnFR+XBPqUZKus0QbBz9xcjk+vNXLCzE8aM77VkwgY8bc9DWzLaXOm2j/YViaS4JUysgDBQOw/SuenB9TqnpoQWcdsyMGudjkFhGT3B/WtCx0iGOG6N/tYO3lq4O9QoPz/T61HobRWsMVxcCDdC2SrNgo5JHzHtx/OtHQpraIQXdzEq2hdo5kZ/nUnqcenQ10xjFaWIbdtDpoLC202KzSy020nLB0ukJHmbW+5jnAbAqrf6RbXEL/Z5kuIWKrEpUl8g8rnpkevtSaQybrly8cstpJ532oLtiZeob2bHGenWrNvILpUDXbWEG5xsQACTPIdPfHHPrQ7S0ZCvHU86v9NezuirSo8bBvKx257988ViQ6bvu2dmMrK3U8Lj611V5Al0j3EbKtsGwJHbJIyeNvaqUljPHcRHPlQJycMMc8AY9q5/hehp8UdTnrrRk/fw2jFg2UXD7cHrj6daj060e2kKTKzmb5Y2Xoy9zz9K2V3LfLNEyz2/mGKUvESYxwAwI6E81ceaKOymgiAkiZtu1VJJ6/lVOTWkmZRpp6ooR2Tus2xkdwoKk8fmKintU2RfOPN25yM4NT+ZAjwzRbWeI7ZIwDuHcHPfim6xKqT+esyyQgg7AmNuf6CsZR0sjoTs9TmNYsY4pJPMi83I3KpOPxzWVLLFZWStIrK2BGjbMsrZ6E+hrpLzU7W6a3WQKYSxj84HPOe/p1/Gsh2jFy1s8ZMKlv3hXgjgBiPaulaqxzzSbujHuzcRSDAZ7VsB3242HOQR78U8vMbZprmV5GRi4HGHB7H1q7atKgWR41uMZdZBzx0wO1QwxrNNLEisguDkK6Dhh/CPTPrVb6MxcWtUXxprQ6fBdRO73COH4YhkGOmO1dX4bs7iK3vJRi6gdS8YkX7xwPx4ya4y3Z47mOK5cwqqkXDb+fXGfpiu4F082kwyW08I+UjcrY+6Oh9yBWdkpN9TZTfKkRaTcedcSWksxd4oywUNwPf8A+tVq+jEiRiFAsiDkDkNWFodxayXxlW3aDaQqpMfmAz8xbv3GK6i8gMMcrm4SSGMjy5k+6xPp61PLd+8Wp/ynP3ltA1oQZpEk6yKw4ODxg1xuoLEs0rPIQgyM45rv70Rz5jKqc9lrjb3SVjaSPdJGv3uT94fSs3dOxekkcbeXFkm60lkeYtLuEy/L8pHTHrmmWdqkds6MGbJ+Vweh9K2Z7S3EhJiUvGCoDDhgeKoqhthHbTR/L97n+YrohO8dTknTXN7pWt5/sl8mVYoylCCOtTXymMFiDInY9xUuo2EckCPHwSOCOxqnCXubZ97kSRHBx39jTSTV0LVPlI4r7dKYVb7oyA461Ub57xi8WUcEgH0qXVnh+0WrxQmPaoEgJ5Y+tWL5C8MTkfuwNq46sK1VkYO8jmgVeZtmQo4FVpgQx+tWZ0JUrHwc84qo7FgM9e9bRd0c00NFIDnmgCgDFVck1tBv9NsXnOqaQuphwBGGmaPy8dTx1zWv/b3hjH/InRf+Br1yRoala4XL2r3Fpd6g82nWIsLYgbbcSFwpA5OT69aKk1PTY7FEMepWN4SF3LbsxKZGe4GcdDjoaKsRVzSE80tFZkBRSZoPUUANbDcVXPykgc1Z7nFV58q/HeqTLQqF0BwcbhimoWPGcA9felVyF+f8KZnv2pstD4/vcA8d6szBwix5+QHg1WUkjhgM9q1re2le0MwQOFGT6rUydncpLm0IbbcXDSR7oxxgn9asX0yzKo2bUU4GRyahlZSYmB8sD7w9aZc8zjzGOG6D0qbe8Un7pJZwfO0mAFP6fWrtzNAyugXJVQECjgmpEQW8RSMBmVeWJ+8T1pLdUDiVkIK8AAdx3rOTuawjbQjQNJLF58gZQQdgHAI6ZrQimeKxSSPCoXzJx8xB4P8A9apbeD/TQQgcOofZjqe4qCNppCUh6lmDLtyAM9KPi1YaQXmSXjxxwSwvG0TBPlPcknr+VGpWqR2cd7KAxlxiPdzjscVPLGlzsu3BdW3cMOoHaksLqKS2a8uUHkLJgqW9AcAClcb13Lnhpp3tcLCnlSbsO4/iHWnXtuk15C1yBJ8n7qOIdMdWOf51W0HVVjHloWVJGYlfUHsPTIxVmK6WZ70RbjMDsEhwdseO341Mk7mkGrWF1OaS5tYbKJQyq2x1ReHxyCT61btIAq2kMCuk0eXcSdzjt6VmWf2tL790NjI6tMztncB2H55roEu5Wmku7dd8UBKM23L49cdOKmd0kXF3bNPTbhbZRG0Modmy2WyD6cntUd8HuNQt1jzPJESxUNjk5Ayf7o61c0yP+0IgnyzI7YgdTgKB94N6c10WqWFpplhDZaSjLqNxH+9duCy85CE8HgGlCDbcmat+7ZHNS2N5f6Yl7f3e4tJth3qAGIOMgenaseDw7FIjoqSpePOzwANy2OMN6Dg5xW39p02GGfy1ujcxFRHBM+GxkbT7HPp1p889zdJpMkcr200SySySuQW3MDlR6D1rbSKZzuPM9RY9HjW+EptfKiKIWjD71bHGc9846V6F4O0qzvbe/aR9kyoY4LZyBkHrk+h6+9clp17K32WK6hjhW4OELNgY+vYdea1rLVLjw9fXN1aeVqtm9zuKsQJUwMYOOOnIrKne7ZvJ2sbGlTLHDLbTF/KlbBGAfmXoPbJGM1p3scT3qXTwTLawkbokfO1s89exrzseIS8iW8sUqRwzMzoR98k5yrDuDzXb6Zq8n9qyxpZl1eFtr3BDeardjjqcntzVJOx0cyexQ1q68uW5P2YT3F2wjiRW+RowMDfx1/nXPRyCw1JLqbT0nt9jF5lkBYkjAjwT/Ceneup0vUDHqSaRcWqyzSSqCjHyyqfU/wAFZ+uWFs2oSy2lsscCy87juMhHOBn371lK97mbtayJ9J8SSXJF1cpHZ2ghWHynUkEtn+EHjIrObUL63NzFLsvY7CPY0kEmUUfeXHqeQKybzTczxPFI5G7y5C7k7WIyD9BnGa0l0S6tY5Q6l7cSATGNvuE9Cfr60rt6JCjG+tyhYzX19NDcIGW1kIeUbuACfQd/au302xFuyNdwziGaItBlgy57NJ+PSuWj0qa4coJozHG7hogeUAPf1FdtBHCnhw291O7xFoxLIDzCOgyvY8/hT5Vuym2cpFYSWMs9nZTCKG45ubeF/mLDJDRkjkd8Vdt7K5vpGhtGVQwBRlAQuoHXaOhzWzqEc81zYMfKkSOMJHNGoMgC8ArjqMcmqcDtJqYfQwhltrSWXUFlcojKz/ej9MdverSTd2Zc3KY8+h3elyxSiKTa5GDxlH6Yb0PtVO+0+fyXdxtdCQYlA9a6qDVJDF9ovrqOONiZFLIGE8YODuXu2P5VgzQ3KWd3cQss9mXbZMGDccHGPxFRUgnsb8zkjzuaJtMvZY5I9sMvzRuB8kjZ9+npUniSTUtT1C0nRlLLDlfJQREoBgqcdW/nWpd2NyFhjCLNalvNI6qgPUEdeKgNi1ziG3tZntY5lIaOTCqvsW96c03Cy3Maa9nO7F0u3uLO3js51V4fvBiuHBPJB+lZ+pWytKvkARvE+5mU5IHfFdVJpF3O6T3NxEAh8tIwo8wKOpY9CTWNf6XDCU2W23GVJLHd9fc1i2bWvscvdPI1wrQbuGUMxGQSeOvpXSeHLS2u76XS9QXKylWiZWO1SM8+/NUtQsJgsaW7Kio4IA7j0qfTUja8VzMYJonCgE9FY8j2q6cuYwqR5USR/Z9Mu7hbmRnvDIQVc/MT0wPUdM5rrW1BrXw9vSeLyZZAsluRiSIgfeHYg9/cVyk1hL596WK7oZ1F0VHmgYHDBuo68460mhXs2JrVkiluGbJ3jOQW4wfft9a2cdLmcZanVWcDTyoy7XK5YsSANnrVLUoo7h8NtVice4z/AErOhuZIVVJg6PG5RfVRn7ppbydkuAgkDKQARjpjpzXK9NDrTvqYdzaF3uIXCMB909CxBziqdxbiSJZGPI4weoqxcXAjvB8hIGed2cUk12skzE7QCBzjGR7+9JJsiUrGZdDdyoYOAdoHQ/WsW62208qgYLDB2dOf61vIr3BMqn7h24rF1JdrOgOPMwqr6HNb039lmNZacyMFlMm5gfmU7cMav2dzviZLglXT5RzWcJyk7BkVmBIYY71diiQO0sDhlAyGK10ztsccG9xuorBAYzbyCTeMucfdNYEzbpmNa1zMQAJMbmPzHFZN3sExEbBh6iqp6GdXVjKPpTKKtGY9FLuqbgu4gZPbJ616Lc6Fo+iXWvXc2nSXNrpSQ2sUNw5xdXL9WOMcY5AFedAbyFAJJ4A9TXpGrxT2Wjp9v8SahPe6Hc2wkjWMGK3L5+6Ty7KB1P0pvQEcr410230vxA8FnG0MMkMVwIGOTCXQMUJ9icc0VF4ws57LxHdLdXjXzS7bhbts5mRwGVjnocEcUU0JmbSE4pelNJzUEIMd6UjNIM06gdhAOlQ3QyAR61P057VFIMgjpQF7Mrg5WkPPtQh9s4oO7G4jFFzUliC5z3FalpcMlvhc4PUDuPSsdSSTjrVm3m27VXkg8Up6ouDJ75ozEhUEyA5b6Ur75ysxPyKABnvSXLbgwUEyEZPtUcW+eHYARgfePaiIpb2LTysjEegyABW1p9uZZiA2cgE89CRWJvYBI9w46r3NamkXDxyTtuUIvJHcnsBUVFoXTfvG1Yu9mrzTKJJF+ZAT2HXmqeiyb9QV7jZEruzswOFHtVq7gykczneQwyAcD6VrTwwy+SkMab/Lyx/5588VkpNKx1uPNqc5Msd5EXifY0MrCONs4ZSM/rVOWaI6YiRsVMkhIQD/AFZ78VpSl455obZWmYx4Vh0X1zUSxo5C28e91wDIegI7/WtU7I52m3oWfD2nm5nWEiRkjbgbRux34qzqAFtdNHaBhLuxLu+4UH3RjsetXvD076fqJmcyvAxyQowM+oqnqFxu1LEapcmXKnCkkEnrxzWcpuR0U6aitTrPs89tFb3VzB5SzgqGHDq3A6d16CteCwF3ZTiNEWVzsGP16etYMlwbrTLOFneSa1HXGAOeAPrXSaVPHGfmmRYzGSxHO0sO/vWc1roawtbU0NNtPsUkbywrFG0OUtkBMZIOCR9eprW8TwSXSG8S3jLFg25c/KMDJCk5Aqraas9vNYSWio0+x/3I5GzGSee1bGmSC5s4DAQ3lN59xtXcY1z0APUD0q4ttDsjzPxFotvZw+bNJMdTt0XfFKRsYdS/HPA61avoP+KZkWf7O6pKq2zQNlCDg5JPXGRgfWrHiOytp9VunMTlfJ3M/wB4u2eKz7W1ksNPtPMiAilmDSZ5CnHZT3PrT5rqzM3G2ptasXbw8yme3uZlDKbdBlwfUH0rPub63uboNBGsfnSxq6xrtMRHHXoalTzLhLu0lnkspolKfL/y0QfMCxrP12yURR/YGUND5UzWpYMGPY/1xQo2M5O5pamYmuLmPU5baKNoWktwd3zMqnaDjoSa2bC/tn8P272lwJL+KLy/IjjI8uTsox1PXJ7Vx99pCXrtMJrqO7kX/VIfnDDBZMfTOK6iwsj4atze2nmRb5TbyTYDPFuXdwM88dSe9PoUm0zMtBdXMiPOschAVGnuXdzCecJwenJ4rRsb4rblIkW7VGJU7im5umST1X0A/Oi6ktYbLTbRfJ3C4DXcwbqrHIYnsSfWppZLVfEGpTW/lNBaKWQHLK+OgHtms5abGkFzPUuaPazzW1xNqE1vKgwQJ1IDuedg/nT9O1qZ4hbm1ZYdoV/4Vftls9SB0PvTdBWW9t4maUQWqAzPLKuUUH7x9z2qzrN3L4fvDqiPHPHdWpkWIOF8sZ+VgPTjkUR2Lqe69Asp7C2sJbtJbiGFZQ7RMmC/ynBc/XgYrOl8Tpa6Zp2P3l3eXS3U0OPkY7tgUk8k4x9Kz9c1ddStoLzTla8lvI/9I/dGONyOdoz0x7Vhx2LT2Uss0aLDI2+NFRv3Q9FPr2NU1Yyu5M9a1HWLHT7iCeylt2t43DKM5CKcCZR6LngemKwrW80qS7S80u4aPa0vnRb8F0Y7fKA6MucN7CvNtLs7q4hu5LlnZYkCKGwPkzyMdifWvTvDXhJTZGdykcF2SqOxDFSACB+OT+VVbmWgob2ZdsLRxpTR3O2b91KSFQHeOgIJ+7n+lbksdrZadPcGyJ0+7twsUfnjbuKgFlQDnn06VzLQ3OnQv9ilZ7Ke3JaDfgh+nX+lXfC6rBcWdzpZNzpsFvcA2kzDAdRjIDc8k8UQ93SxpUdtjl44/s7TXWYzKAYdvOM46Y79eau3eG2W+nRtcmOMPLGeGCgfN14JB5qPV9D1W5E1wTtYI0rbv7o45bPJGf1FJFoVxpb2wunhMV1AswnhDdTwAwP5cUpx6IFUuTi7865ieOMrGeSsmMk/T0rJ1eFJXnaHgq5J9vQgVHf2hWVIoXZrgR72XfkHJ4UjqDn+lUZVW7sJluUZZl+XzF+Voyen1965uXW0jVTdtDI1F3iXMkjEgEkjsazZLi2mbF1nfJgb1P3SMHcatWsyyt5F5guEPzZ4bHH41kpGftUjGEuzgxKhHT0PvmkvdZMnzI3bHXGtp5TfhZJGCEuq/K+OFDfUCtnxDpcMt3bxaXPC9yITcN5ByEGchMd256e1ctLe20+sLbXe+0DxqPNVM7sY+bH9K6S6s2s55ryC/E14Ixm5ixgg9OB0wOCK1ddU43exCpc5TlT7RYPjzXmLf60dOOoI7MDVK4vwZpC5DblAzjG4g/oazNJM0NzFLHK8e9s9chs98VPejbcuzFG3NuK9B+VZzal7y2ZtFOPusr6ywE2yJSoKZz1596x3lcRrEQCMAhie57VfvJohK+DtJXaPT1qgV2wkFkbdwgY8r74rWmtLnLV3NHwg8k+tpZzyJGkjfKX7n3qHxFAtl4klhkO1UbPNZwuGVoTGn+k7tocj9eOtb/xDtdl/DPK/LwIXJGfmwM1bSuiE3ytHGWsSPqM7um5QSfqM9avWqxTO8SyhIgPmyO3tTdKEKyXXz/KwwhHSqtpL/pShjtH3cjvWj3MFtoZWqlRKzI4JU4Kn+KszA5PrzV/WwBfSqqHk8fSqXlEAZOeK0WxjLcbnmgU08H3pwPpVIgUbgy7chsjBHXNerqZdQsL3+2/B2vtdXzRSXX2UbY5XjHDDIyuc84zXlKkblLglQQSBwSO9el67aa3rWrjU/D2uwDSiEMDfbxCLZQB8roTkEc565pPUaOU8Z/2rcas19q2lz6ckqrHBE8ZVERAAqqT1wBRXVeJNVt7vSvFEp1GO6s52t4bZN+TLdIF8yZEP3V+9zxnNFWhM885oYZpMntRmoIsLSLRuOKAfagB1MUeY2xck+1KGGea09HtQyl8AgmolPlVzWlDnlYigsSo5TgU+Sx38EYX6V1dnZfIOMg80T6W6AsxBjJzXI6zuerHDK2p55PAYJ9h6djUkKDzAD8vcVra5bLnAAz2PpWKhYOg27scE11QlzI4KkOSRclOzHGN3WktANjIrcHg561HIQBsVs89aakeP3yMS6nNWtEZvcurbsPmPy8bck9RU24LGkccbRlupPcZqC2lLkBojtZgTk9a6WLSvOs3TiKSI70Zu/sTQ5LYcIt6oPNcWSk8LGwIBPXHNS3tzNbrayWxDSSqfMU9GzWbdzzXlsqFlimXqBxu4xmprGOSeGOTy2LRxHAB++AfT1rJwW7NVUeyI7KR3immLOJiwUbD+mK3LNYpFMcaKiAh3cHB+n1NZgcTXRnASBz824DGHH8JHY4q2k8jWjgAfLICxK7Tj2HelK2xpC9jbvJYogsckbKWRlIRhgHtiue0YCW/Y3MnkPCcM6cs2O496uS7rrD3UuyTBZQeCcnp7UzT7Bv7TtpVlMaq3zMOv/wCqs7NbG8Wn8RpzayIbtZT80IlDAAAHpjJA9xmrlhcvc3iRGB41lLEsvXbjOT74oWxg+1bFEYJJMg6H659KoKs9tLdLbOSuS0bnIKjPGPXNWlZ6ky20OlXWVeRGlVIvKjG1sEctxjPetmy1O2sNHknQPJdzfuY4BnJbux9BXnl55t1qE0H2rMaKHBHygnHavQfDHl3NrFcPCrx2SqqqR9/jkN9emaqSS1REJNuxDdPNdSiVooo7hdroWbgLjlSff0qk90L9YIwTHPKzRNE55R1+bcPbHGKi1ieRr2dVjIEzFViQ5Ck8YX3AqlZTDS/GljdkM0MqukrsNxJUYP8A+uskm2bSdtGbN/pdzdA3ckFzHGqqhkiXKkYO7OaytF01Y7eTUZpZ/OTi3QqXE5XPJ9hkYrqtf1e5soXieU24mCuxB3gKRjjHseadaz/aTLBbzIZgi5lYbPLB7HPSqUktCXBvVGFDpd9plzp99qU8ccku2Z96klcnAzjrxXR65p8UGq2d1Z3qzS3aMzSRngOSRu29OOBt96p6zeQXNlZ28ZDTSBY55jyySA9ADwPrXO67c3Wk6qsE22cR7WjkViyqwIy20dzjkUKV9CXFo1tfjgd7Zr6xSATlVuJYGbbMMcPg9x1xVK1v3hu7sDLO8JBeIfezgLke4quniubULSGB4IJkhkIZ0yfKyTtwp44yeadZQxw3Zmt45NzgSHP8XGCf/rVq1pYIP3tD02wHmeEdIs7WSNYirzXBxyGBPX8OgrFGgCKG4uo0EUBZbRZJWyBuGSoJ6e4qnoOoQ3JgsrmXy7bPzjOOPX8K3NaEYKvIWu1RMxqG+6RgAgdD069a5lLR+R0zj0OZ16WG0kKWMMjlNryCNdrbcBSrKf4h1BHWug8ESLqNmpEqtZW2428UvGVPOP8Aez0psejT6pZzTz2M8ZiUSu87bWkQHGdp5wBWTqFhPp19ND4dkFmpVWTZLldpOeQfetFPqzFQavYt37wXF0BqD+VaxSI0kaxhJmjzzj/a9jSaPrlv9qukju5YbdoWkjSdRkFTwOO+O9ZcUlxGbyeb/S7iZ8l5V3Kz46kHpg9DSQSWkVvbT2d0Rq8e77Qs6hlAzjYuPvA9anm97UfI9zY1fxFHLIEaRHmVVQJFk8dSfSuWOvz2WpXEsUTqsnDooGF/2k/Sg3Yi1BBIkalw+1QMqD61DqbG4u1+zbDJApKsp6tx0I7e1S276mk4XR0T61LeGyCyST2z5aY7gDyfu4+oya2NR1uOedbF7iOSO3gWFpSfuAsDhD278+nFebvHeXN021oLZ48tJNH1YnqCeAf6VNcWRtZYlunEu4KVRXBA7hiB1+hq4zsSovsd54l1K3u76N7MKJtm2V0+Xeeg4H0HNUbqxvls2leFF85Q6tExwoBzyD1Has7Tkktrrc9t5KhwTKYigOeen8OR6Gt+41JJbExxrG8QQqFLZCgn+H3qZWtdlpdjzXxNApkSVVZrYsRJtBHlN9frVCG7uU2jzQzowMbsMZx0INaviS5dJJVV2aNiHltuF56Z9+1c7bXKM8RUqsQXY6s2cN7elJRco3Oe/LKzHX17HNbyuzQ/aHcOrSEhh3OPx4ArUuNQnbyra02lnQbmDZ688471HY6It1bLc3U4kCuGRHOCeOn0FWbVRAhaEZJfaTjoaioua3MddJqOqZa0aEWLLMQrGOEoxA6HPJz6kVS1KXdiNVPnSv09uuat+fJDGyRYKgfN7k+1Zl5JsCXbMWjQFpNvY56e3NRFOXoRKf3mabdzdLuYbsdMYx9aivbWdMSKQ0gGCD/EDxmtSGI3EMl6WLySEMIyQcD0JqwsDxak7xwicPFv8n+76Zz6V1013OWepneFrG2bXNNeUCWPJLxtkDAzwa2vGVoJSrDiNs7FznA9KzbNo4HE0pAeM85OAWPpWtPPDNYOLqTa6j5ABnP+FRUehvTjbU4ILDBHOgh3zkjDbsbPw71VtIpjcozAlUJxntV2/CLHM/Uu2AR2qjaiTzArSnBBJ9K0py5tziqRUXoZepybtQkcHJz0p1p/pEmADkVSnOZnHq3WtvwvbCSd8kEAVrN2iZQjzTSMrUIPKlzgiqo4HtXXeILECInGOPSuQK4OD1pU586uFWnyOzJYwGkRSwUMwBb0z3r1W+TQNMGvwR+FrOf+xDACZmffOjEKzk565II7c15Qil3VFGSxCgfWvTJpI9D1dRqXjJ/7VtbdbSVP7O8+MJ18ts8OBnqatmWxy/jy2ht/E8n2S3htrWWCGaCKJdoWNkBAI/vc8+9FU/FV2t7rtxcrqL6l5gUm5eHyixwOAnYDoB7UVaEyicY4ptOz7Uh5PSoIEoP3vagnDYo70AIdpwD1NdXosR8mNemea5Xiuw8PsJI0JBJxWFf4TtwXxM6OzjKqA2ME4q3qUG60PkrjA6mq0BXedv3RwCfWtp9jWTAkEAdB3rifY9dbHl+rpgkP09qw7iERgFeC1dP4pj2T8cKelZ95AHs1YqMgdRXTSlZI4a8LtmKMPCF29OuDQj/ejSQhWXoBSRgAsQ43Z4FPiRF4kVjk8nH3a6lbqee0yxp6xySossjDaccelbd3cSraokErMg4z3Ht71z1siRXp3OWQYOR1BNaaKxuiQ+5EyynPBqWveNYytFoeFVrNY7mPdODuiwe3Ug1v+HD9mtv3CDc/yrg5xmsuyWCeVUMckk7EFvQL6fWtO4/0W+a3twIXKAcH7vPb86l6rlQ0re8UdSea1vPsoHmASCVmB546g10Dwrd2JlKlSqbtxPoapWlj9qJE+FKnl1+82P8A69SwXDSGWGZiCrnIyBtAHT6E9aifkdFJde5TIuZdQl37VZtpVeuwDvW1lFEdpcyN/qyRjjHIxxVIPDMjRxPi5Y8nGdo6nBqZYWQeZPtbysBmx0Uf05qeboXy63RuRQgvIZEyjhV3gYAAHPX1qq8apbyQszvudV+UE+Wg44IrXgEckEAlCujIrMoJ2o2eQx9cCrC3lpYX0Qwu2csYQi5LAfw+tZpu7uU7bEQt9Oee1e1iTz4t0Y4yhwM5b0qn4fvkb7VHbk/ID5gOSD8x7+g9ar3c6JcXdxAuwmfY+1wG2ke/QisnTr1IhdmA4BkUxxE8eXnLZ9QTnj3rdR5kYSlyyVjubW3W9vnu5wPsokW3VNuBzyzA/wBaq65a2lsq2DmCJNjrDOVywYndjI6Hpz0qW6nT7HbmzZvsiy7jgcZGSP54p1hqUA0y5a5khhkvXbfPPEGUKAcKvoalabGlrrUisFNxGkcx2MsTu5B3AnsMfUcjvWjcfaJbm2t7mwFvK5WWWU4AnB6bT6YyOaxpNRW3ktVspbaK3ikRR5yNukU8sCPQdK3hrMUlytpdbdu4xl3+deDlQD2A6ClLT5lwd2SeLLayFwz2qERovCyP8xB9fWucn0eBkjM9yRGA3Ck+nHPXmusubvT7xY7dAhD5C7xn5TjGPYHOTVPwb4afWp7l4pENrHOy7S3IQHAAz1rJJyeho2lucnb6HPYStcrJ5Nsy/wCrP3ip9TWx4dj+1eI57UtHHZtEqpOzZC9AcDvz1rvPH2itFpOnDT7CdpY1MUsn8DBerGuZ8Jafqt40YkcJJb/ujK+1AMnICjuO9bRbg+V6iUU1zIpS2baZeyQO6syk7GXlXx0wfwr0nwpcWd5FGb+wgmuYeVCyYYg9WJ6cZzXI+JLZJTa3CyHZFG0IHdjnOf1rB0+a5Ny0Kb+Fz1wMfXvWMpezqe7sb8qqR1Z6x4p17TykltaCS4WJSVdhnZ2IyexHWvPdWv31K+ad03SsAhQDAWMDCqPpVa6jba3l4LkZds5ximxqRY+cwbcDtBzgn3qajlImNo6IfqM5+zrEF2wmPbsHRsep7VzGpqLpRJHiO6i+/tGCPyrZjvIZNSgUyFhyrYzgqexHtVK8mtNOu5/skfybykTRk5LYzuJ9OcYppJqzM5Ta1RhTxxXEkS3JmlmTkgHpnqT7Y/nV0PZ27TRIx2KowNw3AdgT61i3N1NAk1wGVbd3ztwSwfsM9B9Kqya3HAI4za85ZvMYbi3H8Q75Nbcja0Of2yT1NyK7hTzWt9zwMcknqH9/etCwuobG+WVVTbjDLJ1BPXAxXJo7yKGghEkNvlv3BKkgnPz+w/pWhPcGbRGuXZnSNtq7SdyE9znqKh0Wi44uNtDtJ9XeZGijfbE4J2glgPrWc95Hb2rbYgCP9btBOefasCxkuYkjee3ysqlodhLANnuOmTVq0vU89WeYokikO49uvSsoxs9TeVTmWhlajcrdlwS56glBgj0rF/sa9aUSyBUwN2BzuJHU+9dLJLBGkzs6eZKVxt68dxQtu1xGSrbOdrOW5NaqTSskYuCm9WYkf2i3i/ehUUgDJ9at6fch3ADg4+/g0mp20FrA8IZp5H4DEEBQOpxXNyOY5ZhA5DRncCo+UiiMFMVScqR19/F51kzxXCwqh8wox+Zsenriqz6o7WDxlUmVmZSGXjJOeB7Vzlwt7dxDEjbR/q1fIZ/90d66XRtOijtreQuGbsoYk/j6GtFDljoZRnzyI7l5Lez+0GEmCMBZCFCkH1x9aTSNa8t/O+0Qi4kUqyzHBA7YPetnVtEddGtLm2uVYTEtMWkyYxnlWB7k45rHsNIstQtjAYVa4Z8gt1X2B9KpyS06kpT3RgSQPqF3nzGEO8vg8dK2dSmH2eLAI67j7YovdKOhSPG0itIB/FzjPb3FZGoXUaw7ZHdgzZJX6fyrOSUnZG6qOMW2U7qVHhwenYE4NV0kAt5WzgdsDrV/VLiFIIpIYUAChSjfxHH3q56GXzPvuFA7Z4reMbKxwzm27lWYkv8ANgnrwK63wLaiQyPjrxXIbgXcjqeK9D+H0YMZ7HvRVdo2Kw8bzuWdftsRtx2rza+QpcNx3r1vxBGDGcc15brkey6PpWNB20N8XHRMoR4LqHbapIBb0HrXpXizUtKtdYeC48LDUjHGirfy3Ege6XaMSEqMHPrXFeHtITVpJg+qWGn+SAQ15IUDkn+HjtXfi68RbQP+Fh6RgDAHn9B/3zXScJ55rE9vc6g8lnp66dCVUC3V2cKccnLc89aKteLHun1yZr/U4dVuCiZuoW3K42jAzgdOlFaIkokCkNJRUEB0/Clppo6UAHaul8NzfumTJyDn8K5vtW14ayZmGM8VnWV4nThXaokdvpjmRwqnnOcetdGq7YU8xcoepHWsnR7bdz0I7jrXTeWUixuVzjOGHSvPS6nuLoeZeJ4V+1jP3d/GfSqd3bhYGKkMMVseLIQbhXBAJPIxVKWFRBwe2MVopWSMZRvJnCyKUuWGAMc1dRlkCjPzNjOe1F7BtvJQR09Kgt9yzKCDjNdsdVc8mXuyaLscMSztGZBuJ5JHapZkVP3Fk/mA/IOx69arSIyynyiCSenXNS2ZQ3iFGZCOCQOVpqXUHHoi1ZTESCFGxKW+fPYjpzVr5TMG8xpARtDkZ8rnqaqxwwpepGH3Ru5O88ZFTXd4JYY7ezVVEUhVyB95c5GT+FCC90dPZMjom9ikakAlf4+tV9dH2NoUXZJHIwYg9x3UmqkWoTxWYupERN/8Kjt61ALoXlxI0QNwjKCznqpPXj1rFxXQ6lLSzJrWYQ3otbcqY1O/3UHHFdLHB59lC6OoDhjIAvJX3rAs4Il8qVkKzbipOOfatm2mmspTKGVlIaORSeQCOtRL3ndG0VypiLet/Zq2VqzSNHLtaRuATnjPt2rZtprO1RJpJfN1V5inmdkUDA2+2QeRXGy3zTaghQAeachGbaB2BP8AOtLTZrdLqOKaRpCsmEXOdpJ5OfTNVFO9zNtLQ1tesfPtXuDNHHLLEGdXG5S45B9uK5WznhGo+e6RyQIf38UPYHsp7jNdPq9vePKtjZypKkp6E5JGc4J9gKrabo8KhpL9Y4i26SAA4XAP3SfzrZPSxjKN5JovQX9rc20FvLcSWXlqVI2/MQOV57noM0sLRNdvCygqkvmuGGQc9CuO3tWPfKjTLCAZNrcLgEqCOo+ldDoNj8y3LQtK+1VUA8KvfPqayWmjN7WZDc3ciSLC6mYSQs+11HGTgDJ7frUeqabPaWls1w08M0GI2BHysn3l5/v9sGr19pq31zAYoZo7MyOtuS4D5HJZs8kf/XrRs9Ve80i9sNWto3kj3RLMsnHBzlVxycZ/OiPYdru6Kuliee3it49hinXakpOWUd1I9R2rtfC99Do+kXGnsrwvC2xUIHz+rg+p7iuR8JRDyLiOMywumCsTru2g9GA7irsyKjLLIwmLJmTI+Z/Q/wD1qiTUUb8utzrdP8U3GmsyM6zLKm3IOQc+o7kZzWTrl2skUdzpbN5xJRNy8sOm0j19frWRDqUBty7SIZW+UKExtx0A/wAalnvZr67tZXhdI1Ix5fy4OOCP61nKSa5XsWl1L9zqzJpAhu7VYrrZuYBcgdsAduDWNNttljMU22JXOx+pI+lbNnfLbWlxLI2dQmmEfzJu3KeuSenas/V7iS5skQWyK8JKj+6fZfehpSVmyVeOxTg1UBysU6DHytnufenm/BhVcsu/BC7uN3tVN7CWaxjWzQLJHlmQjDkE5+93+lQX0DwKkQil848A424GM556c0ON9EJtJXY6/VRJFNANkzS7WKn0HOfb3qKb94uYZWjKnPCbgGrn4dRklubnzmcXFuf7w2sOPx/AV07aNK2kJeRXSjaoKxqcbg2cfiKrkSMedu5j3MsagQRSb7WJix80BcAg5zxzzXLx26X8qrBxMxxhl+UZ6cntxXUzaZJIkD3aieSRlHDlSVx90g8Yqgs32Zf31qq2t0pjBzuVcHAAI5GDVx3MZW2M1UjhvhZZUNGAHnzuCjHt1FXra5uwu3To4vsscZSRu0g6Z57nNdA2gadJpCR2h8ydo/mZcqMn1PpWho9rpsdjHCpSUQsfMJBUg8ZDZ4wDnHrVe0j1GqTZxypqDaZFNZNPHZQPll344PT6UWmozafLd6jewQy2c6mM2qf38YDgjp716rHp9nq2jauHmtbRIoBJgqP3hB4AHQj1NeY29iLaeWCaBHuLkjYo4UZPUegolELNaGNYiR41nQiDAwZHJJPsK66ymH2WCPy0ltUJxhcMPfjrWTDax28TrKwVFcghyGIIOOD9a0baXKKqRttI+XtketZSdtDop23W5Tu7eO6YvbqwIbcWzhSPTJq1o2lW12ZDII2VE8tlwOhPY+tVNRErbYtwCE847VZW48i1W3tSFRl+ZhwCw9aSn2HOKk/eNO20GxS9YMXXyonNvLI/CAc9qhWJbiKGKSPa0ih1KfLkdwfrVMatdXEUaKmWVcZHcH1PvUB1aSeRYHdowSBkck4HGaHN9BKMVubfiG1WUWMCwwfZQCFKqVMjZ6fX/CsmGP8AsjUv3fJBzuJB5qK8me8cRyS+UEA8vJxz65rPvJJIoctK7vnB44z9acpNoI22IPE002oXImkbPBbB6YrktUbZAEcgnAwq9q2/Oku4h+7wzsBknhh7+1Y15bySM7HDLvI46YrWlpuc2I10RVv1ke3gBzjGMVn+WI4zv+9n7tXnY/ddm2oMA1B9nUjzGJ57V0LzON+RTwAgAXn1r0TwMCuAePeuAhUzTLGg78AV6L4VR4JFVgRmsKzOzBq7bN7V4CYS2M8V5d4nj2Sg167qQBtiAcnFeW+LUAOfQ1lTfvG+IV6Zh6bpd/qjSDTrK4uzGAXEMZfaD646Ve/4RXxB/wBAPUf/AAGb/Cs+wvLy1k22F1cW7ykKfJkKbvTOK9Pm07TbKO/W+8W+I2n01okvGhY7FZ+MrzkgHiuq9jzLXPMr20udPna3vbeW2nUAmOVCrAEZHBorV8cWy2Xia4ginu7mNUjKT3T73lUqCHB/ukHI9qKtMhozKM+poNJSIDvmiiigAHWt7wxxdNk8Vgitjw3IEvRkcsO1RUV4s6MO7VEeqaMqqVYgc9PpW3ehFtmaPrWVoKBipHTHSt2/aP7JPFGnBAOa4EtGe4eY6xN5+oRqfU5FW/seUBKkHGaqzQSSawGwcnk/4V1FtE0kaiVeAMCh7Indtnl2uq0F+2Rg9eaoKzphkA54x7V1/jzT1iMEv8Z4NcTKHSTYeV9O9dlPY8uuvfZeDCSZEjYAqM5ra0+yIeScqMFDjHHOK5y0YQuG5JGQT7V3elXMUunxFG/epgYIyMUqjcbWKox5tGcjp7+VqQLYBUZ5PB9qfdmRjNFbKFgDlhtByp781qaxZs90zQ+WitkjA5OabIblgscxKDALhV6Y/mTVxmt0J02lYWK3BaNbl90ZUPwcZGOmK2NEtVWeFo08qG4wASOhHvVKy09bqeKOYAMEOO3WteCHyZlhLAqCFVi3A71nUlfYunBrcc1upvQuDI4O7ABBU9806ziS/vWt/lCuCULHANXLZEs5751bLODjnJBrO0dI1vozLCzxs2WYdVYdqwi9TrcVJFXVNEH2eU+fEblDgRjqwB7GorW7NpK0kUH72QxqgY5KEH5gfQV1OrCLebhXTzYxuZhxj8K5uayS7mLFpIzMwkQlf0PoK1jOza6GMoJpPqdhprtqPzwWrLJGzSu6EFcdODVvU7RftMdtIWkjlQOipklWA6Y/WsLQ7kWjGzUIkoHEYQkbT79xWgUubTUVQOwDAug3ZUH09geKvntoEY6GBpsV4Xul8lHiimRncgFs/jzg16Nostu0EXno3B2AxgKVBJJye9UdO0u1faZDGrngSZ4z6H2rUgW2hlSIEEyMUMmOMkZH4VjKTtobKCe5LcWDXNy9xOoMDpsQYyOOCfas6z0q1tpJVhk2RSMMqVyA3bg1qMRFiLfKI2UFyT8rdiAO3NUZZfsjZZozGw3KVBJ5PT61nzs3hGJXe2aG9e9tR5VxEgcRBvQ9jnke1ZsmrC4upSh3nGX6fIx7YrWvUgeNThgWOfl7cVz862EU01xFtaaHaHIOB16YqZVHJ8tgklEnhYraoZ4VkflgsnH05qM3bGVTI6hMcIpwMVPYyCS3SNWDyMS26QEnGew71fupprqG3iENkJELAM6YKqeue2PTFEU3oZNrcz57rbthSF9zAEEDPHfj+tX766vmt4Ld41FtgyRqRhs/X0qvLBZxN52Zlk27N5GQT1O3HbjimXJlmhWQTGa4f5IgxwGIGefQewqow0E59BbzVYIpbW4zKYcAsuMBxnHX2NZ+u6jatYCaQ4l3sybW5AJxj3xWm+iS3UDFI0jdwG8svlXPfgdO9c7rOlx29rJPbADKkGNs7ce2ec8VrFJaGc03qW9EhsoIfspiKXj7nMrR7mYn7q4/rWnqtpd6dJ5dpcFVmG4xSfcZSOdp9a49NXuWhjN3I0QT92GWP5nx0DfpW5pV3d3kiW2qSJGls++NWYnd6gfX8qG5R31Jioy12IrmC/nEMXkyQq/MIVicf41XltHiMK3xRLVso0aDcSSf4sdDkV02ozWEN9DDIgaJwJFOT8g7jrWZd3EMWp3VxYKHQ7nCBP8AVgY6k9c9aauwlBdCCLWLqWEw21p5joVVJWG1wFHB9OfSqX2y7ina01CIL5p80AHIY57H+ldppsIubaa6BSJpm3ybVBCjHBx+Fc9dh7stdSIgEQUF8Z3E9MA1OjeorOC0ZSkuryeeEorsGIYxIMBB/Tgd6i083ElwtyIFU5OW3Z2tnj8Kt6nbmwuJIVkkhDw7t9s+4M3YbT196oWepqZTDMhhmUFmU8c+uKvkdhe0u9S5K32i5uLi4SMEccLgPjrj8aiVdhMkRyWACgA5FU5dVljkjX5CgOVlj/hf3U8GkOsQKXaeTyZ1yJVZP4j0I9KmVJsqFaKVjbuIbba5n4ZuhPb1Oe1c1rMbxybod8jACQOOmR1GO9W576G58tZ7oeVIMjaMfnVpYyYRLGCI14JBGDURi07MucotXMG21m2cO0oZW4G0D5c/Spb+4j35NukUG3aMfeHfI+tVr6SC5nZZIVin3Ah/4GA759akuNQt8B0UysvGG/pWvKzDnTVmT6Pei6mmMqqxEYQFjkKvuPWsrV5ngnaO2Ly24O0F+ufp6VrwwNdRvc29tuD8b14Ax6+9Ubm0KF5JPwHpUOXQ3VN2uzGmaRpQXZiij5tp6f8A1qhvbqJLVjCOWHU9CanMe/T2km4jdsbhxVC7jiVwIGMkQFbJHHUnqyhCVcAsTzxg0kLEBw/IB4qW4lX5Qq81Vl3JlcYzWxzGj4Yt1m1UYHC16PaQeXMoAxnFcX4FtTJcl+uDXo0cf7xQetcmIetj08LG0R93EI4Cx9K8w8Y/ex6mvV9QVRa5z2rybxmfmGPWopfEi8R/DZywOCCCQeoIr0SS+v8A/hIooNZ0a0V9ctIo7m3a5EPnHdlZWbnymJAPP9a86jco6sMZUgjPTiu41tPDniTU5dYfxAdPa4w9xaz2rySI2ACEK8MOOOldp5Ji+Nbm7ufEdwL+yFhLAqW62oOfKRFCqM9+AOe9FM8Y6rBq+tvcWSyC1jijt4TL99kjQKGb3OM/jRTTEUjjHWkoo7UzITNANGOaRaBjqu6VIYbyNwRnIB+lUhycZ5qS2IWZc+tKWqKi7STPZPDjkRx5JA9fSupuCz2zggFQOQK4rwvMHgjBJ2kZruWX/iXZUjI/WvO6tH0Cd0cMoX+3RxhdvStuOJlclWwuO9Yc/wC61qJ25DcV0rRsqBnUYI44oWyYluzkPHYR7ePPUGvOZgVcEoDzwTXpvjJfMtcgDAOQK8+uYzKpz8o5+tdFORyYiCuU7Uq05bf5aKNwzzk+ldBociefIyrsUrkc8ZrmxmWMRbcMGAz7V0FtafZ1UpJhWGTurWolaxy0m1K5tRRLPcBpU5ILBh0Bq7qM6sYNkYEe3JUDPHrWXpV2zKxCgMSNvBwBVqV41gZhKdxyDjjFY2sdbdxsEivczOoXZuyp6k1o+SokVrraYUUExjjPoSawbVWMipblhlvvH+tdJNa/6B5s5/dpgthuWz0GPSiSb2En3JohBJEHt1xIV6E8YHeodKshFeSMXP2cSZIPrjOcVnu0l1IkjynhQERRtz2ArX0lyg3q77EVkkMh5D9MD6VPL1KjOwy6hM1pDEBGW81nYBfmUnGOfT2pmmWk6wb5FWVI5jE7gE7Rwck/WrM1kUm+1XMrSCQeYU6KQDj6ir2n30Zt2t8gW7tnPUqB0/H3qlvqPpojJhjN1qUnksyu8pQzdSqYxtA+tdOsEFvb+UqjzlCxM3J8xT1YjtxWVY3Nra65IHTy5lbPlDkMP7wPXOa1YJzqOqCJQWSVtu8kKSvXB96rluib2NyJ4IjGAUkZR5eMfwnqfr2qbUjEYYoIwq7nzuxyo6dKrPcLDYTeQqsIEKlSMMCemT3NZt5rfnXHmyRp8qCQpu4cdxxWVr7Gymlub0NnHdNtMqu2Pl7Y9wPX2qj4m057GIbG53BgR6/0pNEjJEsqKYopB5sYZ87QD0HrUmsMLfTmlwJUYn5d+QxPOM9jUuLXQ1UkZVtKtyhW4MkSA7WVRnkDkgVWlihZJbWIx7TnLZ/iIOCakt7aJFihdhG+wsQSSAc85/HiqaWri2v3jvB5LYjW3EYKucjg919jWkEupzzkxNK1a2i8m2kX7HewlYRIy7iSRhh7e3rWhqI1GRra6VwssOUeQrw3px3OK468DG6maeExSKwj+dcKccYz2NdVpt4Dbwx3MskjRYdIsZZ+xYnpgVokkYPXUvams726xXki2sroSPMjyj8E464B/GsO2gjM0cbki4hZWfD4jZff1/CtPVrVNRWaPZ5U0GPJLZy7evpjtSWV+sd1HLLujjjYRvuiEgR+vfjGaybSepvBXRvRaRM9hqOrW2+2tI3SOJd+PMyRxz+OMVVuPDkTmRrhVEg5V1c8ge5/pWjYX2nywPAwMk8hUsAcIvPDkdMjtTr67Nu9n9tkjmifAAU/eY8ZOO/NOyitDRaux55f6XBm5iRZATteKRMMAQTng9RXJW73CTSROjFY3I83O3aT79vYV7Nq+nByGikiTqdxYnK/T68fjXK6xpltd6TqBspCtvBGZvJY5JY43Dj09a0i21d6mNSlZ3Whw0V3dWV2p02585nBRiPmKr34IrqfDrveRyNPbu7mQDJ4yOmT6dquadp9rqNlC6DDFQ0jLwwwOePTiui0rTIrSeaCPYWC+bHk/JKT2PuKTa6BTpvciur9PsqpIfJeM7F2KTx6HjgVhm7aK5lEWbi3UeZIFP3QeBgVseLnijt2uILmVJnRfMQqCufT3wRXE2cglvTFcyySe6HG7247VKVmFR3RLeXUN9LEJ5DthZl2BSrAnoTjtVQyIRDdSwx3i2rlJHQkNtNXYLaIyRqTFIYyQEYYLqevP8hQtu9jFM1stvKUYDyekuDznHSttGjn2Lca6RMWuZAgU4kYYyGHsaNS0qNwt7p0CzeYpK45wvoe2ab4fuJLo3Rs44EjkZs2sihs8dq2EvraKw/sxbXbGXaYtkgqxGBsPp7Gp0a1NUmzkF0qC7iAFj5cjNtXbJj5v72Ov4Vs21pA9uDAxYInzBiSrOD3qnbSywybkk/eg7vm6irNxKv2oTWaEEKG2nuccgjpWCn0NnT5dTL120eeRNkJWQofkQYBHqKwpLJrVxEAXQ4cqBnBxyua6S8vIpJhPG+dibSuPvH09qzr6+Elyp2Eb+CG4wT/AJ61anbRmfJHc3fDtwt1Yz+REsKhsY3d+9YniqRYYPkIO/j61chnFpAWQLhiAFUcZ9c1y2uXMj3UWGyUbJPoaXLdlSqWiyXVLsSabb2kCEKo5Xs59ayzH9ktX3ExydGjZc5FW0nT7ZuJXaPmJPf6VT1i5adshQSxyPWuk8+W5QgjFzKwC428iobshDg8kVas5GiZiwCtVG8G+UYOSSapGdjuvh8n7jcwwc12+3LiuU8Hp5NpGD0rrEcEnPauCq7tnsUFaKGahhLYjJzivKPGJy4+temapLujYYwAK8v8WnMo+tVQWpnifgZj2t/cW1rdWsMipBdbBMCoOdrbhz1HPpXq91PrtncRW91430GGd0VhHJbAEAgY3fu+OPWvH0Yo6uuMqQwz7V6RPp2meLJJNfn07xLE82HuI7Sz86J2xyUcngHHcHFdh5hmeO/D+qLPe6lealY6lPbMkV59mGxoMjCFl2jg4xkUU3WPFNnc2euGO2nivb8RWkcTfcgt4guMnqznaBRQI5ikIpaQmrMhOc9eKWkpc0gAU+PqKaOue9KDwTQB6X4PlzFHhscYrv4mJt9p5z39K8z8Hv8A6LHjk16HYygRbW/KvMndSZ9BT1gmc9rcflXcUncMK6RJBJahe2M1ia6oZWJHI5FJpt6PKRWYkgYpJ+7YtrUz/E7bY2CDgdDXBSPtUsfmzwRXeauPM3iQ43A4rg7oeVNsIJUnqK1pMwxCuQ2tuGcjaAG+76jFXESSXzDvR1jBZvm6DoahMZV02nCHqT1AqeazP2ny7fbGJVycn05rpWp57vHVFqznmhQoo3dCrY6itSWPzIFOzIB+VcYy3es3TGRblBPIRGH+V1GflHtV2K7O/O5guT5Y9qlqzsbKSa1JbILExdiEBUsBjPPv71rRSNc+St1nbt2bR0b3Pt1rNhZJoy+xVIzu4qW1uWR3DxjylXGWPJ45xSi3YpxRceyjj1WN0dXjMgOQdyoAPuih5fNtZUXaWiudnmFuCM5qq8UywF9rbUj8xApxwD0PvinXLm9a3cRr5nop+U9Tg+vFVaxOtzSTUriedZDbieNCFMWNpxzyTVq1t0aOSWcmN5GLIsQHB/u49Kzru9+z3FpdQI3msu52P8WOOBUy6pvvImDhl4AJP3c5HUelSlqXzFyXTSLmK6nhlklVlWQxvyBn5T9MVPHMbW3zDEsUiynEh+bdubr7ccZpxvgYDMkuCEIZh0HPA/Opr6+NtZKIfKkSWT96CB8qnuPb2qW7M06GhZXa/Z5pYg8iB2d89GHfH9K5rVme5lYW8LPd+avkMowqrnOAP4jWs+oR2emtBaxM8OeNvUZ/z0qW+239hCLV0F1ARhCpVlY+9Jb6BHVWZJHeX0E0smxZXKGDkAEe4/wp91dpJaxwrEy4BPlucBj2Gf1rQtNKN7ZtcMqxSIhYtIeC4znb6muS1mO61F2SwjEnkDbMynaAnUY9TVuLlZDlJJFuzuFk1C1V+A0O1+c9Ock/XitA28CqLwmWaNQHwOSO+AB2rnNbvZNKAtZIfJkhyjI/yt0yCw75qydUuNX0mOH7VsCryyfKwA6LnvmpcVFkqTktA1G5swHaARs04P7tWLY5zgjv7VJokyPbkQZS4C42SxdO2Sf7tW7aa0XU4YrdZZFRViycAKe4z1PNTS2dxHa3UuyYyREIZI0wPbJP8qSd9g5bbk0xnaOJbmIcsF3IeMEdAfWsmS836d5UCkZd4yJQMMo7E/3sioo7+W+82IxyJdKpiwOAhJ/iJ61nWdrc2o+03ifard3ZJIySpDdMj1xgHNCjbVi16G3HqUMulxQJatHMBneRtCMTxz/EK0tHhlk2rLE8k0WXJ5Ko/wDeFRGASWMMkU0ckcYUMWUDdzyAaqNezrc/6KGHVAT0UdeR3NVJr5GkIu/mdaqQwFP7Tu4ka4kYbUUnYmOf1rB1i3smmKaJIMzAo4x8m3uxJ7n0pmj6ZezXL3l47OY3ysbcblA7Vr30tvbWkvkBYnu+AWXkAdealNM1a01Zy+lwrJr8lrA7AeUZG28E46jHYd66vXtSgECeaFPkJsAA689T69q5pCDqSPAu3YckqcE5GKTU7uONMsqytkjYD8yr2/GpexSikZev3U1xt28oTkgHpVLT7YWsQkljVlL8+ZgLkc1u3McLKwhjPmGPIiP8R6k1n2METEpPEysU8w5IPUdPpmqhfds56slLRIzdRgZ52LwsjOd0Xkv0HbB/pUMepLHI07GSSZgsWXcMSMdSPbmtwaQt9G0ayOkIOBngxvjsKpX2hpZqpjJMICo7EZJJPc+ta8yZhytG74YbTDIj3EvkyOfkc8FCDzWd4jmgt7tYlUtKknMqy/IY+3HY5qC0htkXy/NdJR8rKRxt9AeuajvYUhwBEpjYcHGT7bqzlKysb0k73KspCXz7fvE/Nzxirludy+ZuwG43N3H09az/ALRa28xDwy7mXDE8nPsPSpob7z1aNIkikbgxnOB6YrJLqXVlfQpXd60E0iMVEMhz2HOO9Z088RkTzXVRwAx5ya0ry284p5yb8ZP0I7Gsm9jiRA8UREgz8o5Aq1G7OdycVobOlWz316lrbMGgAZsFvlBx1J9K5vWwiX8qF96qcMQMCrVhq72L5QpJhCuVGBk+tZWoTrO7zSYEjHgDoa6FGxg5X3KDeb5rGJ9y8bgab5j/AGrOBjHaovJJ8wRvhSemaSKOQNtJGBVnO1qIJXeR8tjmoy26ZeP4gKnEQQkdc96a+FkTvz0p2uh21PRNBcJbIAecVsRSn1PWuW0Ob9yuDgVrmU7htP5V58ots9eElYu38m6M+lea+KyPtCgEGu9upgIDnIrzbX5vOvWx0Fa0Fqc2Kl7pnRlQ6lwSmRkDqR3r07xLpvifVtcS/wDDU8s2jlU+xSWtyEjgQAYUjI2Ed815h+FG5grAMwB6gZ5rqPPOl+ItxBdeK7iSCaKdxHGs80WNkswQCRlx1BbPNFR+PLS3stdjis4EgiNnbOUQcbmhUsfqSSaKAMukNLSN0rYyEope9IetQ9wDNKM/gaQDkk96kij38Z5otYdjufCG5bZD7V3NjLvQZPzVw3hoGOFcdMdK6dLkwqCMA4rzanxM96lpFF3VDuB3dAOawLW52TOowRngVZvL/cFx+IrPml8xzKqBO3FJR7Fykky1qMgkTDDk1yWpowIPHBrYe63fLjkd6yb9g8blhkgGqpp3MqjTRC/LBVYEMucGrUKx3UcAUEBDzg81iQZkJBJXFT2N0wJjiJjLdX9K6krnA5K5Ys90F7LChxiTj1//AFVpohjuVdseX0cdxWdGLYyBklLzKMlwMZradHuYD5BLFgN+ByKSeuoW0FjI+0MyszRZBOP4h6VfCKXfHlm3lAKnPIBPT61i2zOm2JfndSQc8Zrd8NPHdRNZyjEoDSDB6+gpJq5pra7LUUU9tbtFJtlVl3MGPJXPFVLOE2XkySTPiORSqsvbnjP41rrKsUDwblK7gcnkoD2z/SjUYVKBSS0XVW98cfhQN66lWMSPcRBmWJXfahY8K3X8jVe5sra4uUYK0QZsERHAOD6Va8pFeMEBV2FSCciTvj2qtHNItvZzWqKArE7z39qL32EklualvaW0iTwTlEkGdz7SNpH04qxcW1udJlS6ReB0CnOSOCPU96wbPUpPtLQTMEZpNqyZ4I6n6n2rSt5550ee4kAt5G2hQMDI6Ae9S1bc0jLm0RasNPZmjaC55wFJlfA3+pFa0dtNbzSF4JGaQZ/dkLk465rOs5bT97DgiGXDnAwWP41ci1G3At4WGZjIdoPAb0U/lnNNOJsqbSudGkuwWKyJIsJXzTluoHb+vvUY0vzYfMiiJkkG9tpGDhvzHH86z9WtZgpvEaSKDZkRjOUYDBAPcVJY3ot9JZxJ5kjNuK5IOOgH1qudXswdO6uYvijT9lw1vNB5sUu1pGHz7c+h65FYjwQWdq4WGV4HJGEOSmD1x74rsL+9CxxqrBDsDDaRlD7+9c7GyTmSJpdrudwjHp0xn3rOU7uyRHIkrieGJUUB4GVYwAG2jLZznOa6vSfEsgCW10qlwcMh6HHc155Fa3MGt3CaW4g3RlzbzEADjse/4UtrqVx9rhS/JgdOGdEA3e5JqZQk9YsKdSK0kj0PxBpVrJBLqFgJYbjIZ/Kf75z2HqK5zUxerAt3DNbyI5LLbxE7lK4DFlPTNVl16UybLOceXkYfsW/lVi8u3lhGy2gEs0mJLrfgtx049fU1XPc1nTTV0Gl6zM8bKLd45HwY3KDYOeRj0963YruAtGL0IJGcEhl4BPqa5XT5ktJVthI0XzmMGX5lznkZ9Kuap5Ztz57tKY+AUOGRj7elZtSb8hRmlr1OvutTgSJZUTy0+7jOTj19qwbyE3tzDJO5aPafLjPYf/rrOW6T7NJOZ3bJAAkO5gemAKltmkWB7klmklO1YySpVv7v0qVGTepbqxS0NaFI7SAKwQOWzhRz+J7Yz+tU9UsoCrl0QHrk8H6ZFUNUu5pIkkR/LV8b4yOpB4HqKsyXaToA6TRE8SmQnBJ7D2rRGfPdFGSyvPsca2HmXMbf3gVYE8cP6Vm6ZZz/AGiRZY3SaJdpbPLnuxHtW/qurCKARWeFx+73bu3oP51lmViskrSuZZm6njC/WraTRk7pl5mMYbbIGjLYZkOSxHeobic/Zmh/5aO4cqc9QOpHY0ARmGVd7LGMYCnOKzrwuLwrHebTgAsV3DB7GojcG7rUivXuv3M8vlu4O5VLcg+575p17eyNaRARqGOSwHWs57zzJtjxoxXPOSqsfoajghEu1ZZZd6fMY5GwCPaqavuEJJPQEimMaTOrgt90Pj9KncRwRb4Zcyn7ygZYHvUoZZJ3YNkYCgZz+VLMIxE4lYmQHjA/TNRHexU2R2sLtZT3UpJiThDnqx7Vkpe7ssV2Op+XjIH1qWabaku9mWBWG1AehrLuphDFh1Egbou7+dabsxnoijfMRfPLIu/c2SE4FUprxJ5srHhQcBfSl+Uqqhn3sckegpLy2EWCA+D3rdI43cFIB8wJu55OKfLOhUglQeg4qxB5cEIBIYkZwapNALi4BI2nsc0Db0Imbb8pPXmm26Ga4AAJIPJqa6VIht9Dip9CQNcdOM9aL2VxxjzSszoNOjeKMccVqRtwCQKs2lqvljjj1pL8xwRE8YxmuVyuz0Ix5UYWuXvlQNyBxiuFlcu7M3UmtPXr83FwVU/KDisit6ceVHDXnzSNfw/4i1Pw+87aVOsJnADkxq+cdOoOK2P+FjeKP+f+L/wGj/8AiaoeF9MsLqDUtQ1mScWGnxqzR2+PMld22qoJ4A65NWdU0OwvNHk1jwvJPJbwcXdncYM1tno2R95D64471oYmLrWq3mtag99qUoluXCqzhQuQBgcDjoKK0PG2l22ka79lsQ4h+zQS/O247njVjz9SaKAM6kPNKT6ikNbGIlGOc0UUmhoKlg3HAT15IqE9q1tHt/OyRjjtWc5WRpSjzSsddoeBCnHatO7mXbjvisixZokAGFIp19dnaeO1cFrs9lS5UJnJPNMuJmA2IrEH0qtbNJIcjjHUVp2jDGHXJNbWikcrlJyujLkVmwMbT3NVbuPZCyopJNdCbcSSYGAKqasNibVVSR3pNpFJSZyUaOj/AHxkdRU2Q83mIFUcAgd6hudyzsBjcTT3CgDavUc4rVPQ5pLWxsW2mJJd7mYKHwfLH86uwXD2Icnen8IYD3qLRguzdNyyrwT71blmSVREwLBgQD3yOhFSzSG2ot2YbnyrqAqyMRvxxgj1qzpyQxXZkjT5UXcQffuKybPzILCXkEb89OQR/jV+CQKzGQsGAwy5xkUuY1cLamwt4slrNA6xnfjEgOOex/pVRrudrkKzHy870DDjAHQ0wSo6sQudoBALY4NPS2Zoo2jyN2VHORjFJsaHyTMYxcrGXRSC6g8j3xWfPqBiljaJcwht2Mkop9cetaOnMYJZInj3iZNp7hcelU9QsRFOhijyoUNIoPQ9zThvciaIWjiupoJoHb52y4Ixh/Xnp0re3OdNSGcM8Stv2feyy8ZJ7VHBHarBKrpuLjYcj8cg1YtNtvaASu2JBh2JyPQke9VNoqlTd7j9KvLZp13YiG3YxZs49h7VpNZee6zRnpyDjrWN4esZGv2FwsbRjlQQMPz1+uK67fDHvjLGMAEgMcYHauXWx3xfchiE1pp86pJh1+ZXZt2w98exrnNQ1d2hiCSIiDGCB155JqW51gxrJEjh88AAZGfSqEMS3bCdowFIOV3cDFJNyIlZMngtpZN80rEq3yh2b7x9APT3q5EltJcRxxrtkQAu5JAGB2pkbxW6u4jEsRwCSMkD2oukNwIZ7Zgp5Eq5IZvYfSt1ojBq7HeItOjUNLHIZVhYHcVyAx7c84rCxbvDNDPK5jzwOuB3FdJP5N0kCSIrHH+pYnk+47/Wuf1S0s9zxHdE2MBSMHcOcZohK+pE1bYW5tpbe5hCwq8Uag4Xoo9T2NXtPlFvPEkgjLAkZGSrA/4VRhugGjtYSyxxDcUxhunb2rXU26ztGwQHaWHJbcD0H1HrSlEcJPY0gbeaAQ2sX2gx/KRKgy+fb+tYckL29w0MjrcKwyyy+3Qb6mgke1uP3EscAxuYI24ntip38svvBbJGD82B+I9qlScWU4KRREZtNT3SRpDCqjhWJAz/ADq5fSs7RPbRgI7fMX5XJ4DH3zSPbiWMMUYiRsCRTycf3asm1uEWOQsxQvnbnhcf1rTmvsiFTtuyC1tMyG3Ty5Z8gFyCO/cHpV1dNvArsxwu3PzEHH/1hVCe9kjbe0mxzlfk5Zh7k/zqQ3sy2khBeRNuNzH9M1HMyox11M8mZpZQxjkY/KAowMdOn9aIUSHdGRhM8Et19QKjuCsUEe8OsrnAbcRg+v0qA3vl3IWRUD54ZhkEd+tXYybRBd3GyR/Jd4ATgbehHtTIZonceezuMYO0dD70TXMUsZRhtViRgHjj0qZRFEEMQV8jLFT0PpVLuLVk98loyQpbvK7H5maRQNvpii3jR9wLlm7HqRTJSVBJQO2MgAZBJ9ams2W33s2MyYBPv6VE2XBJMlVIo4cyRqzDncBgiqVxJlx8irkZCk4/Or144L5k3Bj/AAgYAFV7aPzLrEnKLhmJHUelTFXZbMW5LSmQBQN+MrmsyaKNEfeN8mehHQVqai6nXJPs/wDqd52rjH5VDcr5rhti7wMEGtImFSDTMqPY0KtGuGJJyfSm37sFB3cY4yMior/Ecg+yqxUYDDtRPMkgxsyGAyB2NbI521YowoZmb5QAec5qdXhCbNwL+tRXNu8KgoCA3SmQQhJBvAGeSTTM7hdP+73Fec4HvUuh3H78Lg4qC7O5cA8CqtjMtu/mM3Pp61LV1YuD5ZXZ6WNQit7cFmGAOa4nxDrbXJMcLHb65rLvdTmuPlLELVAnJzWcKdtWa1cQ5aICcnPWkoorY5jZ8NazPo89xstYr20uI/KubWZSySrnIzjkEEZBFRaPqV/o2pi905GjflWjaMsjoeqMO6npirfgzxLdeGNVFzbsxt5MJcwg48xPb0YdQexq/eeOvEi3MxtNa1H7JvPlGYKG2543YGM4oAyfFesPrusvfS2iWjNHHH5KZ2qFUKMZ5xxRVLVdSvNWvWvNSuHuLlwA0j9SAMD9KKBDzy2KQ0p6mm1qnczCkpaShgHNauiTCOTBOM1k1LDIUbI69xUSjzKxcJcsro7pQ5Ttg9xUE1s7SLzxUOi3IkiVdw+ldFbwqy5YfSuB+6z142nG6KVpCwRge9SrGqxkngjkVorEq9MVSvGVYyooUrjcUkMikwmX6+tU7o7ge9PA2xAE9OagZgwIPaiTuJaI5q/I+05HUVNZvl1BQYByag1LBueePpT4cyW5AOGU8Eda3WxyP4mX2vjDJnb8+7GytCB2lichMSRJlT9aoW0SyI7MQZB91jVm3kkMqo0Z27fvetN72Eu5Wt38p4rdrgrv5bjhSfQ1qrbRWsU6XMhlnPzKqNg49aju7gW0WBDF5MgCAyLnae5rLE5uJAmRjeNu0ZJPTip3N09DfEizIskOFbb0I+7/APXrZtYzFpscwUkleSR8ue341z+mO9vdbtgWJOCJBwzfTtXQR3jmB1jAZVOWz932xVNaGavzCTSbZj5YIIIJwOpx0+lOffdI/ZgAowuM4prgmPBDcHgnsfajzP3SgOpwdo/vDPrWevQ2sipFaHBlgcOvTaBjGew96TZJ5RWeYop+Yg9R+FX7m3SB2BIVJTjHoetQmMyEvncHcE88KAKqyaJUnF6FdY7uKJWgl7fL6/StOfVWmiiju7cyXRTBlz0XvVYjJjc5+V/mB42nsfpVlUQzS/aNo4Dg9Mj2qHBLVFe0ctGZ+ZGDKjBGboFADMO9WrVPJuY4Q+UDZznnGOnvTb2J44UmGwRybVyOoHZqim3NMRsRolYFSpxiqSVgu7kl25czQzxlU9jjZjmobUylFkFwApziQryvoavPOHckRqoKg7mGATjpVeVYRC0Vu8jMw4XZnB759BQ0thKT6mmk8RaW3ktklKRkh1bDBj1IP9KziglkeKVpcuQuRkhvz6EDg1mw3UMM8TebKJyCJG5O33A71r+Wl29v5QeEvlvNc4Rz6iko8oXuXLWKdUmhliWfnbDM/DJ7gimbGmZJRJvZMqSp5+uPWl+1XFtJAk08TAE7XUZj9Oaawha7aclT8m0bDtLHrU3d9S9LWRJPI08IJVHcDGCmGY+hx0PvVQOBIyxSBmIyyFe/cD2x3pb5kuJWePKzEBXOTyOnSrVjbCK3MTxg5+5tXJOPftmqS5tBJ2M9p2XKxRuPLHAzkD6H1rQtbm6SKFZmXywNsgzyc/1p8LTwO1ssXJydrqG4+vrTWtVlEKrGRNuJOG+bFL4di/NlAlbmWaQSnG7aDj7oA9aG1CR9MFoURo+5ZtoBB4x605mOTbvEyxqeoYAH6epqK9lCLF9pQogJ2ouCUqlqZSeoks9s0LwXfJdRgqSFU9ufWo5bWNlgV1LRnoWbgfjSma0uVESOZP8AaVcHHpioJpZrO1ED5KuSFG7PFVbQnqTWel2twJhO5twg3xFlz5nPQGq1tZopkbzDgE4C8A+496fdm5u3SNHVpFXheiqAPbqau2qN5SLhSo+UY6k9zTm9Agle6K/nwoxEO4jGASME0sfEbboyqnkmTufY0XqFWwUAYL8o9frUBmaJUW4yzj+E/dH+NZbltsJLlfsu5X3leCP4s1TaSVRwo3MOTuOce1SSqrTh4gRGOSehY+g9qjnPmOFyUY9SR0pk3bK6HLeZGVJB5PfPpVa7jaZjhuPTPerMSiNXRnDZOV47+tV7t2eARg7VB6rwaaIldkA/cRNAFGepY9KoWqRtvcEs+flFWRG0khjOASOWNU2Z1kCRrtA4z3raLOeaI7iOUuzsTwcKM9KJkkZQzj5VXmphFKzgK+4nk4pt07IxjGCvHXvVN3ISMu44QkDBPYVmH35rVum3k4GAOKy2GD1oExtFFFAgooooA7D4eQtJ/a8tha293rkMCtYwzKGz8w3sqnhmC9BWlb6x8Q5LtYRbX8zZx5MlgpQ+xBXAFc54V0y1uxfahqd3PaWGnIskjW4zK7M2FVPQk9+2K2tcW9m0FtU8P69qt9pMZEdxBPMRNbE9N4BwVPZhxSGZXxAt7W28UXMdmkMXyRmaKE5jjmKAyKp9A2aKg8ZaVb6Lrf2O0aRovs8MuZCCcvGrHp7mimIoN1pO1APGDSHpWtjIQ9aKKGFMBPWkzzkUo469KTGDUDLtleNay7gTtFdfpfiCEr8zDPTrXCEDHPNOtCFm5rKdNSN6Ndw0R6MNWjYkK4z7UIfNJY5x79K5ey+aTj1FdNG2IcA9K55R5TuhUc9xlzjGFPPrVWQgRnJwwFTy/d96z7nBjOSd4rNFyZjXeBNnHJ706wDhSRzznbio5cs+TzVq3zFIrMwANdHQ5d5F+0ikjj5VQrMME1ZV2Eb9c5wCe1R2yBwrE5Oc8mrBiDK6yKXXGR9ahy1NOXQBsmt/KY53DBzzWcun+TLtk3CPcSrbclfcVoW0WyQnPOO9TskhTGRg85PY+tF7DsV9RjKW5kGC3yhZBxwO/wBa1LW4luLGITABPvdcE/XFZ728kjmJj5sbcE+lT2Sm2iW2clRnaCwBp3shcutzagRTGZEkZ/LHzbuMVWnZ2mUnZvdiVPGOBmrNmGCbFAYAYA65HvVC7CrNvVSVQnjHtzUx3saS2uXophcCLd/rpCThvYc/hUgiihilMi7YjnaFOCKpbkkjE671dFDLjtir8aR3ltERuO4Fh7mm9EStR9sqO0olCbo1Aw3O4djUFzKWisWjICs5QN/dzxg+1MmMjm3ktIxHPtKNk9AO2Kz4OVhG0soJlJccfSmlcTdtDavMqPskSqGQYL9MY9KigmjjBYxg/P8AM5H8XQgj0prvuidpGUsFzGxGOPaltZSXeSYNG0o5B75FJXRVk2XLhFjt2Esw8ogFdo4Vj2PrVaFN8rpHJErIDvYcfrViOGU2aCNQsjD5kbt6496hWGFHwzSCVhyQMKMdcikpXKsZ07TSQqqQlZV5WQ8Fx6+1SWoZJY5ZxthK8YfIDdvoatly0gDssaAlfLIz9Dj0qQWscU0TqFMTkeYVHLD6H0qm9CeVp3Q+Kdg372FQWQhRGmV929/wpWimhhjWRkCKNyjG4H645qzbXT28U0USbxn5VYZIxzmpLd4wBJ5exv4gRnk89KlSKtqZixy3RfbujeMAh+m7HpWgskv2WPZK7zAYZQMA46H3p0EEmyZJAGRzlQOMH6+o9Km8mWW3XzFLMFwDgDH+FNPsOxUtY40LyNk5XLM0m08+gpzujKvkp5agnBY/N7c+lM+0K1vJDcWmULZL45z0wTUMjKkf74lpCArZPAA6DFSl0GRXsdo0IRvN2bgQE6se5X1rPnWGCN96kTLym47ic/8A1qvXqTtGSADKrEjD8qMdcdqoJamT/UBg7DazbTkDHXNaRsZSTHx/ZDIskVwEG0kgjndjgf0qOFneBltowQBh8j5kH4/0oNhN50jgebEq4IU4PJ9O9Tv9nS1kjxI9wXAiyMMCOuatIzehDbRqr5MgXeMkdxjoM06R2AGwbJFO0DHH40GOcoxMuI5OdmepHX6VXnIcK8edvDHkkc9vrWb1NU7FmKUyIUBIDja7sMhT7VXlaNSqSM2Q4II5yB7Us4kjh8kZVHG7Abg1XnlidlSNG3FcALwSaLITlcnMpm3hFEZU8bh1FQ3BwoLAF/T096YSwXEpHyLtweoP9aqyLMJAmQ4f17UMkYCFDFzvfOdw6Co7x8s22PdFwN4qQhos7SM9GX1qAs+cdMclCeKES7lZGXLmQEY4zUbkq2Bgr13GgFhIzk4jbgiopIisQJLBi33T6etaxZlJDpGCTI6enY1BKnmHcwKjsD3FOjdpH27chRjI71LcI7oN3AC07kpGTdbRG23vWSe1ad24Clccj0rMNUZS3EooooAKKKKANnw5rf8AZD3Uc9pFfWF3GI7m2kJUOAcghhyrAjINRaHrVzomotdWQQpIrRywSDdHLG3VGHcYqx4X0mHUZp573zTZ2wXdHDjzJpHO1Ilz0LHv2ANbkVvZ3F/qGnT+H7FEslZpPsd2xuAq/eKMzFZCoySMdjQBgeLNaXX9Za/jtVtFMUcYhV9wXYgXg+nFFVtd046XqclsJVniwskUyjAkjYBlbHbII4ooAY3X601uxp7daY3QVsZB1oNHek71LYC00HmnUyjcYppEO2QGimSdqQ1udDp0oDD1roYJMrknArltPOfLroIPuiuSod9LYtyHjJrNvCBuxzVyf7tZtz941nFG72M/O195GRU6qJjuYcdhVef+H61ctuUraWxzLcvROGiCxk4xjI7VdidzuBb7g4wO1VLH7n4Vb3HCc9jWTNkHDSrIpxu+9z2q7CyLKyysNoGfrVIAGI5A5xU64KqCBjHpSZUUOjXhwjtt/vHjHt71aEsEPl7omwGBywz/AJzWbk/a+pxxwelamT5L554PWmndj2RoJqHyM6KQCTuwnSqN7E12gMYx6bjgn/8AXVmwJ2ovVS3IPOacGK3TKD8u7pVbMTV0UYrLzN8a/u+CDg5HPat21txGbWGNFxGCG5zgf/rqoP8AWA981ZlULaTuow5HUUTFFWHXEDPK4hUICwYd8c96zBDHazIxZlGCi45+fPNasDM1vcsWO7C859qogA9efm71KdhtE8+jzRM0Lk/6RtwT04OTimyxQQ+f5j4CYC/0pRNK7Lvkc7GwuT0Ge1Vr5jJ5m87unWkncqxoLIIEjFw3yAfNs6j0xSnfJZt5pDtkYyecjp+lVi7PJ85z8o61Daswac7j1z174oQbk8xRJFEiZMrYBBxg9v8A9VW1aSElSwAjIVhw2B2Of6VThYmNieTtB5559aldRmPgfOhLe9XuA6TM0skYAAX7rD5QR6CpreQLGWjjDsh6gnj1qgjMJY/mY/u16nPenGR2CgsQM844zRa4XLysAR9mjbJDHaeVGehHpUrsGg3ZUhvvRoCQOOtJ5MezftwxAycnmmwDCkLwAvGOMVDVgvcaYBHG3mxyLGDvCEZLD2rPmAlZn5CDkbuDkdKtvl1R2LF8dc1V3tNdytKSxQALntV6i6kwVXZkjO7dgyNjkHFVpikjFUfO1AECtg4pT8m4JlRgdOKoLGr4ZgSxYjOaEDJYml+0sJnwhG4d9vHfFWJiypHIcLswpbr+NRxgf2tJGOE8sHA9abDLI1wULkqcZHai7Fa5WuG2TFiu6Jjkt0UZ74qPfHArRRBi2Rg57VdufmR2IBO8jp2rL1E5mt+2EHTiqJejsPDyNGYlJ8rPykDofeoJwscRUHcVOFdT+dTXA/eY5wVGRmqtsP3DjsDx+dJgLtWJAszEMTkZPJFNIYnDEDGaWQ7lZm5IAwTTXHT60hWKhBdyHypXkY/ipr7mT5o9xPJxUzgEE98VEmSQCTwKa1IKLR5DliVXPC+gqC63bSVbAXj1zVpwPPNVLobVJXjmrRDFjfyYwg7ck1FPK5YvuO09BUsX+pc9zVeX7gqzN6Io3THGR3rPNaF192s9utUZdRKKKKACiiigDqPBN9HDJPZvPFbzPLDdWs0xxGJ4mJVXPZWBYZ7HFdFb6KtjfTX9ro9/YzlXCzX06C0td4IZxIOZAATgd/evNqXJKhSxKjoCeBSA1fE97b3uqf6CWazt4Y7aFmGC6IoXcR2zgnHvRWRRTA//2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Fluctuant nodules and areas of scarring alopecia are present on the scalp.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Dissecting cellulitis of the scalp",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 377px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Extensive scarring in a patient with dissecting cellulitis of the scalp.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_7_16506=[""].join("\n");
var outline_f16_7_16506=null;
var title_f16_7_16507="Pelvic muscle exercises PI";
var content_f16_7_16507=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F81507&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F81507&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Pelvic muscle exercises",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        Identify the correct muscles to contract. Women can do this by placing a finger in the vagina and squeezing the muscles around their finger. Another way is for a woman to imagine that she is sitting on a marble. Imagine using the vaginal muscles to gently lift the marble off the chair. The muscles of the buttocks, abdomen, and thighs should not be used.",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        Second, hold the pelvic muscle contraction approximately 8 to 10 seconds, and then relax the muscles; adequate relaxation is as important as contraction. In the beginning, it may not be possible to hold the contraction for more than one second. Perform 8 to 12 contractions followed by relaxation three times. Try to do this every day, but no less than three or four times a week. The exercise regimen should be continued for at least 15 to 20 weeks.",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        Over time, try to hold the contraction harder and for a longer time. These exercises need to be continued indefinitely to have a lasting effect, similar to other forms of exercise.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        In patients whose muscles are weak, the exercises should initially be done while lying down. As the muscles become stronger, the exercises may be done while sitting or standing. The muscles should be contracted during activities that can cause urine leakage, such as during physical exercise, lifting, coughing or sneezing.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_7_16507=[""].join("\n");
var outline_f16_7_16507=null;
var title_f16_7_16508="Differential diagnosis of viral CNS infection";
var content_f16_7_16508=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F77933&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F77933&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Potentially treatable diseases mimicking viral CNS infection",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Infectious",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Tuberculosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Partially treated bacterial meningitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Listeria meningitis (occasionally)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Spirochetal infection (syphilis, Lyme disease, leptospirosis)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Rocky Mountain spotted fever",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fungal infection (cryptococcosis, coccidioidomycosis, histoplasmosis)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mycoplasma pneumoniae",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Parameningeal infection (brain abscess, epidural or subdural abscess)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Amebic infection",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Trypanosomiasis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Toxoplasmosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cerebral malaria (Plasmodium falciparum)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Disseminated cat-scratch disease (Bartonella henselae)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Whipple's Disease (Tropheryma whipplei)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Legionellosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Noninfectious",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Tumor (meningeal or parenchymal)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Dural venous sinus thrombosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sarcoidosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cerebral vasculitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Behcet's disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Drug-induced meningitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Nonsteroidal antiinflammatory drugs",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Sulfa drugs",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Antithymocyte globulin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Intravenous immune globulin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Migrainous syndromes with pleocytosis",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_7_16508=[""].join("\n");
var outline_f16_7_16508=null;
var title_f16_7_16509="Diagnostic algorithm of parkinsonism";
var content_f16_7_16509=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F79095&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F79095&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Diagnostic algorithm of parkinsonism",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\">",
"        Corticobasal degeneration",
"       </td>",
"       <td class=\"subtitle1\">",
"        Progressive supranuclear palsy",
"       </td>",
"       <td class=\"subtitle1\">",
"        Parkinson disease",
"       </td>",
"       <td class=\"subtitle1\">",
"        Multiple system atrophy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Age at onset, y",
"        </strong>",
"       </td>",
"       <td>",
"        60-75",
"       </td>",
"       <td>",
"        65-75",
"       </td>",
"       <td>",
"        65-80",
"       </td>",
"       <td>",
"        50-60",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Resting tremor",
"        </strong>",
"       </td>",
"       <td>",
"        No",
"       </td>",
"       <td>",
"        No",
"       </td>",
"       <td>",
"        Characteristic",
"       </td>",
"       <td>",
"        Sometimes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Action tremor",
"        </strong>",
"       </td>",
"       <td>",
"        Sometimes",
"       </td>",
"       <td>",
"        No",
"       </td>",
"       <td>",
"        Sometimes",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Asymmetry",
"        </strong>",
"       </td>",
"       <td>",
"        Characteristic",
"       </td>",
"       <td>",
"        No",
"       </td>",
"       <td>",
"        Sometimes early",
"       </td>",
"       <td>",
"        No",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Dystonia",
"        </strong>",
"       </td>",
"       <td>",
"        Focal",
"       </td>",
"       <td>",
"        Axial",
"       </td>",
"       <td>",
"        Sometimes",
"       </td>",
"       <td>",
"        Bilateral",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Memory",
"        </strong>",
"       </td>",
"       <td>",
"        Sometimes",
"       </td>",
"       <td>",
"        Sometimes",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"       <td>",
"        No",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Aphasia",
"        </strong>",
"       </td>",
"       <td>",
"        Often",
"       </td>",
"       <td>",
"        Dysarthria",
"       </td>",
"       <td>",
"        No",
"       </td>",
"       <td>",
"        Dysarthria",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Apraxia",
"        </strong>",
"       </td>",
"       <td>",
"        Characteristic",
"       </td>",
"       <td>",
"        Sometimes",
"       </td>",
"       <td>",
"        No",
"       </td>",
"       <td>",
"        No",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Alien hand",
"        </strong>",
"       </td>",
"       <td>",
"        Characteristic",
"       </td>",
"       <td>",
"        No",
"       </td>",
"       <td>",
"        No",
"       </td>",
"       <td>",
"        No",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Behavior",
"        </strong>",
"       </td>",
"       <td>",
"        Disinhibited",
"       </td>",
"       <td>",
"        Apathetic",
"       </td>",
"       <td>",
"        Impulsive",
"       </td>",
"       <td>",
"        No",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Cognitive",
"        </strong>",
"       </td>",
"       <td>",
"        Parietal",
"       </td>",
"       <td>",
"        Slowing",
"       </td>",
"       <td>",
"        Dysexecutive",
"       </td>",
"       <td>",
"        No",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Autonomic",
"        </strong>",
"       </td>",
"       <td>",
"        No",
"       </td>",
"       <td>",
"        No",
"       </td>",
"       <td>",
"        Some",
"       </td>",
"       <td>",
"        Characteristic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Gaze palsy",
"        </strong>",
"       </td>",
"       <td>",
"        Often",
"       </td>",
"       <td>",
"        Characteristic",
"       </td>",
"       <td>",
"        No",
"       </td>",
"       <td>",
"        No",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Pseudobulbar",
"        </strong>",
"       </td>",
"       <td>",
"        No",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"       <td>",
"        No",
"       </td>",
"       <td>",
"        No",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Falls",
"        </strong>",
"       </td>",
"       <td>",
"        Later",
"       </td>",
"       <td>",
"        Yes",
"       </td>",
"       <td>",
"        Later",
"       </td>",
"       <td>",
"        Ataxic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Course",
"        </strong>",
"       </td>",
"       <td>",
"        Faster",
"       </td>",
"       <td>",
"        Faster",
"       </td>",
"       <td>",
"        Slower",
"       </td>",
"       <td>",
"        Faster",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Kertesz A, Fealey RD, Keegan BM, Parisi JE. A 74-year-old woman with progressive right-hand tremor and inability to use her right side. Neurology 2009; 73:1399. Copyright &copy; 2009 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_7_16509=[""].join("\n");
var outline_f16_7_16509=null;
var title_f16_7_16510="AGEP inducing drugs 1";
var content_f16_7_16510=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F86916%7EDERM%2F86917&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F86916%7EDERM%2F86917&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Antimicrobials most frequently reported as cause of acute generalized exanthematous pustulosis (AGEP)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Antibiotics",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Aminopenicillins",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Macrolides",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Cephalosporins",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Quinolones",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Tetracyclines",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Chloramphenicol",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Clindamycin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Gentamicin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Isoniazid",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Lincomycin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Metronidazole",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Trimethoprim/sulfamethoxazole",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Telavancin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent2\">",
"        Vancomycin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Antimycotics",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Amphotericin B",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Fluconazole",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Griseofulvin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Itraconazole",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Ketoconazole",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Nystatin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Terbinafine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Other antimicrobials",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        (Hydroxy-)chloroquine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Diaphenylsulfone",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Nifuroxazide",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Pyrimethamine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Protease inhibitors",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Non-antimicrobial drugs reported as cause of acute generalized exanthematous pustulosis (AGEP)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Acarbose",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Acetylsalicylic acid",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Allopurinol",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Allylisopropylacetylurea",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Amoxapine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Azathioprine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bamiphylline",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bleomycin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Boldoflorine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Buphenine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bufexamac",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Calcium channel blockers",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Carbamazepine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Carbimazole",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Carbutamide",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Celecoxib",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Chemotherapy (high dose)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Chromium picolinate",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cimetidine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Clemastine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Clobazam",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Clopidogrel",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Clozapine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Contrast media",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Corticosteroids",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cytarabine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Dalteparin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Dextropropoxyphene",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Disulfiram",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Docetaxe",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Enalapril",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Eperisone hydrochloride",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Epoetin alpha",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Eprazinon",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Etoricoxib",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Etodolac",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fenoterol",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fluindione",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Furosemide",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Gefitinib",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Herbal medications",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hydrochlorothiazide",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ibuprofen",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Icodextrin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Illicit street drugs",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Imatinib",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Isotretinoin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Laquer chicken",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Meladinine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mercury",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Metamizole",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Methylphenidate",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Milk Thistle Tea",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Morphine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Nadoxolol",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Nifedipine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Nimesulide",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Omeprazole",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Paracetamol (acetaminophen)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pemetrexed",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Phenytoin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Piperazine ethionamate",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Propaphenone",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Prostaglandin E1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pseudoephedrine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        PUVA",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Quinidine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ranibizumab (intravitreal)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ranitidine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Rhus (lacquer)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sennoside",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sertraline",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Simvastatin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Spider bites",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sulbutiamine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sulfasalazine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Teicoplanin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Terazosin hydrochloride",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Tetrazepam",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Thalidomide",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Thallium",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ticlopidine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Topical agents",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vaccines",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Valdecoxib",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_7_16510=[""].join("\n");
var outline_f16_7_16510=null;
var title_f16_7_16511="Sinus biopsy 1A answer";
var content_f16_7_16511=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F53937&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F53937&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Mucor from sinus biopsy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 359px; height: 240px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Lactophenol-blue wet mount of sinus biopsy specimen (x400) shows large, irregular, non-septate hyphae which are characteristic of Mucor, Rhizopus, or other zygomycetes. Mucor was identified from this specimen on Sabouraud's agar.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Harriet Provine.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f16_7_16511=[""].join("\n");
var outline_f16_7_16511=null;
